pancreatic cancer (Cancer)
Information
- Disease name
- pancreatic cancer
- Disease ID
- DOID:1793
- Description
- "An endocrine gland cancer located_in the pancreas." [url:http\://en.wikipedia.org/wiki/Pancreatic]
Disease area statistics
Chromosome band
| Gene symbol | Chromosome | Start | Stop | The number of variant |
|---|---|---|---|---|
| TP53 | 17 | 7,668,421 | 7,687,490 | 24 |
| KRAS | 12 | 25,205,246 | 25,250,929 | 18 |
| CDKN2A | 9 | 21,968,056 | 21,974,866 | 10 |
| SMAD4 | 18 | 51,030,209 | 51,085,042 | 4 |
| MSH2 | 2 | 47,403,156 | 47,483,223 | 4 |
| CTNNB1 | 3 | 41,220,551 | 41,239,888 | 4 |
| CDKN2B-AS1 | 9 | 21,994,778 | 22,039,498 | 2 |
| FLCN | 17 | 17,212,212 | 17,237,168 | 2 |
| KDM6A | X | 44,873,188 | 45,112,779 | 2 |
| NF1 | 17 | 31,094,977 | 31,377,675 | 2 |
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03520790 | Active, not recruiting | Phase 1/Phase 2 | Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer | December 5, 2018 | July 1, 2024 |
| NCT04241276 | Active, not recruiting | Phase 2 | A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer | April 30, 2020 | May 29, 2025 |
| NCT04332653 | Active, not recruiting | Phase 1/Phase 2 | NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors | June 10, 2020 | March 31, 2025 |
| NCT04503265 | Active, not recruiting | Phase 1/Phase 2 | A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies | August 12, 2020 | January 2025 |
| NCT02568267 | Active, not recruiting | Phase 2 | Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) | November 19, 2015 | April 1, 2025 |
| NCT03699319 | Active, not recruiting | Phase 1/Phase 2 | CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer | December 7, 2018 | September 23, 2024 |
| NCT00582647 | Active, not recruiting | Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract | March 2000 | December 2024 | |
| NCT04476537 | Active, not recruiting | N/A | RNA Precision Oncology in Advanced Pancreatic Cancer | August 10, 2018 | August 2024 |
| NCT03621644 | Active, not recruiting | N/A | Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer | January 1, 2019 | January 2027 |
| NCT05438927 | Active, not recruiting | N/A | Early Supportive Care and Nutritional Support in Adults With Pancreatic Cancer | July 15, 2022 | July 2024 |
| NCT05292859 | Active, not recruiting | Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs | October 1, 2022 | June 2039 | |
| NCT02919787 | Active, not recruiting | Phase 2/Phase 3 | Nordic Pancreatic Cancer Trial (NorPACT) - 1 | September 2016 | April 30, 2026 |
| NCT05311618 | Active, not recruiting | Phase 1 | Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors | May 11, 2022 | June 2025 |
| NCT04862260 | Active, not recruiting | Early Phase 1 | Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma | October 4, 2021 | December 31, 2026 |
| NCT04883450 | Active, not recruiting | PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic Cancer | February 1, 2021 | June 30, 2025 | |
| NCT04763642 | Active, not recruiting | N/A | The Comparison of Miniinvasive and Open Pancreaticoduodenectomy for Cancer Pancreaticobiliary Zone | January 1, 2020 | January 1, 2025 |
| NCT02723331 | Active, not recruiting | Phase 2 | Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates | December 30, 2016 | May 2024 |
| NCT03553004 | Active, not recruiting | Phase 2 | Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 Trial | January 22, 2019 | February 1, 2025 |
| NCT03829501 | Active, not recruiting | Phase 1/Phase 2 | Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancer | January 28, 2019 | August 5, 2024 |
| NCT05436704 | Active, not recruiting | Is One Pass Enough for the Diagnosis of the Pancreatic Masses During EUS-FNB? | June 21, 2022 | June 30, 2024 | |
| NCT02581215 | Active, not recruiting | Phase 2 | Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer | August 2016 | December 2023 |
| NCT03572400 | Active, not recruiting | Phase 2 | Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic Cancer | November 29, 2018 | December 31, 2024 |
| NCT03623464 | Active, not recruiting | N/A | RCT of Mobile Apps & FitBit v. Usual Care | May 31, 2017 | February 2025 |
| NCT04931069 | Active, not recruiting | N/A | Correlation Between Complications After Pancreaticoduodenectomy and Microbiota | August 6, 2021 | December 31, 2023 |
| NCT03586869 | Active, not recruiting | Phase 1/Phase 2 | QUILT-3.080: NANT Pancreatic Cancer Vaccine | July 28, 2018 | December 2019 |
| NCT04398446 | Active, not recruiting | Phase 2 | Effect of Hemp-CBD on Patients With CIPN | May 27, 2020 | April 1, 2023 |
| NCT02206360 | Active, not recruiting | Pancreatic Cancer Early Detection Program | April 2014 | June 2024 | |
| NCT01781728 | Active, not recruiting | Phase 2 | Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma | January 1, 2013 | December 2024 |
| NCT01595321 | Active, not recruiting | N/A | Pancreatic Tumor Cell Vaccine (GVAX), Low Dose Cyclophosphamide, Fractionated Stereotactic Body Radiation Therapy (SBRT), and FOLFIRINOX Chemotherapy in Patients With Resected Adenocarcinoma of the Pancreas | October 29, 2012 | September 2024 |
| NCT01351103 | Active, not recruiting | Phase 1 | A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands | December 1, 2011 | June 18, 2024 |
| NCT04068896 | Active, not recruiting | Phase 1/Phase 2 | Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy | October 16, 2019 | January 2025 |
| NCT06334458 | Active, not recruiting | N/A | Epigenomic and Machine Learning Models to Predict Pancreatic Cancer | February 3, 2023 | December 31, 2024 |
| NCT04383210 | Active, not recruiting | Phase 2 | Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors | September 29, 2020 | March 2025 |
| NCT00526578 | Active, not recruiting | Pancreatic Cancer Genetic Epidemiology (PACGENE) Study | June 19, 2002 | June 2025 | |
| NCT04421820 | Active, not recruiting | Phase 1/Phase 2 | BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours | August 28, 2020 | September 30, 2024 |
| NCT04205227 | Active, not recruiting | Phase 1/Phase 2 | ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors | February 18, 2020 | March 31, 2026 |
| NCT04164069 | Active, not recruiting | Phase 1 | Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab | September 2, 2020 | December 31, 2023 |
| NCT01580241 | Active, not recruiting | Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic Cancer | October 2010 | December 2024 | |
| NCT02921022 | Active, not recruiting | N/A | Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma | October 2016 | October 2024 |
| NCT03192462 | Active, not recruiting | Phase 1/Phase 2 | TAA Specific Cytotoxic T Lymphocytes in Patients With Pancreatic Cancer | January 18, 2018 | May 1, 2027 |
| NCT05519605 | Active, not recruiting | Bile Duct Drainage After ERCP Failure: EUS-BD vs PTBD | August 1, 2022 | July 1, 2024 | |
| NCT03875820 | Active, not recruiting | Phase 1 | Phase I Trial of Defactinib and VS-6766. | December 12, 2017 | October 31, 2023 |
| NCT03797326 | Active, not recruiting | Phase 2 | Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005) | February 12, 2019 | December 20, 2024 |
| NCT02745847 | Active, not recruiting | N/A | Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic Cancer | May 2016 | December 2023 |
| NCT04404595 | Active, not recruiting | Phase 1/Phase 2 | Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers | October 23, 2020 | September 1, 2035 |
| NCT03552718 | Active, not recruiting | Phase 1 | QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers. | August 10, 2018 | December 30, 2025 |
| NCT03819387 | Active, not recruiting | Phase 1 | A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer | March 18, 2019 | August 2024 |
| NCT03382340 | Active, not recruiting | Phase 1/Phase 2 | IMX-110 in Patients With Advanced Solid Tumors | February 15, 2018 | December 31, 2023 |
| NCT04731467 | Active, not recruiting | Phase 1/Phase 2 | A Study of CM24 in Combination With Nivolumab in Adults With Advanced Solid Tumors | March 19, 2021 | January 2025 |
| NCT04544046 | Active, not recruiting | N/A | Supportive Oncology Care At Home RCT | September 16, 2020 | December 31, 2024 |
| NCT05102500 | Active, not recruiting | Second Opinions in Oncology | May 14, 2021 | June 2024 | |
| NCT03256201 | Active, not recruiting | N/A | Exercise and Nutrition to Improve Pancreatic Cancer Outcomes | February 1, 2016 | August 30, 2024 |
| NCT05251233 | Active, not recruiting | Phase 2 | Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy | April 21, 2022 | June 30, 2024 |
| NCT03060720 | Active, not recruiting | Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy | February 24, 2017 | February 2026 | |
| NCT02481635 | Active, not recruiting | Phase 1/Phase 2 | A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer | July 2016 | June 2024 |
| NCT03775525 | Active, not recruiting | Phase 1 | Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer | March 1, 2019 | December 2023 |
| NCT05196334 | Active, not recruiting | Pharmacotyping of Pancreatic Patient-derived Organoids | July 1, 2021 | December 31, 2024 | |
| NCT03269994 | Active, not recruiting | Phase 3 | Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy? | November 21, 2017 | August 28, 2024 |
| NCT03678883 | Active, not recruiting | Phase 2 | 9-ING-41 in Patients With Advanced Cancers | January 4, 2019 | November 2025 |
| NCT05194735 | Active, not recruiting | Phase 1/Phase 2 | Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors | April 4, 2022 | November 30, 2024 |
| NCT04447092 | Active, not recruiting | Phase 2 | Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer | July 1, 2020 | December 31, 2025 |
| NCT04152018 | Active, not recruiting | Phase 1 | Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. | November 13, 2019 | August 30, 2024 |
| NCT03329248 | Active, not recruiting | Phase 1/Phase 2 | QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy | November 6, 2017 | December 2020 |
| NCT05169437 | Active, not recruiting | Phase 2 | Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors | March 15, 2022 | January 1, 2025 |
| NCT03523312 | Active, not recruiting | Phase 2 | Use of High-dose Radiation Therapy Plus Chemotherapy to Improve the Likelihood of Surgical Treatment in Patients With Locally Advanced Pancreatic Cancer | April 30, 2018 | April 2025 |
| NCT04431076 | Active, not recruiting | Patient Reported Outcomes Measures to Predict Pancreatic Surgery Outcomes | May 7, 2020 | June 30, 2024 | |
| NCT05014776 | Active, not recruiting | Phase 2 | Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer | August 22, 2022 | April 3, 2025 |
| NCT03563248 | Active, not recruiting | Phase 2 | Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer | August 10, 2018 | June 2027 |
| NCT04662112 | Active, not recruiting | Phase 1/Phase 2 | Liposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic Adenocarcinoma | June 15, 2021 | December 30, 2024 |
| NCT02955940 | Active, not recruiting | Phase 2 | An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib | November 30, 2016 | December 31, 2024 |
| NCT04427761 | Active, not recruiting | A Study of the Life Changes Experienced by Patients With Pancreatic Cancer | June 5, 2020 | June 2024 | |
| NCT02293954 | Active, not recruiting | N/A | Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer | November 11, 2015 | December 30, 2024 |
| NCT05658679 | Active, not recruiting | Radiomics in Pancreatic Cancer | January 2016 | December 2024 | |
| NCT03033927 | Active, not recruiting | Predicting Effective Therapy in Pancreatic Cancer | January 24, 2017 | January 24, 2025 | |
| NCT02791334 | Active, not recruiting | Phase 1 | A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors | June 29, 2016 | July 2024 |
| NCT03187951 | Active, not recruiting | N/A | PancFit: Multimodal Exercise During Preoperative Therapy for Pancreatic Cancer | June 13, 2017 | December 31, 2026 |
| NCT05083780 | Active, not recruiting | Phase 1 | Hydroxychloroquine and Chlorphenesin Carbamate in Combination With mFOLFIRINOX in Pancreatic Cancer | November 30, 2021 | December 2024 |
| NCT04634539 | Active, not recruiting | Phase 1 | Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer | May 13, 2021 | July 6, 2025 |
| NCT03902600 | Active, not recruiting | Moderately Hypofractionated Photon and Proton Chemoradiotherapy as Definitive or Neoadjuvant Therapy in Non-metastatic Pancreas Cancer With Assessment of Treatment Response Utilizing Molecular Biomarkers | May 10, 2018 | May 15, 2035 | |
| NCT04361162 | Active, not recruiting | Phase 2 | Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer | May 18, 2020 | October 2026 |
| NCT05182112 | Active, not recruiting | Phase 1 | Radiation Therapy (RT) and Chemotherapy for the Treatment of Pancreatic Cancer With Homologous Recombination Deficiency That Has Spread to the Liver | December 20, 2021 | December 2024 |
| NCT03816163 | Active, not recruiting | Phase 2 | A Study to Assess the Efficacy and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma | March 15, 2019 | April 30, 2025 |
| NCT03086642 | Active, not recruiting | Phase 1 | Study of Talimogene Laherparepvec (T-VEC) in Pancreatic Cancer | November 16, 2017 | April 2026 |
| NCT02643498 | Active, not recruiting | Phase 1 | A Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) After Induction Chemotherapy for Locally Advanced Pancreatic Cancer | December 2015 | December 2024 |
| NCT03601923 | Active, not recruiting | Phase 2 | Niraparib in Patients With Pancreatic Cancer | August 22, 2018 | February 28, 2025 |
| NCT03997968 | Active, not recruiting | Phase 1/Phase 2 | A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors | October 9, 2019 | December 30, 2024 |
| NCT05689138 | Active, not recruiting | Using Digestive Microbial Information to Enhance the Early Detection of Pancreatic Cancer | September 1, 2020 | December 30, 2023 | |
| NCT04245644 | Active, not recruiting | Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study | March 2, 2019 | December 31, 2024 | |
| NCT01088789 | Active, not recruiting | Phase 2 | A Trial of Boost Vaccinations of Pancreatic Tumor Cell Vaccine | April 20, 2010 | August 2024 |
| NCT03851133 | Active, not recruiting | Florida Pancreas Collaborative Next Generation Biobank | March 4, 2019 | September 1, 2024 | |
| NCT05043532 | Active, not recruiting | N/A | Randomized Trial for Optimal Number of Passes Required for Molecular Profiling During EUS-FNB of Pancreatic Cancer | August 18, 2021 | June 30, 2023 |
| NCT04137536 | Active, not recruiting | Phase 1 | A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer | October 17, 2019 | April 2025 |
| NCT05451849 | Active, not recruiting | Phase 1/Phase 2 | A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer | June 21, 2022 | October 30, 2028 |
| NCT03434678 | Active, not recruiting | Phase 3 | Use of Epidurals Intraoperatively for Patients Undergoing Pancreas Resection | January 30, 2018 | January 2025 |
| NCT04660929 | Active, not recruiting | Phase 1 | CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | February 2, 2021 | December 31, 2024 |
| NCT04883775 | Active, not recruiting | Phase 1 | Study of a New Technique for Imaging Pancreatic Cancer | May 10, 2021 | May 2025 |
| NCT03351296 | Active, not recruiting | Phase 2 | Two Chemotherapy Regimens Plus or Minus Bevacizumab | June 26, 2018 | December 2028 |
| NCT05546476 | Active, not recruiting | Phase 2 | Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15 | November 21, 2022 | April 30, 2025 |
| NCT04161755 | Active, not recruiting | Phase 1 | Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery | December 13, 2019 | November 11, 2024 |
| NCT04390399 | Active, not recruiting | Phase 2 | Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer | July 21, 2020 | September 30, 2024 |
| NCT05052723 | Active, not recruiting | Phase 2 | Cabozantinib and Pembrolizumab in Metastatic Pancreas | January 4, 2022 | December 19, 2024 |
| NCT04825288 | Active, not recruiting | Phase 1/Phase 2 | XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer | May 27, 2021 | May 10, 2024 |
| NCT03631173 | Active, not recruiting | N/A | Monitoring of patIents With Microdialysis Following Pancreaticoduodenectomy | April 2, 2019 | December 31, 2025 |
| NCT00786058 | Approved for marketing | A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003 | |||
| NCT04566393 | Available | Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies | |||
| NCT05974410 | Available | Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients | |||
| NCT03906331 | Available | Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation | |||
| NCT04100694 | Available | Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor | |||
| NCT04091295 | Available | BLESSED: Expanded Access for DeltaRex-G for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast | |||
| NCT03207724 | Completed | Phase 1 | Study of Onivyde and 5-FU in Combination With Xilonix for Pancreatic Cancer With Cachexia | October 16, 2017 | October 27, 2020 |
| NCT02200055 | Completed | N/A | Using Electrical Bioimpedance Assessments to Estimate Perioperative Total Body Water and Postoperative Fluid Need | May 2012 | July 2015 |
| NCT01995240 | Completed | N/A | Functional Magnetic Resonance Imaging of Pancreatic Cancer: a Feasibility and Reproducibility Study | April 2013 | February 2017 |
| NCT00582699 | Completed | Depression, Cytokines and Pancreatic Cancer | November 2005 | April 2014 | |
| NCT03302637 | Completed | Oral Microbiome and Pancreatic Cancer | December 1, 1992 | December 1, 2010 | |
| NCT01935453 | Completed | Phase 1 | A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat Cancer | May 2012 | |
| NCT00551096 | Completed | Phase 1 | Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors | October 2007 | May 2013 |
| NCT01488513 | Completed | Phase 1 | ABC294640 in Treating Patients With Advanced Solid Tumors | August 2011 | July 2015 |
| NCT02162823 | Completed | Clinical Trial of Pancreatic Cancer in Stockholm. | May 2007 | February 2017 | |
| NCT00125021 | Completed | Phase 2 | Tarceva and Capecitabine for Pancreatic Cancer | October 2003 | September 2008 |
| NCT03403049 | Completed | Phase 1 | Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer | April 1, 2016 | July 9, 2019 |
| NCT02841436 | Completed | N/A | A Clinical Research About Using Irreversible Electroporation to Treat Locally Advanced Pancreatic Cancer | November 2012 | May 27, 2020 |
| NCT00320749 | Completed | Phase 1 | Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer | December 2005 | January 2011 |
| NCT00004910 | Completed | Phase 1/Phase 2 | Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction | January 2000 | February 2003 |
| NCT00679913 | Completed | Phase 3 | Standardization of Surgery on the Pancreatic Cancer | November 2005 | December 2013 |
| NCT02670265 | Completed | N/A | Parenteral Nutrition in Patients With Biliopancreatic Mass Lesions | June 2012 | February 2014 |
| NCT03404661 | Completed | Optical and Biochemical Biomarkers in Early Pancreatic Cancer | January 11, 2018 | March 10, 2022 | |
| NCT00033735 | Completed | Phase 3 | Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer | January 2000 | |
| NCT00003591 | Completed | Phase 2 | Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer | November 1998 | October 2005 |
| NCT02245217 | Completed | N/A | Multi-Tracer PET Prediction and Assessment of Response to Gemcitabine in Pancreatic Cancer Patients | December 12, 2014 | March 17, 2016 |
| NCT02648282 | Completed | Phase 2 | Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer | July 18, 2016 | June 1, 2022 |
| NCT00743379 | Completed | Phase 1/Phase 2 | Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors | August 2008 | March 2014 |
| NCT05350384 | Completed | An Unusual Association Between Pancreatic Cancer and Purtscher-like Retinopathy | June 18, 2021 | November 1, 2021 | |
| NCT03614910 | Completed | Ablation of Unresectable Locally Advanced Pancreatic Cancer With Irreversible Electroporation (IRE) System | May 15, 2018 | May 1, 2021 | |
| NCT00465725 | Completed | Phase 1 | A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors | April 2007 | July 2009 |
| NCT01384617 | Completed | N/A | Trial Assessing Roux-en-Y Anastomosis of the Pancreatic Stump to Prevent Pancreatic Fistula Following Distal Pancreatectomy | June 2011 | June 2016 |
| NCT02068677 | Completed | N/A | Evaluation of Injection Techniques in Celiac Plexus Neurolysis | August 2013 | November 2014 |
| NCT00585078 | Completed | Phase 2 | Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma | May 2004 | December 2011 |
| NCT00897741 | Completed | Gene Expression Profiles in Patients With Metastatic Pancreatic Cancer | December 2004 | March 2009 | |
| NCT00547144 | Completed | Phase 1 | Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer | October 2005 | April 2008 |
| NCT00425360 | Completed | Phase 3 | Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | September 2006 | March 2013 |
| NCT04196816 | Completed | Surgery for Pancreatic Cancer With Oligo-Metastasis | January 1, 2020 | December 1, 2020 | |
| NCT00967603 | Completed | Phase 2 | Maintenance Therapy With Sunitinib or Observation in Metastatic Pancreatic Cancer | February 2008 | January 2012 |
| NCT01304160 | Completed | Phase 1/Phase 2 | Role of Cyberknife Stereotactic Radiation Therapy (SBRT) Followed by Gemcitabine for Patients With Locally Advanced Pancreatic Cancer | September 2010 | July 2016 |
| NCT00006467 | Completed | Phase 2 | Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas | February 2001 | January 2004 |
| NCT00003427 | Completed | Phase 1 | Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer | April 1998 | April 2002 |
| NCT01774643 | Completed | A Study of Pancreatic Cancer in Xenografts From Liver Metastases | January 2013 | November 2022 | |
| NCT03662204 | Completed | Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors | August 23, 2018 | March 31, 2022 | |
| NCT01450046 | Completed | Phase 1 | Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects | October 2011 | April 2016 |
| NCT01296763 | Completed | Phase 1 | Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer | January 2011 | February 2016 |
| NCT00325494 | Completed | Phase 1 | A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer | May 2006 | September 2008 |
| NCT02718859 | Completed | Phase 1/Phase 2 | Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer | March 1, 2016 | March 1, 2019 |
| NCT00002689 | Completed | Phase 2 | Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer | September 1995 | June 2007 |
| NCT00003546 | Completed | Phase 2 | Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer | September 1998 | January 2006 |
| NCT02704143 | Completed | N/A | Combination of SBRT With Sequential S-1 for Treating Locally Advanced Pancreatic Cancer | February 2016 | May 2020 |
| NCT02027311 | Completed | Phase 4 | Etomidate vs. Midazolam for Sedation During ERCP | April 2013 | August 2013 |
| NCT00233415 | Completed | Phase 2 | Cyberknife Radiosurgery for Locally Advanced Pancreatic Cancer | July 2003 | May 2007 |
| NCT01273805 | Completed | Phase 2 | Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic Cancer | January 2011 | February 2014 |
| NCT01442974 | Completed | N/A | Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer | January 2011 | June 2012 |
| NCT03058289 | Completed | Phase 1/Phase 2 | A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 | February 9, 2017 | February 22, 2023 |
| NCT01542177 | Completed | A Study Using 18F-FAZA and PET Scans to Study Hypoxia in Pancreatic Cancer | February 2012 | September 2019 | |
| NCT00548626 | Completed | N/A | Evaluation of Multiple Needle Use in EUS-FNA for Pancreatic Cancer | October 2007 | November 2015 |
| NCT00709826 | Completed | Phase 2 | APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer | August 2008 | May 2011 |
| NCT02498665 | Completed | Phase 1 | A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies | November 2015 | September 2018 |
| NCT02399137 | Completed | Phase 2 | A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer | May 2015 | August 2018 |
| NCT01397019 | Completed | Phase 2 | Chemotherapy for Patients With Locally Advanced Pancreatic Cancer (LAPC) With Additional Chemo-radiotherapy (CRT) for Patients With Borderline Resectable Tumours | April 2011 | February 2018 |
| NCT03161379 | Completed | Phase 2 | GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer | February 2, 2018 | February 28, 2024 |
| NCT00112528 | Completed | Phase 2 | Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer | June 2005 | November 2010 |
| NCT04109495 | Completed | N/A | Usefulness of Smartphone Application for Improving Nutritional Status of Pancreatic Cancer Patients | February 22, 2017 | March 27, 2018 |
| NCT00376948 | Completed | Phase 2 | Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | May 2005 | March 2010 |
| NCT00703638 | Completed | Phase 1 | Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors | May 2008 | November 2010 |
| NCT00402025 | Completed | Phase 1 | Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer | November 2006 | January 2008 |
| NCT01188785 | Completed | Phase 1 | Phase I - Escalating Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Locally Advanced Adenocarcinoma of the Pancreas, and a Single Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Non-operable Adenocarcinoma of the Pancreas | January 2011 | December 2013 |
| NCT02574663 | Completed | Phase 1 | TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors | September 11, 2015 | August 2018 |
| NCT00602602 | Completed | Phase 2 | Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer | March 2007 | September 2011 |
| NCT01395017 | Completed | Phase 2 | Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer | June 2011 | March 2015 |
| NCT00365508 | Completed | Phase 4 | Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking | February 2006 | August 2009 |
| NCT02349412 | Completed | Phase 3 | Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers | April 2015 | July 15, 2019 |
| NCT03415126 | Completed | Phase 1 | A Study of ASN007 in Patients With Advanced Solid Tumors | January 19, 2018 | June 30, 2020 |
| NCT02713529 | Completed | Phase 1/Phase 2 | Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer | April 14, 2016 | May 17, 2019 |
| NCT01458717 | Completed | Phase 2/Phase 3 | Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer | November 2011 | January 2018 |
| NCT01401894 | Completed | Perception Prognosis, Goals of Treatment, and Communication | October 2010 | June 2014 | |
| NCT02295956 | Completed | Early Phase 1 | Preoperative Rehabilitation During Neoadjuvant Therapy for Pancreatic Cancer | February 2, 2015 | June 6, 2019 |
| NCT01072981 | Completed | Phase 3 | Immunotherapy Study for Surgically Resected Pancreatic Cancer | April 2010 | May 2016 |
| NCT01423604 | Completed | Phase 2 | Study of Ruxolitinib in Pancreatic Cancer Patients | July 2011 | November 2016 |
| NCT01844817 | Completed | Phase 2 | Phase II Trial Of Gemcitabine Plus Nab-Paclitaxel +/- OGX-427 In Patients With Metastatic Pancreatic Cancer | September 2013 | March 2016 |
| NCT00966706 | Completed | Phase 2 | Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic Cancer | June 2005 | October 2009 |
| NCT00557492 | Completed | Phase 2 | Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas Cancer | December 2006 | December 2016 |
| NCT00255827 | Completed | Phase 1/Phase 2 | Vaccine Treatment for Surgically Resected Pancreatic Cancer | November 2005 | September 2007 |
| NCT01360593 | Completed | Phase 2 | Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma | July 25, 2011 | October 2018 |
| NCT02289898 | Completed | Phase 2 | Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma | April 20, 2015 | September 2017 |
| NCT00882310 | Completed | Phase 2 | A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer | September 2006 | October 2014 |
| NCT00019474 | Completed | Phase 2 | Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer | March 1998 | August 2000 |
| NCT00005926 | Completed | Phase 2 | Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas | June 2000 | December 2000 |
| NCT04290364 | Completed | Early Palliative Care in Pancreatic Cancer - a Quasi-experimental Study | September 21, 2019 | September 1, 2023 | |
| NCT02020252 | Completed | Effect of Multi-Media Tool on Enrollment in Oncology Clinical Trials | November 26, 2013 | December 2018 | |
| NCT01094561 | Completed | N/A | Secretin-Stimulated Magnetic Resonance Cholangiopancreatography (S-MRCP) in Pancreatic Patients | July 2006 | March 2015 |
| NCT00024427 | Completed | Phase 3 | Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer | February 2001 | |
| NCT04409002 | Completed | Phase 2 | Niraparib + Dostarlimab + RT in Pancreatic Cancer | July 23, 2020 | February 25, 2022 |
| NCT01827553 | Completed | Phase 3 | Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy | April 4, 2013 | November 8, 2023 |
| NCT00112658 | Completed | Phase 2/Phase 3 | Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer | November 2004 | June 30, 2010 |
| NCT00026130 | Completed | Phase 2 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer | September 2001 | June 2010 |
| NCT00019084 | Completed | Phase 2 | Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer | February 1996 | May 2003 |
| NCT00089024 | Completed | Phase 2 | Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer | February 25, 2004 | December 1, 2014 |
| NCT02957981 | Completed | N/A | The Genetic Education for Men Trial: Web-Based Education vs. Standard Care | October 1, 2018 | April 1, 2022 |
| NCT00685763 | Completed | N/A | Proton Therapy for Unresectable Cancer (CA) of Pancreas | March 2008 | June 29, 2017 |
| NCT01386931 | Completed | On-site Cytopathology EUS-FNA | June 2011 | June 16, 2017 | |
| NCT00779688 | Completed | A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers | November 2008 | October 2010 | |
| NCT00369109 | Completed | Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors | February 2006 | June 2007 | |
| NCT01803282 | Completed | Phase 1 | Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors | March 29, 2013 | April 23, 2019 |
| NCT03829436 | Completed | Phase 1 | TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers | March 20, 2019 | September 7, 2022 |
| NCT00660270 | Completed | Phase 2 | Chemotherapy and Radiation Following Pancreatic Surgery | May 2002 | February 2009 |
| NCT02588443 | Completed | Phase 1 | Study of Neo-adjuvant RO7009789 Alone or Neo-adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine Followed by Adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine for Patients With Newly Diagnosed Resectable Pancreatic Carcinoma | October 2015 | November 2018 |
| NCT01485744 | Completed | Phase 1 | LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer | December 2011 | November 2019 |
| NCT01446952 | Completed | Phase 1 | Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy Subjects | September 2011 | April 2016 |
| NCT01989000 | Completed | N/A | The Role of the Tumor Microenvironment of Pancreatic Cancer to Predict Treatment Outcome | November 2013 | December 2017 |
| NCT02948309 | Completed | Phase 3 | Mistletoe Therapy in Primary and Recurrent Inoperable Pancreatic Cancer | June 2016 | September 2022 |
| NCT01945879 | Completed | Phase 1/Phase 2 | Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic Cancer | January 2003 | April 2004 |
| NCT02208024 | Completed | N/A | Neoadjuvant Stereotactic Body Radiation Therapy for Resectable Adenocarcinoma of the Pancreatic Head and/or Body | August 27, 2014 | May 12, 2019 |
| NCT00614653 | Completed | Phase 1 | Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer | January 2008 | July 2016 |
| NCT02810652 | Completed | N/A | Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection | September 2016 | January 2022 |
| NCT00897832 | Completed | Biomarkers in Predicting Response to Treatment in Patients Who Have Undergone Surgery for Pancreatic Cancer | January 2007 | December 2007 | |
| NCT05573776 | Completed | N/A | A Pilot Study of the Effect of High Protein Supplement and Exercise Therapy on Preservation of Skeletal Muscle Mass and Quality of Life in Patients With Gastric Cancer and Pancreatic Cancer Treated With Chemotherapy | August 1, 2020 | January 10, 2023 |
| NCT02873598 | Completed | Phase 1 | A Dose Escalation Trial of SBRT After Induction Chemotherapy for Locally Advanced Pancreatic Cancer | November 17, 2016 | November 28, 2022 |
| NCT03054987 | Completed | N/A | Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography for Malignant Distal Biliary Obstruction | September 2016 | October 2018 |
| NCT00033241 | Completed | Phase 1 | Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors | July 23, 2001 | April 22, 2004 |
| NCT02358161 | Completed | Phase 1/Phase 2 | Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer | September 2015 | January 2019 |
| NCT00040092 | Completed | Phase 3 | A Study to Test the Effectiveness of Virulizin® Given in Combination With Standard Chemotherapy for Pancreatic Cancer | July 2002 | |
| NCT02626195 | Completed | N/A | Preoperative Nutritional Support in Malnutritional Cancer Patients | October 2013 | April 5, 2017 |
| NCT02021500 | Completed | A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046. | January 2, 2014 | April 16, 2015 | |
| NCT00064051 | Completed | Phase 2 | 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer | January 2003 | August 2008 |
| NCT00417976 | Completed | Phase 2 | Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer | December 2006 | February 2011 |
| NCT04420039 | Completed | Plastic Stent Within a Lumen-Apposing Stent for Malignant Biliary Obstruction | May 2015 | March 2021 | |
| NCT00128622 | Completed | Phase 1 | Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer | September 2005 | May 2009 |
| NCT00634725 | Completed | Phase 3 | Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery | February 2008 | September 2014 |
| NCT00826982 | Completed | Minimally Invasive Detection of Lymphatic Micrometastases in Pancreatic Cancer | January 2008 | ||
| NCT00684801 | Completed | Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers | August 2007 | December 2011 | |
| NCT00313560 | Completed | Phase 2 | ChemoRT With Adjuvant Chemo in Pancreatic Cancer (TARCEVA) | March 16, 2006 | February 27, 2019 |
| NCT03415854 | Completed | Phase 2 | Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD) | January 31, 2018 | December 11, 2023 |
| NCT03883919 | Completed | Phase 1 | Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy | July 11, 2019 | July 2, 2022 |
| NCT02028845 | Completed | N/A | Loop-tipped Guidewire in Selective Biliary Cannulation | January 2014 | December 2015 |
| NCT04133155 | Completed | Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic Cancer | September 16, 2019 | February 1, 2020 | |
| NCT01420874 | Completed | Phase 1 | Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer) | August 17, 2011 | October 19, 2020 |
| NCT06267690 | Completed | A CT-based Radiomics Model to Predict Survival-graded Fibrosis in PDAC | January 13, 2021 | August 31, 2023 | |
| NCT00900016 | Completed | Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery | August 2007 | June 23, 2017 | |
| NCT01138124 | Completed | Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD) | March 2010 | August 2010 | |
| NCT00379132 | Completed | Phase 1 | 131-I-TM-601 Study in Adults With Solid Tumors | August 2006 | August 2008 |
| NCT00040183 | Completed | Phase 3 | OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. | November 29, 2001 | January 15, 2004 |
| NCT03627559 | Completed | Early Detection of Anastomotic Leakage by Microdialysis Catheters | October 1, 2013 | July 1, 2018 | |
| NCT01845805 | Completed | Phase 2 | Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine) | January 10, 2014 | April 9, 2021 |
| NCT00099294 | Completed | Phase 3 | Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer | September 2004 | January 2007 |
| NCT04893408 | Completed | Pancreatic Surgery in Elderly Patients | January 1, 2010 | December 31, 2019 | |
| NCT00025168 | Completed | Phase 2 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer | November 1, 2001 | August 29, 2003 |
| NCT03410030 | Completed | Phase 1/Phase 2 | Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) | December 15, 2017 | January 10, 2022 |
| NCT03023722 | Completed | Phase 2 | Phase II Anetumab Ravtansine in Pre-treated Mesothelin-expressing Pancreatic Cancer | May 11, 2017 | December 11, 2019 |
| NCT02704156 | Completed | Phase 2 | SBRT Plus Pembrolizumab and Trametinib for Pancreatic Cancer | October 2016 | December 2020 |
| NCT03490669 | Completed | Phase 1 | Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors | May 21, 2018 | September 23, 2019 |
| NCT02546531 | Completed | Phase 1 | Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced Cancer | February 3, 2016 | January 11, 2021 |
| NCT00005843 | Completed | Phase 2 | R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer | May 2000 | |
| NCT02988635 | Completed | Phase 3 | Early Palliative Care on Quality of Life of Advanced Cancer Patients | November 2014 | November 2016 |
| NCT00593866 | Completed | Phase 1/Phase 2 | Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer | June 2006 | October 2014 |
| NCT02947165 | Completed | Phase 1 | Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies. | April 25, 2017 | June 18, 2021 |
| NCT00882973 | Completed | Phase 1 | Trial to Determine the Maximum Tolerated Dose of Genexol-PM Plus Gemcitabine and Evaluate Efficacy and Safety of Genexol-PM Regimens in Subjects With Advanced Pancreatic Cancer | September 2008 | November 2010 |
| NCT06254430 | Completed | Effects of Erector Spina Plan Block and Epidural Analgesia in Whipple Surgery | March 20, 2023 | July 30, 2023 | |
| NCT00648102 | Completed | Phase 1 | Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer | January 2006 | December 2009 |
| NCT00056537 | Completed | Phase 1 | ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer | April 2003 | December 2006 |
| NCT03077334 | Completed | Oncologic Outcomes Based on Clinical Pattern of Preoperative PET-CT in Resected Pancreatic Cancer | October 7, 2014 | September 17, 2018 | |
| NCT04386057 | Completed | Phase 2 | LY3214996 +/- HCQ in Pancreatic Cancer | May 27, 2020 | February 5, 2024 |
| NCT00032175 | Completed | Phase 3 | Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | April 2002 | May 2007 |
| NCT00004190 | Completed | Phase 2 | Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic Cancer | October 1999 | June 2003 |
| NCT02400398 | Completed | Evaluating Weight Stability of Pancreatic Cancer Cachexia Patients | April 27, 2015 | May 15, 2020 | |
| NCT02894944 | Completed | Phase 1 | Clinical Trial Phase I for Theragene in Combination With Chemotherapy for the Locally Advanced Pancreatic Cancer | August 2016 | April 2019 |
| NCT01523808 | Completed | Phase 1 | Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase)in Patients With Pancreatic Cancer | November 2009 | March 2011 |
| NCT00576940 | Completed | Phase 4 | Standard and Immunostimulating Enteral Nutrition in Surgical Patients | June 2004 | September 2007 |
| NCT04334239 | Completed | Effectiveness of Care in Certified Cancer Centres in Germany | May 1, 2017 | August 31, 2021 | |
| NCT01033695 | Completed | Interobserver Agreement of Endoscopic Ultrasonography and Endoscopic Sonoelastography in the Evaluation of Lymph Nodes | January 2008 | June 2009 | |
| NCT00005594 | Completed | Phase 2 | ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas | July 2000 | |
| NCT00019513 | Completed | Phase 1 | Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas | August 1998 | June 2004 |
| NCT04188990 | Completed | N/A | Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related Malnutrition | June 15, 2020 | June 30, 2023 |
| NCT00902733 | Completed | N/A | Nurse-Provided Care or Standard Care in Treating Patients With Pancreatic Cancer | July 2008 | February 2010 |
| NCT00467116 | Completed | Phase 1 | PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas Ca | October 2005 | October 2007 |
| NCT01815606 | Completed | N/A | Trial Comparing 19 and 25G Needles for Fine Needle Aspiration (FNA) of Solid Pancreatic Mass Lesions Greater Than 35mm | February 2013 | December 2013 |
| NCT01396668 | Completed | Phase 2 | Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic Cancer | December 2004 | June 2011 |
| NCT00898482 | Completed | Collecting and Storing Samples of Blood From Patients With Pancreatic Cancer and Healthy Participants | May 2005 | June 2011 | |
| NCT02777463 | Completed | The Prediction Using Diffusion MRI of the Response Evaluation in BRPC in NAT. | June 2016 | January 2020 | |
| NCT00490373 | Completed | Phase 2 | Trial of Pemetrexed for Patients With Pancreatic Cancer Which Cannot be Treated With Surgery or is Metastatic | October 2003 | April 2005 |
| NCT00897494 | Completed | Identification of Biomarkers for Early Detection of Pancreatic Cancer | February 2005 | April 2011 | |
| NCT03340974 | Completed | Phase 1/Phase 2 | Pilot Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in Combination With GC4419 in Pancreatic Cancer | February 12, 2018 | May 26, 2021 |
| NCT02098239 | Completed | Phase 2 | Single Centre Study to Determine the Antibody Response to G17DT in Patients With Advanced Pancreatic Cancer. | August 1999 | May 2002 |
| NCT01438476 | Completed | Phase 3 | Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas | January 26, 2012 | October 18, 2017 |
| NCT01401907 | Completed | N/A | Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies | May 2011 | December 2019 |
| NCT04066361 | Completed | N/A | OPTimizing Treatment Focused Genetic Testing IN Cancer | December 19, 2019 | November 30, 2022 |
| NCT02079623 | Completed | Electroporation (NanoKnife) as Treatment for Advanced Pancreatic Cancer | November 2013 | May 1, 2019 | |
| NCT00003046 | Completed | Phase 1 | Interleukin-12 in Treating Patients With Cancer in the Abdomen | August 1997 | October 2001 |
| NCT00003125 | Completed | Phase 2 | Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors | January 1998 | November 2004 |
| NCT01492907 | Completed | Phase 1 | Pilot Study of Meat-Borne Carcinogens and Pancreatic Cancer | January 2012 | April 2013 |
| NCT00661882 | Completed | Pancreatic Cancer Collaborative Registry | February 2003 | September 9, 2013 | |
| NCT01339754 | Completed | Phase 2 | Trabectedin in Treating Patients With Metastatic Pancreatic Cancer After First-Line Chemotherapy | February 2011 | March 2013 |
| NCT03512756 | Completed | Phase 2/Phase 3 | A Randomized Phase 2/3 Multi-Center Study of SM-88 in Patients With Metastatic Pancreatic Cancer | March 27, 2018 | April 19, 2022 |
| NCT00733746 | Completed | Phase 2 | Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery | April 2009 | June 15, 2019 |
| NCT01015820 | Completed | N/A | Early Increase in Blood Flow (EIBS) in the Duodenum in Patients With Pancreatic Cancer | June 2010 | October 2012 |
| NCT00836407 | Completed | Phase 1 | Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer | February 2009 | July 2012 |
| NCT00004884 | Completed | Phase 2 | Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer | July 1999 | |
| NCT01703026 | Completed | Contrast Enhanced EUS in the Evaluation of Pancreatic Cancer and Pancreatic Masses | August 2009 | October 2011 | |
| NCT01658917 | Completed | Collecting Solid Tumor Tissue to Identify New Treatments | July 24, 2012 | October 23, 2017 | |
| NCT02465892 | Completed | N/A | Pillars4Life Trial | May 2015 | October 2016 |
| NCT00424827 | Completed | Phase 2 | A Trial of Chemo & Radiation Therapy for Pancreatic Cancer | June 2006 | December 2014 |
| NCT00260364 | Completed | Phase 1/Phase 2 | Combining Erlotinib Plus Bevacizumab and Gemcitabine Plus Capecitabine to Treat Advanced Pancreatic Cancer | November 2005 | August 2011 |
| NCT03790423 | Completed | Phase 1 | 18F-ASIS PET/CT Imaging of Tissue Factor Expression In Patients With Primary and Metastastic Cancer | January 3, 2019 | November 18, 2019 |
| NCT02841800 | Completed | N/A | Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis | June 2016 | May 10, 2019 |
| NCT00019435 | Completed | Phase 1 | LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors | May 1998 | |
| NCT02250638 | Completed | Longitudinal Pancreatic Cancer Study | May 2014 | June 30, 2021 | |
| NCT00008099 | Completed | Phase 1 | Vaccine Therapy in Treating Patients With Resected or Locally Advanced Unresectable Pancreatic Cancer | May 1998 | February 2004 |
| NCT02403271 | Completed | Phase 1/Phase 2 | A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors | March 2015 | August 2017 |
| NCT06461598 | Completed | Signature for Precise Chemosensitivity Prediction in PDAC | January 1, 2018 | May 31, 2021 | |
| NCT00251355 | Completed | Phase 1 | Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer | January 1998 | August 2008 |
| NCT00062283 | Completed | Phase 2 | Alanosine in Treating Patients With Cancer | March 2003 | December 2009 |
| NCT03982446 | Completed | Germline Mutations in Pancreatic Adenocarcinoma | March 1, 2016 | January 3, 2020 | |
| NCT06079229 | Completed | Quality of Life in Elderly Patients After Pancreatic Cancer Surgery | November 6, 2023 | April 24, 2024 | |
| NCT00003760 | Completed | Phase 2 | Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer | November 1998 | May 2000 |
| NCT03977272 | Completed | Phase 2 | Combination of Anti-PD-1 Antibody and Chemotherapy in Metastatic Pancreatic Cancer | March 27, 2019 | July 1, 2022 |
| NCT01392027 | Completed | N/A | Biospecimens for Identification of Diseases of the Pancreas. | April 2011 | August 31, 2017 |
| NCT02923921 | Completed | Phase 3 | Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer | March 1, 2017 | March 5, 2020 |
| NCT01097512 | Completed | Phase 1 | AS703569 and Gemcitabine Combination in Advanced Malignancies | June 2007 | February 2011 |
| NCT02284139 | Completed | Phase 2/Phase 3 | Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects | April 2015 | December 2017 |
| NCT00016965 | Completed | Phase 2 | BMS-247550 in Treating Patients With Advanced Pancreatic Cancer | July 2001 | April 2006 |
| NCT00727441 | Completed | Phase 2 | Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery | July 2, 2008 | February 2019 |
| NCT02190071 | Completed | Comparison Between Base and Cover Slide From Endoscopic Ultrasound Guided Fine Needle Aspiration for Pancreatic Cancer | June 2014 | March 2016 | |
| NCT00885066 | Completed | Phase 1 | Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer | May 2008 | October 2009 |
| NCT00810953 | Completed | Phase 1/Phase 2 | A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy | January 2009 | June 2011 |
| NCT00461708 | Completed | Phase 2 | A Study of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship Between Skin Toxicity and Survival | May 2007 | November 2010 |
| NCT00026403 | Completed | Phase 2 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer | September 2001 | July 2009 |
| NCT00899158 | Completed | Biological Markers in Patients With Pancreatic Cancer Experiencing Weight Loss | June 2005 | December 2008 | |
| NCT00068575 | Completed | Phase 2 | Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer | May 2002 | December 2010 |
| NCT00652366 | Completed | Phase 2 | A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer | May 2008 | February 2012 |
| NCT00075686 | Completed | Phase 3 | S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer | January 2004 | April 2009 |
| NCT01663272 | Completed | Phase 1 | A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer | July 2012 | March 1, 2017 |
| NCT01104129 | Completed | Stool Testing for Pancreatic Cancer | July 9, 2009 | November 29, 2016 | |
| NCT05012540 | Completed | SII And PALBI is Associated With the Prognosis of Pancreatic Cancer Surgery(SII,PALBI) | August 1, 2013 | December 31, 2020 | |
| NCT00369460 | Completed | Changes in Muscle Tissue in Patients With Pancreatic Cancer | January 2006 | July 2009 | |
| NCT01657383 | Completed | Surgical Outcomes Database For Faculty of Hepatopancreatic Biliary Surgery | April 2012 | February 2017 | |
| NCT01908478 | Completed | Phase 1 | Veliparib in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With Pancreatic Cancer | October 2, 2013 | July 6, 2020 |
| NCT00051467 | Completed | Phase 3 | A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer | ||
| NCT01059097 | Completed | N/A | Effect of Surgeon Volume on Outcome of Pancreaticoduodenectomy | August 2001 | January 2010 |
| NCT01631552 | Completed | Phase 1/Phase 2 | Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer | December 17, 2012 | August 13, 2020 |
| NCT00126633 | Completed | Phase 2 | Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer | April 2004 | October 2008 |
| NCT00044031 | Completed | Phase 3 | Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma | February 2001 | October 2007 |
| NCT04431258 | Completed | Phase 1/Phase 2 | ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study | May 6, 2021 | January 10, 2024 |
| NCT02155088 | Completed | Phase 1 | BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer | October 30, 2014 | January 31, 2020 |
| NCT00534001 | Completed | Phase 2 | Bupropion in Helping Adults Stop Smoking | January 2006 | July 2015 |
| NCT00987766 | Completed | Phase 1 | Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer | November 2009 | October 2016 |
| NCT00667641 | Completed | Phase 1 | Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | March 2007 | February 2009 |
| NCT02238847 | Completed | N/A | Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy | March 24, 2015 | April 10, 2018 |
| NCT02210364 | Completed | Phase 1 | Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC). | April 2013 | October 2016 |
| NCT00900094 | Completed | UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer | June 2000 | October 2007 | |
| NCT03515356 | Completed | N/A | Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy | June 13, 2018 | June 24, 2019 |
| NCT01675908 | Completed | N/A | Trial Comparing Metal Versus Plastic Stents for Preoperative Biliary Decompression | August 22, 2012 | August 21, 2019 |
| NCT02657330 | Completed | Phase 1 | Study of SBP-101 in Pancreatic Cancer | January 2016 | October 2017 |
| NCT00365144 | Completed | Phase 2 | Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With Gemcitabine | February 2006 | March 2010 |
| NCT00002475 | Completed | Phase 2 | Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | April 1991 | June 2009 |
| NCT04293497 | Completed | N/A | Development of a New Immunochemistry Method Using Antibodies of Proteins Related Pancreatic Cancer | February 17, 2020 | July 2, 2021 |
| NCT03998566 | Completed | N/A | Radiopaque Hydrogel Spacer in Patients Undergoing Radiotherapy for Pancreatic Cancer | April 24, 2019 | May 1, 2021 |
| NCT00960284 | Completed | Phase 2/Phase 3 | Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer | June 2003 | June 2009 |
| NCT00324428 | Completed | N/A | TMS for the Treatment of Pancreatic Cancer Pain | May 2006 | November 2011 |
| NCT00294840 | Completed | Dynamic PET acquisition-a Quantitative Technique for Grading of Malignant Tumors and Prediction of Response to Treatment | August 2006 | April 2010 | |
| NCT00109941 | Completed | Phase 2 | Opioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That Cannot Be Removed By Surgery | October 2003 | April 2009 |
| NCT03454451 | Completed | Phase 1 | CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers | April 25, 2018 | February 19, 2023 |
| NCT01640522 | Completed | N/A | Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms | January 2008 | December 2014 |
| NCT00100815 | Completed | Phase 2 | Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer | August 2004 | |
| NCT00789633 | Completed | Phase 3 | Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer | November 25, 2008 | August 31, 2012 |
| NCT00578279 | Completed | Phase 4 | Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN)With Alcohol in Unresectable Pancreatic Cancer: a Pilot Study | March 2007 | June 2009 |
| NCT00456599 | Completed | Phase 2 | Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic Cancer | April 2007 | January 2013 |
| NCT00225784 | Completed | Phase 2 | Cetuximab, Radiotherapy and Twice Weekly Gemcitabine to Treat Pancreatic Cancer | February 2005 | September 2012 |
| NCT00042939 | Completed | Phase 2 | Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer | December 9, 2003 | August 2009 |
| NCT00681798 | Completed | Phase 1 | Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma | July 2006 | June 2009 |
| NCT00004604 | Completed | Phase 1 | Biological Therapy in Treating Patients With Metastatic Cancer | February 1997 | July 2002 |
| NCT01198821 | Completed | Phase 1 | Gem-TABS in Unresectable Pancreatic Carcinoma | August 2010 | June 2011 |
| NCT00112580 | Completed | Phase 2 | MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery | July 31, 2005 | June 30, 2009 |
| NCT03200821 | Completed | Phase 3 | An Open Label Study to Evaluate G17DT Compared to Gemcitabine | August 14, 2000 | September 19, 2002 |
| NCT00957424 | Completed | N/A | Acceptability of Less Harmful Alternatives to Cigarettes | June 2009 | November 2011 |
| NCT00433602 | Completed | Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors | November 2006 | ||
| NCT06258824 | Completed | MicroRNAs as Bile-based Biomarkers in Pancreaticobiliary Cancers | January 1, 2018 | July 27, 2020 | |
| NCT01777477 | Completed | Phase 1 | Adjuvant Effect of Chloroquine on Gemcitabine | July 2012 | May 2015 |
| NCT00902291 | Completed | Phase 2 | A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer | April 2009 | April 2012 |
| NCT03250273 | Completed | Phase 2 | A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma | November 6, 2017 | November 20, 2020 |
| NCT00521404 | Completed | Phase 2 | Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic Cancer | August 15, 2007 | August 20, 2010 |
| NCT00478010 | Completed | N/A | Making Decisions About Participating in a Cancer Clinical Trial for Patients With Stage II, Stage III, or Stage IV Pancreatic Cancer or Stage III or Stage IV Colon Cancer or Rectal Cancer | January 19, 2007 | September 29, 2008 |
| NCT04306874 | Completed | N/A | Whipple Protein Study | August 20, 2019 | November 15, 2022 |
| NCT01487785 | Completed | Phase 1 | Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients | March 2012 | July 2014 |
| NCT03146962 | Completed | Phase 2 | High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies | March 29, 2017 | April 21, 2023 |
| NCT02000999 | Completed | Diagnosis of Bile Duct Strictures | November 2013 | January 2, 2019 | |
| NCT01730222 | Completed | Phase 1/Phase 2 | A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma | November 2012 | August 2017 |
| NCT01505413 | Completed | Phase 2 | Phase 2 Study of Erlotinib, Gemcitabine and Oxaliplatin Combination Chemotherapy to Advanced Pancreatic Cancer | January 2011 | March 2014 |
| NCT00558155 | Completed | Phase 4 | The Impact of Immunostimulating Nutrition on the Outcome of Surgery | June 2001 | December 2005 |
| NCT01794676 | Completed | Genetic Evaluation of Families With Endocrine Cancers | March 2013 | October 2015 | |
| NCT00499486 | Completed | Phase 2 | Sirolimus in Treating Patients With Advanced Pancreatic Cancer | January 2005 | June 2009 |
| NCT03158779 | Completed | Phase 2 | Evaluation of SBRT for Patients With Locally Advanced Unresectable Pancreatic Cancer | May 10, 2017 | July 1, 2022 |
| NCT00059982 | Completed | Phase 2 | Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer | July 2003 | August 2005 |
| NCT00763516 | Completed | N/A | Proton Radiation for Resectable Carcinoma of the Pancreas | February 2009 | August 17, 2017 |
| NCT03644173 | Completed | N/A | Personal Resilience Empowerment Program Study | May 30, 2018 | June 14, 2021 |
| NCT03914950 | Completed | N/A | TOF-18F-FDG-PET/CT in Patients With Suspected Pancreatic Cancer | February 7, 2014 | March 5, 2019 |
| NCT01470417 | Completed | Phase 2 | Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma | October 2011 | October 2019 |
| NCT03517176 | Completed | Phase 1 | CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer | July 31, 2018 | June 19, 2020 |
| NCT00310115 | Completed | Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy | April 2002 | August 2016 | |
| NCT00004861 | Completed | Phase 2 | Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer | October 1999 | September 2001 |
| NCT06378580 | Completed | The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma | July 1, 2022 | April 1, 2024 | |
| NCT02431676 | Completed | Phase 2 | Survivorship Promotion In Reducing IGF-1 Trial | May 2015 | December 2018 |
| NCT01661114 | Completed | Phase 2 | A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary Cancers | July 2011 | March 2016 |
| NCT00871169 | Completed | Phase 2 | Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer | October 2008 | April 2015 |
| NCT00335543 | Completed | Phase 2 | Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By Surgery | June 2003 | October 2009 |
| NCT00583271 | Completed | A Prospective Study of EUS Guided Celiac Block | June 2002 | December 2012 | |
| NCT02489422 | Completed | N/A | Programs To Support You During Chemotherapy | August 2016 | January 2020 |
| NCT00112697 | Completed | Phase 2 | Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery | October 6, 2003 | March 1, 2012 |
| NCT02459041 | Completed | Clinical Impact of EUS Elastography Mean Strain Histograms (SH) and Contrast Peak-enhancement in Focal Pancreatic Masses and Lymph Nodes | January 2015 | January 2017 | |
| NCT00316420 | Completed | Phase 1 | Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer | December 2003 | August 2009 |
| NCT05139199 | Completed | N/A | Effectiveness of Auricular Point Acupressure in Improving Quality of Life in Patients With Pancreatic Cancer | February 23, 2022 | August 1, 2023 |
| NCT03602079 | Completed | Phase 1/Phase 2 | Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene | July 16, 2018 | January 12, 2022 |
| NCT04846985 | Completed | Nutritional Problems in Pallative Cancer | April 26, 2021 | October 7, 2021 | |
| NCT00789763 | Completed | Phase 1 | Phase I-II to Evaluate Efficacy/Safety of Sorafenib+Gemcitabine+Radiotherapy in Locally Advanced Pancreatic Carcinoma | December 2007 | January 2012 |
| NCT03331055 | Completed | N/A | PENS or TENS for Pain in Pancreatic Cancer | October 27, 2017 | August 26, 2019 |
| NCT00831571 | Completed | Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin | February 2009 | April 2022 | |
| NCT03001518 | Completed | Immunologic Signatures Following Surgery for Pancreatic Cancer | May 4, 2017 | January 6, 2023 | |
| NCT00243854 | Completed | Phase 1 | Pilot Study Using Neoadj Chemo-Rad & EGFR-tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic Cancer | November 2005 | October 2011 |
| NCT00898287 | Completed | Phase 1/Phase 2 | Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer | May 2009 | |
| NCT00411762 | Completed | Phase 1/Phase 2 | A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma | December 2006 | December 2009 |
| NCT01995084 | Completed | N/A | In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility Study | May 2012 | June 2014 |
| NCT02459652 | Completed | Phase 2 | Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer | December 28, 2012 | July 17, 2018 |
| NCT01761240 | Completed | Phase 1 | Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC | June 19, 2013 | February 9, 2016 |
| NCT02277834 | Completed | Characterizing the Pancreatic Cancer Proteome From Pancreatic Juice | August 2014 | April 2016 | |
| NCT00003677 | Completed | Phase 2 | Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer | February 1, 1999 | January 16, 2002 |
| NCT01770405 | Completed | Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract | September 2013 | December 21, 2016 | |
| NCT04430842 | Completed | Phase 1 | Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S | July 20, 2020 | December 22, 2022 |
| NCT00077519 | Completed | Phase 1 | Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer | January 2004 | December 31, 2019 |
| NCT00438256 | Completed | Phase 1/Phase 2 | Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer | December 2007 | December 2017 |
| NCT01128296 | Completed | Phase 1/Phase 2 | Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the Pancreas | October 2010 | July 2014 |
| NCT02191761 | Completed | Phase 1 | Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer | June 19, 2014 | May 20, 2015 |
| NCT01373164 | Completed | Phase 1/Phase 2 | A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer | June 2011 | December 2016 |
| NCT02702986 | Completed | Phase 1 | Safety and Feasibility of imILT Locally Advanced Pancreatic Cancer (LAPC) | February 2016 | October 2021 |
| NCT04247126 | Completed | Phase 1 | A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors | January 23, 2020 | March 30, 2023 |
| NCT00696696 | Completed | Phase 2 | Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer | September 2007 | June 2013 |
| NCT00529984 | Completed | Phase 1/Phase 2 | A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies | September 2007 | May 2010 |
| NCT01926197 | Completed | Phase 3 | Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer | August 14, 2013 | September 30, 2022 |
| NCT02343835 | Completed | N/A | Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer | January 1, 2015 | May 1, 2021 |
| NCT00902759 | Completed | Early Phase 1 | Fatigue and Pancreas and Bile Duct Cancer Study | January 9, 2009 | April 15, 2015 |
| NCT00588640 | Completed | Phase 1/Phase 2 | Study of D-Methadone in Patients With Chronic Pain | October 2004 | July 2008 |
| NCT00003018 | Completed | Phase 2 | S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer | September 1997 | January 2007 |
| NCT01646697 | Completed | N/A | Slide Interpretation or Standard Surgical Pathology in Assessing Margin Status in Patients With Pancreatic Cancer Undergoing Surgery | November 7, 2011 | February 6, 2016 |
| NCT02079285 | Completed | Prospective Evaluation of Diagnostic Accuracy of Endoscopic Ultrasound-guided Fine Needle Aspiration and Biopsy (EUS-FNAB) in the Absence of Rapid Onsite Evaluation | April 2014 | September 2015 | |
| NCT02131493 | Completed | Phase 2 | S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic Cancer | January 2015 | December 2021 |
| NCT00375310 | Completed | Phase 1 | Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer | September 2006 | November 2014 |
| NCT01661088 | Completed | Phase 2 | A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients | June 2011 | August 30, 2019 |
| NCT03953235 | Completed | Phase 1/Phase 2 | A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens | July 18, 2019 | March 10, 2023 |
| NCT00965718 | Completed | Phase 2 | Evaluate the Efficacy and Safety of Activated T-lymphocyte Cell Therapy in Advanced Pancreatic Cancer | September 2009 | December 2010 |
| NCT01430052 | Completed | Phase 2 | Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer | April 2009 | September 2015 |
| NCT00033384 | Completed | Phase 2 | CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer | February 2002 | November 2003 |
| NCT00559598 | Completed | Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer | August 2004 | April 2009 | |
| NCT02539537 | Completed | Phase 3 | A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma | October 23, 2015 | September 25, 2023 |
| NCT01929720 | Completed | N/A | Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors | August 2011 | September 2014 |
| NCT00003798 | Completed | Phase 1 | Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery | April 2000 | |
| NCT00597129 | Completed | Phase 1/Phase 2 | Safety and Efficacy Study of 90Y-hPAM4 at Different Doses | August 2004 | October 2007 |
| NCT00862524 | Completed | Phase 1/Phase 2 | A Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic Cancer | March 2009 | February 2011 |
| NCT00416507 | Completed | Phase 3 | Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery | March 2000 | January 2007 |
| NCT00620295 | Completed | Phase 1 | Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors | March 2007 | October 2009 |
| NCT02541370 | Completed | Phase 1/Phase 2 | Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133 | June 2015 | June 2019 |
| NCT00049348 | Completed | Phase 2 | Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer | October 13, 2003 | May 2009 |
| NCT00053924 | Completed | Phase 2 | Perifosine in Treating Patients With Advanced Pancreatic Cancer | May 2003 | |
| NCT00305760 | Completed | Phase 2 | Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer | December 2005 | March 2009 |
| NCT01248663 | Completed | N/A | Reconstruction Method and Delayed Gastric Emptying After Pancreatic Surgery | April 2007 | August 2010 |
| NCT02340728 | Completed | Phase 3 | Endoscopic Biliary Co-axial Stent Placement Plus/Minus Use of Radiofrequency Ablation (RFA) for Clearance of Occluded Self Expandable Metal Stents (SEMS) in Patients With Distal Biliary Obstruction From Unresectable Biliary-pancreatic Malignancies | January 2015 | November 2019 |
| NCT05305001 | Completed | Germline Mutations Associated With Hereditary Pancreatic Cancer in Unselected Patients With Pancreatic Cancer in Mexico | September 9, 2020 | June 30, 2022 | |
| NCT01553019 | Completed | Phase 2 | Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer | October 2011 | August 31, 2017 |
| NCT04476082 | Completed | Nutrition in Gastrointestinal Tumors | June 25, 2020 | December 6, 2022 | |
| NCT02639026 | Completed | Phase 1 | Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers | January 26, 2016 | June 27, 2023 |
| NCT00176813 | Completed | Phase 2 | Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer | March 2003 | November 2006 |
| NCT03871790 | Completed | Peptide-based Immunization for Colon- and and Pancreas-carcinoma | April 1, 2019 | August 31, 2022 | |
| NCT00338039 | Completed | Phase 2 | Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients | September 2005 | June 2011 |
| NCT00547612 | Completed | Phase 1 | Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer | September 2007 | December 2008 |
| NCT00810719 | Completed | Phase 2 | Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic Cancer | April 2009 | December 2013 |
| NCT03319459 | Completed | Phase 1 | FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors | January 18, 2018 | December 15, 2020 |
| NCT02681796 | Completed | Phase 1 | Epidural Analgesia Use in Pancreatic Resections | June 7, 2016 | February 7, 2020 |
| NCT01327794 | Completed | Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer | June 2011 | August 2014 | |
| NCT00944463 | Completed | Phase 2 | Trial of Simvastatin and Gemcitabine in Pancreatic Cancer Patients | October 2008 | February 2014 |
| NCT03801915 | Completed | Phase 2 | Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers | November 13, 2019 | May 27, 2022 |
| NCT02092948 | Completed | Phase 1 | Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer | August 22, 2013 | January 6, 2017 |
| NCT00630552 | Completed | Phase 1/Phase 2 | QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer | June 2007 | April 2012 |
| NCT01150630 | Completed | Phase 2 | Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer | May 2010 | August 2017 |
| NCT03016637 | Completed | Phase 1/Phase 2 | Pancreatic Core Biopsy Needle Study in Patients Suspected of Pancreatic Malignancy | January 2016 | December 2016 |
| NCT00425841 | Completed | Phase 2 | Stereotactic Radiation Therapy and Combination Chemotherapy in Treating Patients Undergoing Surgery for Locally Advanced Pancreatic Cancer | May 2006 | December 2009 |
| NCT00587964 | Completed | Phase 2 | Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases | June 2004 | January 2009 |
| NCT06129812 | Completed | An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer | January 2007 | December 2021 | |
| NCT01160367 | Completed | N/A | Trial of Ascertaining Individual Preferences for Loved One's Role in End-of-Life | August 26, 2010 | March 26, 2014 |
| NCT02132325 | Completed | N/A | Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer | April 2014 | February 5, 2018 |
| NCT00769483 | Completed | Phase 1/Phase 2 | MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer | November 13, 2008 | September 1, 2020 |
| NCT02694536 | Completed | Phase 3 | A Study of Erlotinib in Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer | August 1, 2006 | November 19, 2009 |
| NCT02428270 | Completed | Phase 2 | A Study of GSK2256098 and Trametinib in Advanced Pancreatic Cancer | April 2016 | October 27, 2022 |
| NCT00066651 | Completed | Phase 1 | Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors | July 2003 | |
| NCT00014456 | Completed | Phase 1 | Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors | March 2000 | October 2005 |
| NCT00002773 | Completed | Phase 2 | Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer | May 1996 | April 2004 |
| NCT00111904 | Completed | Phase 2 | Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer | May 2005 | |
| NCT01664169 | Completed | Biomarkers in Plasma Specimens From Patients Treated on Study CALGB-80303 | August 2012 | August 2018 | |
| NCT00805688 | Completed | Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer | November 12, 2008 | February 27, 2018 | |
| NCT01978184 | Completed | Phase 2 | Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine | November 2013 | February 28, 2018 |
| NCT00004087 | Completed | Phase 1/Phase 2 | Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer | March 1997 | |
| NCT02332863 | Completed | N/A | Comparison of Back-loaded vs Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement in Pancreatic Cancer. | August 3, 2016 | May 1, 2020 |
| NCT00010166 | Completed | Phase 2 | Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the Pancreas | December 1, 2000 | October 3, 2003 |
| NCT00006981 | Completed | Phase 1 | Immunotoxin Therapy in Treating Patients With Advanced Cancer | December 2000 | |
| NCT00265876 | Completed | Phase 1/Phase 2 | AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery | April 26, 2006 | January 6, 2012 |
| NCT00851955 | Completed | Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic Cancer | May 2007 | November 2011 | |
| NCT02565641 | Completed | Phase 2 | A Study of Capecitabine (Xeloda) in Participants With Locally Advanced or Metastatic Pancreatic Cancer | March 2003 | September 2006 |
| NCT01560949 | Completed | Phase 2 | Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas | June 14, 2012 | February 20, 2019 |
| NCT04257955 | Completed | COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer | September 15, 2020 | April 19, 2022 | |
| NCT02984501 | Completed | Phase 2 | Study of Induction Chemotherapy Followed by Radiochemotherapy in Locally Advanced Pancreatic Cancer | March 2013 | August 2016 |
| NCT00192842 | Completed | Phase 2 | Gemcitabine With Curcumin for Pancreatic Cancer | July 2004 | September 2010 |
| NCT02720666 | Completed | Phase 1 | K-001 Treatment of Advanced Pancreatic Cancer: Clinical Trial of Monotherapy's Tolerability | January 2016 | December 2016 |
| NCT01845337 | Completed | Phase 2 | Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine | February 5, 2014 | October 8, 2020 |
| NCT02454140 | Completed | N/A | Stereotactic Body Radiotherapy Dose Escalation in Pancreatic Cancer | June 20, 2014 | December 31, 2022 |
| NCT03127098 | Completed | Phase 1/Phase 2 | QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer | June 26, 2017 | December 7, 2017 |
| NCT01581307 | Completed | Phase 2 | Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets | April 2012 | March 2016 |
| NCT00691054 | Completed | Phase 2 | Abraxane Therapy in Patients With Pancreatic Cancer Who Failed First-Line Gemcitabine Therapy | June 2008 | December 2012 |
| NCT00577564 | Completed | EUS-CPN: A Retrospective Review | July 2006 | December 2007 | |
| NCT02080650 | Completed | N/A | Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) | March 2014 | July 19, 2016 |
| NCT02118077 | Completed | Phase 3 | Sequential Trial of G17DT for the Treatment of Advanced Pancreatic Cancer | April 2001 | |
| NCT04776837 | Completed | Predicting Disease Progression and/or Recurrence in Cancer | May 15, 2019 | November 19, 2021 | |
| NCT04210128 | Completed | Glucose Monitoring to Predict and Treat High Glucose Levels After Steroid Treatment | December 20, 2019 | October 31, 2023 | |
| NCT02345408 | Completed | Phase 1 | Phase 1b Study of CCX872-B in Patients With Pancreatic Adenocarcinoma | February 2015 | May 6, 2020 |
| NCT00003411 | Completed | Phase 1 | Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer | November 1998 | June 2002 |
| NCT00962312 | Completed | Phase 2 | Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer | January 2009 | |
| NCT00004095 | Completed | Phase 1 | Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors | August 1999 | October 2008 |
| NCT00436410 | Completed | Early Phase 1 | Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | December 2006 | August 2009 |
| NCT00790569 | Completed | N/A | Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking | September 2008 | October 2012 |
| NCT01364805 | Completed | Phase 1 | New Treatment Option for Pancreatic Cancer | April 2011 | October 2015 |
| NCT00003049 | Completed | Phase 3 | Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas | May 1997 | July 2007 |
| NCT03267966 | Completed | N/A | Margin Status After Pancreaticoduodenectomy for Cancer | March 2013 | June 2019 |
| NCT03525067 | Completed | Colonization of Bile Ducts and Postoperative Infectious Complications of Pancreaticoduodenectomies | February 1, 2017 | April 2, 2018 | |
| NCT03021668 | Completed | N/A | Comparison Between Wound Vacuum Dressing and Standard Closure to Reduce Rates of Surgical Site Infections | January 2017 | June 30, 2018 |
| NCT00837239 | Completed | Phase 2 | Huachansu & Gemcitabine in Pancreatic Cancer | June 2007 | July 2012 |
| NCT01396681 | Completed | Phase 2 | Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic Cancer | December 2004 | June 2011 |
| NCT01656044 | Completed | N/A | Negative Pressure Therapy in Preventing Infection After Surgery in Patients With Colon, Rectal, Pancreatic, or Peritoneal Surface Cancer | June 2012 | October 2016 |
| NCT00504998 | Completed | Phase 1/Phase 2 | Safety/Efficacy Study of Rexin-G to Treat Pancreatic Cancer | July 2007 | June 2011 |
| NCT04672460 | Completed | Phase 1 | A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors | December 21, 2020 | July 22, 2022 |
| NCT01472198 | Completed | Phase 2 | A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma | November 2011 | February 2015 |
| NCT01888978 | Completed | Phase 2 | Molecularly Tailored Therapy for Pancreas Cancer | December 2012 | January 24, 2018 |
| NCT00785421 | Completed | Phase 2/Phase 3 | Chemotherapy With or Without Enoxaparin in Pancreatic Cancer | April 2004 | June 2009 |
| NCT00225745 | Completed | Ghrelin Levels in Pancreatic Cancer Patients | April 2004 | September 2015 | |
| NCT01444456 | Completed | Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia | October 2011 | ||
| NCT01905150 | Completed | Phase 2 | Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer | July 2014 | January 2020 |
| NCT00389610 | Completed | Phase 2 | Adjuvant GVAX Vaccine Therapy in Patients With Pancreatic Cancer | September 11, 2006 | December 10, 2022 |
| NCT02695966 | Completed | EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary Pancreatic Cancer | May 2015 | July 2018 | |
| NCT00660699 | Completed | Phase 2 | A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers | September 2002 | September 2012 |
| NCT01947166 | Completed | N/A | Pancreatic Resection, Malnutrition and Readmission | December 2013 | June 2016 |
| NCT06195254 | Completed | Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Cancer | December 1, 2020 | December 15, 2023 | |
| NCT02648880 | Completed | N/A | Preoperative Exercise in Pancreatic Cancer | May 10, 2016 | January 2021 |
| NCT00994721 | Completed | A Phase III Study of Pancreatic Cancer | February 2009 | January 2016 | |
| NCT01809028 | Completed | N/A | Evaluating the Number of Passes Required for Diagnostic Cell Block During EUS-FNA of Solid Pancreatic Mass Lesions | February 2013 | January 2014 |
| NCT04542291 | Completed | Phase 1 | Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition | February 25, 2021 | January 19, 2022 |
| NCT00252889 | Completed | Phase 1 | Doxil Topotecan Doublet Cancer Study | May 2004 | June 2008 |
| NCT02887599 | Completed | N/A | Assessment of the Cytotoxic Immune Status of Pancreatic Cancer Patients and the Severity of the Cancer Using Measurement of Natural Killer Cell Activities | August 8, 2016 | December 20, 2017 |
| NCT02628860 | Completed | Phase 2 | Efficacy of Ferric Carboxymaltose (Ferinject®) in Anemic Patients Anticipating Pancreatoduodenectomy | January 2014 | April 27, 2020 |
| NCT04560270 | Completed | N/A | CIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic Cancer | April 25, 2016 | November 15, 2019 |
| NCT00674973 | Completed | Phase 2 | A Biomarker Identification Trial of Tarceva (Erlotinib) in Patients With Advanced Pancreatic Cancer | June 2008 | March 2015 |
| NCT02024997 | Completed | Early Phase 1 | Improving Pancreas Radiotherapy Plans Using Respiration-driven Anatomic Deformation: A Pilot Study | January 2013 | |
| NCT01236053 | Completed | Cancer in Patients With Gabapentin (GPRD) | June 2010 | September 2010 | |
| NCT00303927 | Completed | Phase 2 | Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase Gene | December 2005 | |
| NCT00045747 | Completed | Phase 2 | UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer | July 2002 | September 2004 |
| NCT00600002 | Completed | Phase 1 | Administration as a Biological Adjuvant in Clinically-Staged, Resectable Pancreatic Adenocarcinoma | June 2004 | April 2018 |
| NCT00012220 | Completed | Phase 2 | Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas | January 2001 | April 2009 |
| NCT00084383 | Completed | Phase 2 | Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas | January 2002 | July 2006 |
| NCT00040833 | Completed | Phase 2 | Acupuncture and Acupressure in Treating Patients With Moderate or Severe Pain Related to Stage III or Stage IV Pancreatic Cancer | February 2002 | June 2003 |
| NCT01662609 | Completed | Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic Cancer | August 23, 2007 | August 16, 2022 | |
| NCT00401570 | Completed | Phase 2 | A Study of Volociximab in Combination With Gemcitabine in Metastatic Pancreatic Cancer | March 2005 | June 2008 |
| NCT00925769 | Completed | Phase 1 | ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer | January 2009 | December 2013 |
| NCT01189929 | Completed | Phase 1 | A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer | August 2010 | December 2016 |
| NCT04299048 | Completed | Phase 1 | Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia. | November 17, 2020 | March 30, 2022 |
| NCT00047710 | Completed | Phase 1 | Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer | September 2002 | July 2006 |
| NCT02511223 | Completed | Phase 2 | Efficacy and Safety of PARPi to Treat Pancreatic Cancer | July 2016 | April 18, 2021 |
| NCT02551991 | Completed | Phase 2 | Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma | October 19, 2015 | February 15, 2021 |
| NCT01459614 | Completed | Phase 2 | Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer | November 2011 | November 2016 |
| NCT01256034 | Completed | Phase 4 | Effects of Preoperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy | May 2009 | March 2012 |
| NCT02154737 | Completed | Phase 1 | Gemcitabine and Pulse Dose Erlotinib in Second Line Treatment of Advanced Pancreatic Cancer | July 2013 | September 3, 2020 |
| NCT02395016 | Completed | Phase 3 | A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer | April 2015 | November 2021 |
| NCT01186731 | Completed | Phase 2 | Efficacy and Safety Study of LE-DT to Treat Locally Advanced or Metastatic Pancreatic Cancer | April 2010 | December 2011 |
| NCT02055313 | Completed | Perceptions of Exceptional Patients in Cancer Care Relating to Their Unusual Survival | May 2012 | December 2020 | |
| NCT00338026 | Completed | Phase 1 | A Phase I Study of ECO-4601 in Patients With Advanced Cancer | February 2006 | August 2007 |
| NCT02080260 | Completed | Phase 2 | A Study of Regorafenib in Advanced Pancreatic Cancer Patients | June 6, 2014 | June 28, 2017 |
| NCT01986738 | Completed | A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer | January 2012 | September 2013 | |
| NCT00057876 | Completed | Phase 3 | Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer | August 29, 2003 | May 2009 |
| NCT00003810 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas | August 11, 1999 | |
| NCT03190265 | Completed | Phase 2 | Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer | December 14, 2017 | August 23, 2023 |
| NCT02347618 | Completed | N/A | Pilot Study of Short-Course Preoperative Stereotactic Body Radiation Therapy for Resectable Pancreatic Cancer | December 2014 | April 13, 2022 |
| NCT00068432 | Completed | Phase 2 | Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer | December 2003 | July 2005 |
| NCT00767273 | Completed | N/A | Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx | October 2006 | December 2007 |
| NCT00350142 | Completed | Phase 2 | Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer | April 2006 | October 2008 |
| NCT01317836 | Completed | PET-CT in Diagnosis of Pancreatic Cystic Neoplasms | March 2011 | January 2014 | |
| NCT00059826 | Completed | Phase 2 | Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer | March 2003 | February 2011 |
| NCT00003769 | Completed | Phase 2 | Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer | February 1999 | July 2001 |
| NCT00974610 | Completed | Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer. | August 2008 | January 2017 | |
| NCT04504916 | Completed | Phase 2 | A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Solid Tumors (MK-2140-002) | October 7, 2020 | June 12, 2023 |
| NCT00638612 | Completed | Phase 1 | AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01) | August 2008 | June 2015 |
| NCT00379639 | Completed | Phase 1 | A Study of Romidepsin (Depsipeptide) in Combination With Gemcitabine in Patients With Pancreatic and Other Advanced Solid Tumors | July 1, 2006 | July 1, 2008 |
| NCT04330716 | Completed | N/A | Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers | December 1, 2020 | December 31, 2023 |
| NCT00005832 | Completed | Phase 2 | S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | June 2000 | October 2005 |
| NCT02981719 | Completed | N/A | Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer | October 1, 2016 | October 1, 2020 |
| NCT01214720 | Completed | Phase 3 | A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer | July 2005 | October 2008 |
| NCT00019331 | Completed | Phase 2 | Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors | October 1997 | May 2007 |
| NCT03008304 | Completed | Phase 1/Phase 2 | High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic Cancer | December 1, 2016 | September 1, 2019 |
| NCT04395898 | Completed | Pancreaticoduodenectomy: Outcomes of a Complex Surgical Procedure From a Developing Country | January 1, 2020 | March 15, 2020 | |
| NCT00514163 | Completed | Phase 2 | GEM vs GEM+TS-1 for Advanced Pancreatic Cancer | June 2007 | December 2010 |
| NCT00499265 | Completed | Phase 2 | Gemcitabine With or Without WX-671 in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery | April 2007 | May 2010 |
| NCT01032057 | Completed | Phase 2 | Gemcitabine, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery | July 2009 | June 2013 |
| NCT03645148 | Completed | Phase 1 | Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Pancreatic Cancer | October 24, 2017 | April 1, 2021 |
| NCT00603863 | Completed | Phase 1/Phase 2 | Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic Cancer | January 2008 | December 2013 |
| NCT02974764 | Completed | Changes in Biomarkers From Blood Over Time in Patients With Pancreatic Adenocarcinoma | March 2016 | December 2018 | |
| NCT00003216 | Completed | Phase 3 | Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas | July 1998 | |
| NCT01135849 | Completed | B-Receptor Signaling in Cardiomyopathy | November 2008 | October 2010 | |
| NCT00511264 | Completed | Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal Tract | May 2007 | May 2008 | |
| NCT00639314 | Completed | N/A | Trial on the Evaluation of Pylorus-ring in Pancreaticoduodenectomy | October 2005 | March 2011 |
| NCT01320241 | Completed | Phase 2 | Radiation Stent Versus Self-expanding Metallic Stents (SEMS) for Palliative Treatment of Malignant Biliary Stricture | November 2008 | March 2012 |
| NCT04686747 | Completed | COVID - 19 and Advanced Gastro-intestinal Cancer Treatment | January 1, 2021 | June 30, 2021 | |
| NCT05906615 | Completed | Phase 2 | Intravenous Lidocaine for Pain Associated With Pancreatic Cancer and Chronic Pancreatitis | January 14, 2021 | July 1, 2023 |
| NCT00058201 | Completed | Phase 3 | Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer | July 2001 | September 2010 |
| NCT00540579 | Completed | Phase 1/Phase 2 | CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the Pancreas | November 2007 | January 2011 |
| NCT01833546 | Completed | Phase 1 | A Japanese Phase 1 Trial of TH-302 in Subjects With Solid Tumors and Pancreatic Cancer | April 18, 2013 | January 25, 2016 |
| NCT00002955 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas | August 1995 | June 2006 |
| NCT00735306 | Completed | Phase 1 | Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic Adenocarcinoma | July 2008 | October 2011 |
| NCT02241187 | Completed | N/A | Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection | September 12, 2014 | September 13, 2016 |
| NCT00183846 | Completed | Phase 1 | Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers | December 2000 | July 2009 |
| NCT02368860 | Completed | Phase 1 | OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma | September 17, 2013 | May 21, 2020 |
| NCT00967577 | Completed | Phase 1 | 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors | July 2009 | December 31, 2021 |
| NCT01693523 | Completed | Phase 2 | Minocycline Study in Pancreatic Cancer Patients | January 28, 2013 | September 19, 2018 |
| NCT02106884 | Completed | Phase 2 | Quality of Life in Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine and Nab-paclitaxel | April 2014 | April 29, 2019 |
| NCT01789073 | Completed | N/A | Preoperative Oral Immunonutrition for Patients With Pancreatic Cancer Undergoing Elective Surgery - Effect on Complications and Length of Hospital Stay | February 2013 | December 2013 |
| NCT00004879 | Completed | Phase 1 | Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer | April 2000 | |
| NCT04660695 | Completed | Nasobiliary Drain Assisted EUS-guided Gastroenterostomies in Unresectable Malignant Gastric Outlet Obstruction | August 15, 2019 | May 12, 2021 | |
| NCT00003025 | Completed | Phase 1 | Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer | March 1997 | July 2002 |
| NCT00005053 | Completed | Phase 2 | Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer | December 1999 | |
| NCT00462852 | Completed | Phase 2 | Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | April 2003 | November 2011 |
| NCT01058746 | Completed | N/A | Randomized Trial of Restrictive Versus Liberal Perioperative Fluid Management for Patients Undergoing Pancreatic Resection | January 2010 | September 2019 |
| NCT03316599 | Completed | Phase 1 | Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic Cancer | January 17, 2018 | July 29, 2021 |
| NCT01146054 | Completed | Phase 2 | Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma | October 2009 | October 2015 |
| NCT01346410 | Completed | N/A | Stereotactic Body Radiotherapy for Unresectable Pancreatic Cancer | September 2008 | July 2012 |
| NCT01175733 | Completed | Phase 1/Phase 2 | Chemoradiation With Gemcitabine in Combination With Panitumumab for Patients With Locally Advanced Pancreatic Cancer | July 8, 2010 | May 2016 |
| NCT00626158 | Completed | Phase 1 | Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers | February 2008 | December 2010 |
| NCT01608711 | Completed | Phase 2 | A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002 | August 7, 2012 | November 16, 2015 |
| NCT00556023 | Completed | Phase 1 | A Phase 1 Study Testing CP-675,206 In Combination With Gemcitabine In Patients With Previously Untreated, Advanced Pancreatic Cancer | June 2008 | August 2011 |
| NCT03205176 | Completed | Phase 1 | AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas | June 30, 2017 | April 8, 2021 |
| NCT02678442 | Completed | N/A | Endoscopic Ultrasound Guided Fine Needle Biopsy (EUS-FNB-SC) Using a Novel Fork Needle | May 16, 2016 | November 10, 2018 |
| NCT03869294 | Completed | GS Regimen as the First-line Chemotherapy in Chinese Advanced PC Patients | January 1, 2014 | December 31, 2017 | |
| NCT01383538 | Completed | Phase 1 | FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma | August 23, 2011 | May 26, 2015 |
| NCT00498225 | Completed | Phase 3 | Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer | July 2007 | June 2012 |
| NCT00427752 | Completed | Early Phase 1 | Abdominal Exploration Without Incisions | October 2006 | January 2012 |
| NCT00570713 | Completed | Phase 2 | An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer | December 2007 | December 2009 |
| NCT00806611 | Completed | Phase 3 | Intraoperative Celiac Plexus Neurolysis for Patients With Operable Pancreatic and Periampullary Cancer | September 2008 | April 2013 |
| NCT00266097 | Completed | Phase 1 | Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer | August 2004 | September 2011 |
| NCT00003951 | Completed | Phase 2 | DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas | June 1999 | April 2005 |
| NCT02022033 | Completed | Phase 2 | BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial | February 1, 2014 | March 17, 2022 |
| NCT03813368 | Completed | Whipples Resection in Octogenarians | February 20, 2019 | July 1, 2019 | |
| NCT02637596 | Completed | N/A | Quality of Life After Radiofrequency Ablation of Pancreatic Cancer | February 2013 | December 2015 |
| NCT00489515 | Completed | Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder | February 1999 | August 2010 | |
| NCT01041612 | Completed | Phase 4 | Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi | January 2010 | September 2012 |
| NCT00655785 | Completed | Phase 1/Phase 2 | Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2) | September 2007 | March 2013 |
| NCT02526017 | Completed | Phase 1 | Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers | September 8, 2015 | November 18, 2019 |
| NCT04803305 | Completed | Phase 1 | Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia | May 11, 2021 | August 9, 2022 |
| NCT01977066 | Completed | N/A | Exercise Intervention Study for Pancreatic Cancer Patients | November 2013 | December 2016 |
| NCT00628186 | Completed | N/A | Randomized Controlled Trial on Pancreatic Stent Tube in Pancreaticoduodenectomy | April 2005 | February 2008 |
| NCT01038713 | Completed | N/A | Plastic vs. Covered Metal vs. Uncovered Metal Biliary Stents for the Management of Malignant Biliary Obstruction | December 2009 | December 2013 |
| NCT00666978 | Completed | Phase 4 | Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking | December 2007 | June 2010 |
| NCT00900003 | Completed | Studying Biomarkers in Patients With Pancreatic Cancer | May 2007 | March 2013 | |
| NCT02646748 | Completed | Phase 1 | Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors | January 25, 2016 | November 20, 2020 |
| NCT01984658 | Completed | Phase 1 | A Prospective, Open Phase I Study to Investigate the Tolerability and Efficacy of ALECSAT to Pancreas Cancer Patients | October 2013 | September 2015 |
| NCT04596865 | Completed | Recurrence After Whipple's (RAW) Study | October 12, 2020 | June 30, 2023 | |
| NCT04595058 | Completed | N/A | LAMS Choledochoduodenostomies: With or Without Coaxial Plastic Stent | November 17, 2020 | October 17, 2023 |
| NCT01838109 | Completed | N/A | Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery | April 2013 | April 2014 |
| NCT01589328 | Completed | N/A | Effect of Early Management on PAin and DEpression in Patients With PancreatoBiliary Cancer, EPADE-PB | March 15, 2012 | June 30, 2017 |
| NCT01769248 | Completed | N/A | Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle | September 2012 | February 2014 |
| NCT00733850 | Completed | Phase 2 | Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer | August 2008 | June 2014 |
| NCT03187028 | Completed | N/A | Diet and Exercise After Pancreatic Cancer | August 3, 2017 | September 30, 2021 |
| NCT00202800 | Completed | Phase 2 | Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer | March 2002 | January 2011 |
| NCT03152487 | Completed | N/A | Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis | April 24, 2017 | August 1, 2018 |
| NCT00366457 | Completed | Phase 2 | Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer | August 2006 | July 2011 |
| NCT01051284 | Completed | Phase 1 | A Study of Gemcitabine and Cyberknife Radiation Therapy for Pancreatic Cancer | November 2009 | March 2012 |
| NCT00003923 | Completed | Phase 2 | Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas | March 1999 | February 2002 |
| NCT01298401 | Completed | Phase 1 | Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas | February 2012 | November 2013 |
| NCT00288925 | Completed | Phase 1/Phase 2 | Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment | September 2005 | |
| NCT03017599 | Completed | N/A | Yield Rate for Procurement the Histologic Core With Endoscopic Ultrasound-guided Fine Needle Biopsy With 20-gauge Ultrasound Biopsy Needles for Solid Pancreatic Masses: Pilot Study | July 11, 2016 | July 10, 2017 |
| NCT00997958 | Completed | Phase 1 | Study of CellCept for Advanced Pancreatic Cancer | June 2004 | January 2009 |
| NCT02777710 | Completed | Phase 1 | Evaluation of Safety and Activity of an Anti-PDL1 Antibody (DURVALUMAB) Combined With CSF-1R TKI (PEXIDARTINIB) in Patients With Metastatic/Advanced Pancreatic or Colorectal Cancers | June 2016 | December 2019 |
| NCT01020006 | Completed | Phase 2 | Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine | November 2009 | |
| NCT00192712 | Completed | Phase 2/Phase 3 | Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer | November 2002 | September 2010 |
| NCT00030732 | Completed | Phase 3 | Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer | June 2001 | April 2008 |
| NCT03717298 | Completed | Phase 2 | Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma | October 30, 2018 | January 20, 2023 |
| NCT00544193 | Completed | Phase 1 | Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer | December 1997 | August 2012 |
| NCT00536614 | Completed | Phase 2 | Gemcitabine/Cisplatin +/-Cetuximab in Patients With Locally Advanced or Metastatic EGFR-Positive Pancreatic Cancer | May 2005 | September 2006 |
| NCT01209962 | Completed | A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response | May 2008 | May 26, 2015 | |
| NCT02237157 | Completed | Phase 1 | A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic Cancer | March 2015 | September 2016 |
| NCT01781520 | Completed | Phase 1/Phase 2 | Study of S-1 Plus DC-CIK for Patients With Unresectable Locally Advanced Pancreatic Cancer | June 1, 2013 | June 13, 2017 |
| NCT03599154 | Completed | Evaluation of GEMCITEST in Patients With Pancreatic Cancer and Treated by Chemotherapy | January 30, 2018 | November 25, 2020 | |
| NCT06093009 | Completed | The Significance of Postoperative Muscle Wasting in Pancreatic Cancer | June 2002 | June 2023 | |
| NCT00565487 | Completed | Phase 1 | Combination Study of Capecitabine and Erlotinib Concurrent With Radiotherapy for Non-Operable Advanced Pancreatic Cancer | December 2007 | August 5, 2014 |
| NCT00583479 | Completed | Phase 4 | Prospective Study of Celiac Block Injection: 1 vs. 2 | June 2002 | July 2008 |
| NCT01587534 | Completed | Phase 2 | Pancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer (PESUP) | October 2011 | December 2014 |
| NCT01593995 | Completed | Phase 2 | EGF Ointment for Erlotinib Skin Lesion | May 2012 | October 2014 |
| NCT00569387 | Completed | Phase 2 | Vaccine Study for Surgically Resected Pancreatic Cancer | December 2007 | December 2014 |
| NCT01931644 | Completed | At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions | July 2013 | April 2024 | |
| NCT02283372 | Completed | Phase 1 | Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic Cancer | January 21, 2015 | April 18, 2019 |
| NCT02311361 | Completed | Phase 1/Phase 2 | Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer | March 25, 2015 | December 31, 2020 |
| NCT00599833 | Completed | Phase 2 | Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery | May 2007 | October 2010 |
| NCT00290693 | Completed | Phase 2 | Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer | July 2004 | June 2010 |
| NCT03510754 | Completed | Endoscopic Ultrasound-guided Biliary Drainage for Malignant Biliary Obstruction After Failed ERCP | January 1, 2011 | December 8, 2017 | |
| NCT06378853 | Completed | Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients | January 1, 2019 | February 28, 2024 | |
| NCT00673504 | Completed | Phase 2 | First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic Cancer | April 2008 | November 2011 |
| NCT00983268 | Completed | Phase 1 | Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer | October 2009 | February 2013 |
| NCT00709462 | Completed | Phase 1 | A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01) | March 2004 | June 2010 |
| NCT00004895 | Completed | Phase 2 | Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | October 1999 | October 2002 |
| NCT00303758 | Completed | Phase 3 | Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery | October 2005 | March 2012 |
| NCT00053222 | Completed | Phase 2 | Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine | February 2003 | July 2007 |
| NCT00096707 | Completed | Phase 1 | Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors | February 2004 | July 2008 |
| NCT03117920 | Completed | Phase 2 | A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic Cancer | April 10, 2017 | July 1, 2019 |
| NCT00837876 | Completed | Phase 2 | Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery | October 2008 | November 2012 |
| NCT03331562 | Completed | Phase 2 | A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer | December 27, 2017 | July 10, 2020 |
| NCT02650804 | Completed | Phase 2 | BPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer Patients | July 6, 2016 | June 11, 2019 |
| NCT04624217 | Completed | Phase 1/Phase 2 | A Trial of SHR-1701 in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Pancreatic Cancer | November 24, 2020 | February 8, 2023 |
| NCT00489671 | Completed | Urine Cadmium Levels in Predicting Pancreatic Cancer Risk in Patients With Chronic Pancreatitis | June 2003 | August 2007 | |
| NCT00027534 | Completed | Phase 1 | Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer | January 2002 | October 2007 |
| NCT02578732 | Completed | Phase 2 | FOLFOX-A For Locally Advanced Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial | July 12, 2016 | March 16, 2022 |
| NCT00376987 | Completed | Phase 2 | Zinc Supplements in Lowering Cadmium Levels in Smokers | December 2003 | June 2015 |
| NCT02909296 | Completed | Endoscopic Drainage of Collections After Pancreatic Surgery | April 2007 | April 2016 | |
| NCT00950144 | Completed | Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver Cancer | December 2008 | October 2010 | |
| NCT02940067 | Completed | N/A | Enhancing Fitness Before Pancreatic Surgery | March 28, 2017 | August 20, 2018 |
| NCT01858883 | Completed | Phase 1/Phase 2 | Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors | June 2013 | March 2016 |
| NCT01939665 | Completed | Phase 1/Phase 2 | PANFIRE Study: Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma | September 2013 | October 2016 |
| NCT03180437 | Completed | Phase 1/Phase 2 | Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer | June 15, 2017 | June 15, 2019 |
| NCT00234416 | Completed | Phase 1/Phase 2 | IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic Cancer | August 2002 | March 2005 |
| NCT01505530 | Completed | Phase 2 | A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer | December 2011 | January 2016 |
| NCT00581815 | Completed | Phase 1 | Spectroscopy With Surface Coils and Decoupling | February 1997 | February 2014 |
| NCT03829748 | Completed | N/A | Intermittent Suction Technique in the Diagnosis of Pancreatic Solid Lesions | January 16, 2019 | March 1, 2020 |
| NCT01104077 | Completed | Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN) | November 17, 2008 | April 27, 2021 | |
| NCT01782690 | Completed | An Observational Study of Erlotinib Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer | March 31, 2012 | February 28, 2015 | |
| NCT00568646 | Completed | Phase 2 | Phase 2 Study of Oral MKC-1 in Patients With Unresectable or Metastatic Pancreatic Cancer | November 2007 | May 2009 |
| NCT00901680 | Completed | Creation of the BioBank, Early Detection and Discovery Biomarkers | August 2008 | January 2012 | |
| NCT04281511 | Completed | A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy | April 3, 2019 | September 30, 2023 | |
| NCT00026338 | Completed | Phase 3 | Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer | October 29, 2001 | February 10, 2009 |
| NCT03494023 | Completed | EUS Evaluation of CBD Diameter in Malignant Obstructive Jaundice | March 27, 2018 | April 15, 2020 | |
| NCT00584363 | Completed | Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection | June 2004 | September 2017 | |
| NCT00968175 | Completed | N/A | Endoscopic Ultrasound (EUS) Guided-Celiac Plexus Neurolysis (CPN) in Unresectable Pancreatic Cancer | June 2009 | December 2013 |
| NCT01219829 | Completed | Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic Adenocarcinoma | March 18, 2009 | April 27, 2021 | |
| NCT01268384 | Completed | Phase 2 | Neoadjuvant FDR GX in Locally Advanced Pancreatic Cancer | April 2006 | August 2011 |
| NCT02960594 | Completed | Phase 1 | hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse | December 2014 | November 9, 2018 |
| NCT01385956 | Completed | Phase 1 | SOM 230 and Gemcitabine in Advanced Pancreatic Cancer | June 2011 | November 2014 |
| NCT00280709 | Completed | Phase 4 | Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction | January 2006 | August 2010 |
| NCT01129167 | Completed | Frequency of Methods of Local Invasion of Pancreatic Adenocarcinoma | September 15, 2009 | September 30, 2022 | |
| NCT00601627 | Completed | Phase 2 | Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery | June 2009 | May 2013 |
| NCT00745381 | Completed | A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors | August 2008 | July 30, 2020 | |
| NCT03153410 | Completed | Early Phase 1 | Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas | September 27, 2018 | January 25, 2024 |
| NCT00460174 | Completed | Phase 2 | Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients With Localized Pancreatic Cancer | October 10, 2005 | July 16, 2010 |
| NCT00923299 | Completed | Phase 1/Phase 2 | Cetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With Gemcitabine | December 2008 | March 2011 |
| NCT00003332 | Completed | Phase 1/Phase 2 | Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer | July 1997 | |
| NCT00102700 | Completed | Phase 2 | ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer | January 2005 | January 2007 |
| NCT00664482 | Completed | N/A | A Single-Patient Study Using AGS 006 | May 2007 | October 2011 |
| NCT00064207 | Completed | Phase 2/Phase 3 | Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer | May 2003 | |
| NCT00550836 | Completed | Phase 2 | Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer | March 2009 | May 2013 |
| NCT02138383 | Completed | Phase 1 | Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic Cancer | May 22, 2014 | October 7, 2019 |
| NCT00448838 | Completed | N/A | Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | May 2006 | March 2011 |
| NCT00372944 | Completed | Phase 2 | AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy | August 2006 | October 2008 |
| NCT00003426 | Completed | Phase 1 | Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer | April 1998 | March 2002 |
| NCT00003157 | Completed | Phase 1 | Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach | February 1998 | May 2003 |
| NCT02050178 | Completed | Phase 1 | Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer | November 2013 | June 15, 2017 |
| NCT00919659 | Completed | Phase 2 | Parenteral Nutrition Support for Patients With Pancreatic Cancer | January 2002 | May 2004 |
| NCT04807972 | Completed | Phase 1/Phase 2 | Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis | May 28, 2021 | March 25, 2024 |
| NCT00383760 | Completed | Phase 2 | Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients | August 2006 | July 2011 |
| NCT03469375 | Completed | Modified-FOLFIRINOX Regimen Based Neoadjuvant Therapy in Chinese Patients With Locally Advanced Pancreatic Cancer | April 1, 2014 | November 1, 2017 | |
| NCT01523457 | Completed | Phase 2 | Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer | October 2011 | December 2015 |
| NCT00185588 | Completed | Phase 1/Phase 2 | Phase 1-2 Vatalanib and Gemcitabine in Advanced Pancreatic Cancer | October 2004 | December 2009 |
| NCT00003029 | Completed | Phase 3 | Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas | May 1997 | |
| NCT00409292 | Completed | Phase 2 | RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer | January 2007 | May 2009 |
| NCT00994110 | Completed | Phase 3 | Placebo Controlled Trial of SOM230 for the Reduction of Post-Pancreatectomy Fistula, Leak, and Abscess | October 2009 | September 2014 |
| NCT02486497 | Completed | N/A | Adjuvant Gemcitabine Versus 5-FU/Leucovorin Based on hENT1 Immunostaining | June 2015 | May 2017 |
| NCT05589480 | Completed | Machine Learning for Recurrence Risk of Pancreatic Cancer After Radical Resection | August 1, 2022 | September 1, 2022 | |
| NCT01202136 | Completed | The Clinical,Radiologic,Pathologic and Molecular Marker Characteristics of Pancreatic Cysts Study | October 2012 | September 2019 | |
| NCT00006387 | Completed | Phase 1 | Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer | October 2000 | January 2002 |
| NCT06278493 | Completed | Phase 1/Phase 2 | A Clinical Study of AL2846 Capsule Combined With Gemzar Injection in the Treatment of Advanced Pancreatic Cancer | August 23, 2018 | May 1, 2023 |
| NCT00667082 | Completed | Phase 1 | NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma | March 2008 | January 2010 |
| NCT03985072 | Completed | Phase 1 | Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor | April 26, 2019 | February 17, 2022 |
| NCT00078975 | Completed | Phase 2 | 3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer | April 2004 | January 7, 2009 |
| NCT01132755 | Completed | Phase 2 | Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal Lavage | May 2010 | August 16, 2017 |
| NCT00058149 | Completed | Phase 3 | Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | March 2003 | |
| NCT02098291 | Completed | Phase 2 | An Open, Single-center Study to Determine the Antibody Repsonse to Gastrimmune and Its Safety and Tolerability in Patients With Advanced Pancreatic Carcinoma | April 1999 | February 2002 |
| NCT00920023 | Completed | Phase 4 | Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI) | July 2008 | February 2013 |
| NCT01416662 | Completed | Phase 2 | Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery | June 2011 | September 2015 |
| NCT02005315 | Completed | Phase 1 | A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer | September 2013 | November 2017 |
| NCT00004003 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery | April 1999 | August 2003 |
| NCT02042378 | Completed | Phase 2 | A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation | April 2014 | May 2016 |
| NCT00352131 | Completed | Phase 1 | Maytansinoid DM4-Conjugated Humanized Monoclonal Antibody huC242 in Treating Patients With Solid Tumors | February 2005 | December 2009 |
| NCT00536874 | Completed | Phase 2 | Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery | October 2007 | February 2017 |
| NCT00408564 | Completed | Phase 2 | Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery | January 2006 | April 2013 |
| NCT01161186 | Completed | Phase 1 | Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma | July 2010 | October 2012 |
| NCT00238199 | Completed | Phase 2 | Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer | June 2002 | August 2006 |
| NCT01876069 | Completed | N/A | Comparing Newly Developed PreCore Needle With Conventional Fine Needle in Suspected Unresectable Pancreatic Cancer | July 2013 | February 2015 |
| NCT01041235 | Completed | Phase 1 | Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies | December 2009 | December 2011 |
| NCT01098344 | Completed | Phase 1 | MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by Surgery | April 2010 | October 2014 |
| NCT01248637 | Completed | Study of Intratumoral Hypoxia Using Pre-operative Administration of Pimonidazole | October 2010 | December 2017 | |
| NCT00055250 | Completed | Phase 2 | A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer | January 2003 | October 2005 |
| NCT00622674 | Completed | Phase 1 | Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors | November 2005 | February 2010 |
| NCT00761241 | Completed | Phase 2 | Borderline Resectable Pancreatic Cancer: Gemcitabine/Docetaxel and Oxaliplatin Based Chemo/RT | September 2008 | April 2010 |
| NCT00023972 | Completed | Phase 3 | Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | July 2001 | April 2005 |
| NCT00836992 | Completed | Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer | January 2009 | July 27, 2015 | |
| NCT01191814 | Completed | N/A | Comparison of Metal and Plastic Stents for Preoperative Biliary Decompression | July 2010 | October 13, 2022 |
| NCT00966277 | Completed | Phase 4 | Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients | April 2010 | September 2014 |
| NCT00654160 | Completed | Phase 1 | Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer | June 2008 | December 3, 2012 |
| NCT00622622 | Completed | Phase 1 | Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic Cancer | November 2006 | February 2009 |
| NCT04380766 | Completed | Covid-19 Pandemic and Pancreatic Surgery in Italy | January 1, 2019 | July 31, 2020 | |
| NCT00005858 | Completed | Phase 1 | LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer | April 2000 | December 2003 |
| NCT00161213 | Completed | Phase 2 | Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer | September 2005 | October 2010 |
| NCT01521325 | Completed | Phase 1 | A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers | September 2011 | March 2013 |
| NCT02272738 | Completed | Phase 1 | A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic Cancer | August 2013 | April 2016 |
| NCT03184870 | Completed | Phase 1/Phase 2 | A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors | August 8, 2017 | June 14, 2023 |
| NCT03228095 | Enrolling by invitation | Volatiles in Breath and Headspace Analysis - Diagnostic Markers | July 24, 2017 | December 31, 2025 | |
| NCT06283576 | Enrolling by invitation | Pancreatic Cancer Initial Detection Via Liquid Biopsy | May 1, 2024 | December 31, 2027 | |
| NCT05600933 | Enrolling by invitation | Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment | May 15, 2023 | June 15, 2033 | |
| NCT05223218 | Enrolling by invitation | Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study | August 25, 2021 | December 2023 | |
| NCT04137822 | No longer available | Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer | |||
| NCT02449135 | No longer available | Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Carcinoma | |||
| NCT04087889 | No longer available | Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer | |||
| NCT05585554 | Not yet recruiting | N/A | Locally Advanced Pancreatic Cancer Treated With ABLAtivE Stereotactic MRI-guided Adaptive Radiation Therapy | July 2023 | December 2028 |
| NCT06276803 | Not yet recruiting | The LINFU® U.S. Registry for the in the General Population Without Risk Factors | June 15, 2024 | June 15, 2034 | |
| NCT05188573 | Not yet recruiting | N/A | EpiDetect Study: Clinical Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Patients | June 1, 2022 | May 31, 2025 |
| NCT06319755 | Not yet recruiting | Characteristics of Intestinal Microbiome Following Pancreatic Surgery | March 2024 | February 2025 | |
| NCT06166147 | Not yet recruiting | A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early Detection | December 22, 2023 | March 31, 2027 | |
| NCT06465069 | Not yet recruiting | Phase 1 | A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors | June 2024 | May 2027 |
| NCT06196658 | Not yet recruiting | Early Phase 1 | Early Phase I Study of Autologous T Cells (EX02 CAR-T) for Unresectable Pancreatic/Bile Duct Cancer | January 1, 2024 | December 31, 2027 |
| NCT06233877 | Not yet recruiting | Phase 2 | Clinical Trial Evaluating Low Dose G-FLIP Plus Mitomycin C for Stage IV Pancreatic Cancer | March 15, 2024 | January 31, 2028 |
| NCT06375473 | Not yet recruiting | Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients | April 19, 2024 | April 19, 2027 | |
| NCT05369312 | Not yet recruiting | Phase 1 | Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients | June 2022 | May 1, 2025 |
| NCT06134765 | Not yet recruiting | Phase 2 | Bemalenograstim Alfa for the Prevention in Patients With Colorectal Cancer/Pancreatic Cancer | November 30, 2023 | March 30, 2025 |
| NCT06435260 | Not yet recruiting | Phase 2 | To Explore the Efficacy of Hypofractionated Radiotherapy Followed by AG Regimen Chemotherapy Plus Camrelizumab Immunotherapy as Neoadjuvant Therapy for Locally Advanced Pancreatic Cancer | June 1, 2024 | June 1, 2027 |
| NCT05903703 | Not yet recruiting | N/A | Canagliflozin With Gemcitabine in Pancreatic Carcinoma | October 1, 2023 | March 31, 2027 |
| NCT06203821 | Not yet recruiting | Phase 1 | Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer | July 1, 2024 | December 31, 2027 |
| NCT06134960 | Not yet recruiting | Phase 1 | NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor | November 16, 2023 | November 15, 2026 |
| NCT05470738 | Not yet recruiting | PAncreas Borderline and Locally Advanced Snapshot Study | September 15, 2022 | September 15, 2024 | |
| NCT06370754 | Not yet recruiting | Phase 1/Phase 2 | Newly Emerging Immunotherapy for Pancreatic Cancer Treatment | April 30, 2024 | April 30, 2027 |
| NCT06409429 | Not yet recruiting | Phase 2/Phase 3 | Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer | May 1, 2024 | May 30, 2027 |
| NCT06310993 | Not yet recruiting | N/A | Exercise to Boost Immunity in Advanced Cancer | September 1, 2024 | March 1, 2026 |
| NCT05755594 | Not yet recruiting | N/A | A Prospective Study on the Safety and Efficacy of Robot-assisted Pancreaticoduodenectomy | June 1, 2023 | June 1, 2031 |
| NCT05632328 | Not yet recruiting | Phase 2 | AGEN1423 Plus Balstilimab With or Without Chemo in Pancreatic Cancer | April 2024 | May 1, 2027 |
| NCT05010226 | Not yet recruiting | Focused Ultrasound for the Treatment of Pancreatic Cancer - an International Registry | September 2021 | September 2026 | |
| NCT06353646 | Not yet recruiting | N/A | XH001 Combination With Ipilimumab and Chemotherapy for Patients With Resected Pancreatic Cancer | April 2024 | December 2026 |
| NCT06054308 | Not yet recruiting | N/A | Mesothelin-targeted CAR-T Cells as a Neo-adjuvant Treatment in Patients With Resectable Pancreatic Cancers: a Feasibility Study | February 2, 2024 | August 2, 2026 |
| NCT06384417 | Not yet recruiting | N/A | Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2 | June 2024 | December 2026 |
| NCT05755607 | Not yet recruiting | N/A | A Multicenter Prospective Randomized Controlled Study of RPD Versus LPD | June 1, 2023 | July 1, 2031 |
| NCT05663515 | Not yet recruiting | A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs | June 17, 2024 | March 31, 2025 | |
| NCT04381130 | Not yet recruiting | Phase 1/Phase 2 | A Phase I/IIa Study of EF-009 in Patients With Pancreatic Cancer | September 1, 2024 | December 1, 2026 |
| NCT06205849 | Not yet recruiting | Phase 1 | Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer | June 1, 2024 | August 2029 |
| NCT06427239 | Not yet recruiting | Phase 1/Phase 2 | Exploratory Clinical Study of HRS-4642 Combined With Adebelimab in the Treatment of Advanced Pancreatic Cancer | June 2024 | September 2026 |
| NCT06026943 | Not yet recruiting | N/A | Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic Cancer | September 2024 | January 2028 |
| NCT06313970 | Not yet recruiting | Phase 2 | First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC Patients | April 15, 2024 | April 15, 2026 |
| NCT06234072 | Not yet recruiting | Phase 2 | Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer Patients | February 2024 | January 2027 |
| NCT06196671 | Not yet recruiting | Phase 2 | Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic Cancer | December 1, 2024 | January 1, 2028 |
| NCT05185869 | Not yet recruiting | Phase 2 | SHR6390 Plus Nab-paclitaxel and Gemcitabine in Advanced/Metastatic Pancreatic Cancer | January 2022 | October 2025 |
| NCT05810792 | Not yet recruiting | Phase 2 | Histamine Dihydrochloride and Interleukin-2 in Primary Resectable Pancreatic Cancer | April 1, 2024 | April 1, 2028 |
| NCT05289895 | Not yet recruiting | Prognostic Biomarkers of Pancreatic Cancer Based on Proteomic Techniques | April 1, 2022 | December 30, 2024 | |
| NCT05859750 | Not yet recruiting | Phase 2 | A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer | May 2023 | June 2025 |
| NCT06456281 | Not yet recruiting | Multi-omics Model for Pancreatic Cancer Screening Using cfDNA | June 15, 2024 | December 30, 2025 | |
| NCT05184790 | Not yet recruiting | LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology | January 31, 2024 | January 31, 2026 | |
| NCT06153368 | Not yet recruiting | Phase 2 | Cadonilimab Plus mFOLFIRINOX as Conversion Therapy in LAPC | December 19, 2023 | November 27, 2025 |
| NCT06411691 | Not yet recruiting | Phase 2 | KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer | August 2024 | August 2027 |
| NCT05093231 | Not yet recruiting | Phase 2 | Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer | June 17, 2024 | May 4, 2026 |
| NCT06282809 | Not yet recruiting | N/A | The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy | June 2024 | January 2026 |
| NCT04847297 | Not yet recruiting | Preoperative Biliary Drainage in Malignant Biliary Obstruction | September 1, 2021 | December 31, 2026 | |
| NCT06387342 | Not yet recruiting | Phase 2 | Namodenoson Treatment of Advanced Pancreatic Cancer | July 15, 2024 | December 15, 2026 |
| NCT04449289 | Not yet recruiting | Phase 2 | Influence of Local Anesthetic Administration on the Cancer Recurrence Rate After Pancreatic Oncologic Surgery | July 1, 2020 | December 31, 2024 |
| NCT06210360 | Not yet recruiting | Phase 2 | Perioperative Treatment in High-risk Resectable Pancreatic Cancer With NALIRIFOX | February 1, 2024 | April 1, 2027 |
| NCT03301805 | Not yet recruiting | Phase 2 | A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer | July 1, 2024 | June 30, 2026 |
| NCT06276738 | Not yet recruiting | The LINFU® U.S. Registry in Patients With Clinical Signs and/or Symptoms of Disease | June 30, 2024 | May 1, 2034 | |
| NCT06298916 | Not yet recruiting | Phase 1/Phase 2 | 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer | May 2024 | April 2026 |
| NCT06291324 | Not yet recruiting | WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer Treatment | July 2024 | December 15, 2025 | |
| NCT05400408 | Not yet recruiting | N/A | Chemical Profiling of Colorectal and Pancreatic Cancers Using Breath Analysis - Feasibility Study | May 1, 2024 | March 31, 2025 |
| NCT06156267 | Not yet recruiting | Early Phase 1 | Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino | January 2024 | March 2027 |
| NCT06440018 | Not yet recruiting | INSPIRE: A Multi-Cancer Early Detection Study | June 20, 2024 | February 28, 2025 | |
| NCT06268106 | Not yet recruiting | N/A | Graphic Novel for Patients Undergoing EUS-FNB | March 1, 2024 | August 1, 2024 |
| NCT06233864 | Not yet recruiting | Phase 2 | A Study of the Treatment of Disitamab Vedotin in Patients With Locally Advanced or Metastatic Pancreatic Cancer | April 17, 2024 | April 17, 2026 |
| NCT06395337 | Not yet recruiting | Phase 1/Phase 2 | Multimodal Imaging in Rectal Cancer & Pancreatic Cancer | May 2, 2024 | June 2, 2025 |
| NCT06259058 | Not yet recruiting | Phase 1/Phase 2 | Stereotactic Body Radiation Therapy Followed by NALIRIFOX vs NALIRIFOX for Borderline Resectable Pancreatic Cancer | April 1, 2024 | December 1, 2027 |
| NCT06346808 | Not yet recruiting | Phase 1 | Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPC | May 1, 2024 | May 1, 2027 |
| NCT06375954 | Not yet recruiting | N/A | EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial) | May 1, 2024 | May 1, 2027 |
| NCT06361030 | Not yet recruiting | Phase 2 | Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer | June 1, 2024 | June 1, 2027 |
| NCT06217042 | Not yet recruiting | Phase 3 | HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer | February 5, 2024 | July 30, 2028 |
| NCT05438459 | Recruiting | Phase 1/Phase 2 | GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites | June 8, 2022 | June 8, 2027 |
| NCT05827796 | Recruiting | Phase 1/Phase 2 | IN10018+ Standard Chemotherapy (+KN046) in Subjects With Advanced Pancreatic Cancer | December 8, 2022 | March 2026 |
| NCT06224387 | Recruiting | Phase 1/Phase 2 | CTS2190 Phase I /II Clinical Study in Patients | June 26, 2023 | October 31, 2025 |
| NCT03787056 | Recruiting | N/A | Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients | December 4, 2018 | January 4, 2028 |
| NCT05861336 | Recruiting | Phase 2 | GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic Cancer | June 14, 2023 | August 2029 |
| NCT04371224 | Recruiting | Phase 2 | NaliCap (Irinotecan Liposome (Nal-IRI)/Capecitabine) vs. NAPOLI (Nal-IRI/5-FU/LV) ) in Advanced Pancreatic Cancer | June 23, 2020 | December 31, 2025 |
| NCT04801095 | Recruiting | Phase 1 | A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors | July 14, 2021 | August 8, 2025 |
| NCT05802407 | Recruiting | N/A | The Value of Molecular Residual Disease Monitoring Based on ctDNA in Resected Pancreatic Cancer | February 1, 2023 | February 1, 2030 |
| NCT04396821 | Recruiting | Phase 1/Phase 2 | A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors | May 28, 2020 | December 31, 2024 |
| NCT06202014 | Recruiting | Phase 2 | Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC | January 31, 2024 | December 31, 2025 |
| NCT05259696 | Recruiting | Phase 1/Phase 2 | Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) | February 11, 2022 | June 2025 |
| NCT05111353 | Recruiting | Phase 1 | Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery | December 15, 2022 | December 31, 2027 |
| NCT06388967 | Recruiting | Pancreatic Cancer Detection Consortium | March 15, 2023 | November 21, 2025 | |
| NCT05638269 | Recruiting | A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China | March 1, 2022 | December 2025 | |
| NCT05964621 | Recruiting | Venous Thromboembolism in Primary Pancreatic Tumour Resection | September 1, 2023 | October 1, 2024 | |
| NCT05657743 | Recruiting | N/A | A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer | August 16, 2023 | November 2025 |
| NCT05989724 | Recruiting | Phase 1 | A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors | September 19, 2023 | March 2026 |
| NCT03556228 | Recruiting | Phase 1 | Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma | June 8, 2018 | June 2026 |
| NCT04104230 | Recruiting | Quebec Pancreas Cancer Study | March 12, 2012 | January 2025 | |
| NCT06071507 | Recruiting | Management of Malignant Gastric Outlet Obstruction Between Surgery and Endoscopy | April 15, 2024 | December 2027 | |
| NCT05727020 | Recruiting | Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma | December 15, 2022 | January 2025 | |
| NCT05141513 | Recruiting | Phase 1 | Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma | May 6, 2022 | April 2028 |
| NCT05975593 | Recruiting | MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial | December 19, 2023 | December 31, 2032 | |
| NCT05700110 | Recruiting | Porto-Venous Radiomics in Pancreatic Cancer | May 5, 2022 | May 5, 2024 | |
| NCT05239143 | Recruiting | Phase 1 | P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors | February 15, 2022 | April 2039 |
| NCT05500027 | Recruiting | sCD8, as a Novel Biomarker for Pancreatic Cancer | May 1, 2021 | December 2025 | |
| NCT05461430 | Recruiting | Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) | July 15, 2022 | July 2026 | |
| NCT05875753 | Recruiting | Early Phase 1 | 68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic Cancer | June 1, 2022 | June 1, 2024 |
| NCT05411133 | Recruiting | Phase 1 | Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients | May 30, 2022 | August 2025 |
| NCT05886075 | Recruiting | Early Phase 1 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors | March 30, 2023 | March 2025 |
| NCT05494866 | Recruiting | Phase 1 | A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients With Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma | December 7, 2022 | February 28, 2025 |
| NCT03398291 | Recruiting | Phase 3 | Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy | July 1, 2018 | June 1, 2025 |
| NCT05583201 | Recruiting | Early Phase 1 | NKG2D/CLDN18.2 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumors | October 13, 2022 | June 1, 2026 |
| NCT06054984 | Recruiting | Early Phase 1 | TCR-T Cells in the Treatment of Advanced Pancreatic Cancer | September 7, 2021 | September 7, 2024 |
| NCT05076760 | Recruiting | Phase 1 | MEM-288 Oncolytic Virus Alone and in Combination With Nivolumab in Solid Tumors Including Non-Small Cell Lung Cancer | February 23, 2022 | November 2026 |
| NCT06447064 | Recruiting | Cancer Loyalty Card Study 2 (CLOCS-2) | April 29, 2024 | March 31, 2027 | |
| NCT03770559 | Recruiting | N/A | The Therapeutic Evaluation(Both Short-term and Long-term Outcome) of Minimal Invasive Radical Antegrade Modular Pancreatosplenectomy for Left-sided Pancreatic Cancer Patients | July 1, 2020 | December 30, 2024 |
| NCT05178628 | Recruiting | Phase 3 | The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic Cancer | February 10, 2022 | December 31, 2024 |
| NCT05415475 | Recruiting | Phase 1 | Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors | September 10, 2021 | September 15, 2025 |
| NCT05438667 | Recruiting | Early Phase 1 | TCR-T Cell Therapy on Advanced Pancreatic Cancer | June 7, 2022 | May 30, 2026 |
| NCT05860374 | Recruiting | Early Phase 1 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors | March 2, 2023 | March 2, 2026 |
| NCT06340620 | Recruiting | N/A | EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope | March 25, 2024 | December 2027 |
| NCT04146298 | Recruiting | Phase 1/Phase 2 | Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer | October 21, 2021 | March 2025 |
| NCT03311776 | Recruiting | BIOmarkers in Patients With Pancreatic Cancer ("BIOPAC") | July 3, 2008 | July 2, 2035 | |
| NCT06129422 | Recruiting | Phase 1 | Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer | October 31, 2023 | October 28, 2024 |
| NCT05249075 | Recruiting | Micro-Tech FNB Needle to Obtain Tissue Specimens of Pancreas Malignancy for Personalized Based Chemotherapy | March 1, 2022 | January 1, 2025 | |
| NCT06001268 | Recruiting | N/A | Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS) | August 14, 2023 | August 2027 |
| NCT05831488 | Recruiting | Assessing the Accuracy of Seismofit® as an Estimate of VO2 Peak in Patients With Hepato-pancreato-biliary, Colorectal, and Gastro-oesophageal Cancer | March 1, 2023 | March 1, 2024 | |
| NCT05957250 | Recruiting | N/A | [68Ga]Ga-FAPI-46 Positron Emission Tomography (PET) Scan to Improve the Imaging of Pancreatic and Bile Duct Cancer | February 3, 2023 | July 1, 2026 |
| NCT05737615 | Recruiting | Phase 1 | PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9 | February 10, 2023 | February 10, 2025 |
| NCT06177522 | Recruiting | Phase 2 | Adbelizumab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer | December 2023 | December 2026 |
| NCT00912717 | Recruiting | Pancreatic Adenocarcinoma Gene Environment Risk Study | January 2004 | December 2027 | |
| NCT05086250 | Recruiting | Early Phase 1 | Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer | October 20, 2022 | December 2025 |
| NCT05836870 | Recruiting | Phase 3 | Tele-PancFit: A Multi-site Trial of Video-based Strengthening Exercise Prehabilitation for Patients With Resectable Pancreatic Cancer | July 18, 2023 | December 31, 2032 |
| NCT05188586 | Recruiting | N/A | New Onset Diabetes Management for Earlier Detection of Pancreatic Cancer (NODMED) | December 6, 2022 | December 1, 2024 |
| NCT03129139 | Recruiting | Phase 1 | A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors | October 10, 2017 | December 1, 2024 |
| NCT04007640 | Recruiting | N/A | Early Screening of Pancreatic Lesions : Development of New Imaging Tools | June 18, 2019 | October 27, 2023 |
| NCT04543071 | Recruiting | Phase 2 | Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma | November 9, 2020 | August 2025 |
| NCT05187312 | Recruiting | Registry for Advanced Endoscopy | January 14, 2022 | January 14, 2032 | |
| NCT06168812 | Recruiting | Phase 2 | A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer | December 5, 2023 | December 5, 2025 |
| NCT06323291 | Recruiting | Early Phase 1 | Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study | April 1, 2024 | March 2026 |
| NCT06050395 | Recruiting | N/A | The MONITOR Study: Remote Monitoring Of a Nutrition Intervention To Optimize Treatment Response | September 12, 2023 | December 2024 |
| NCT06363123 | Recruiting | Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis | March 29, 2024 | April 2025 | |
| NCT05462496 | Recruiting | Phase 2 | Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer | March 13, 2023 | July 2025 |
| NCT05451043 | Recruiting | Phase 2 | Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED) | July 5, 2023 | October 1, 2028 |
| NCT03050268 | Recruiting | Familial Investigations of Childhood Cancer Predisposition | April 6, 2017 | March 31, 2037 | |
| NCT05419479 | Recruiting | Phase 1/Phase 2 | Switch Maintenance in Pancreatic | November 30, 2022 | September 30, 2028 |
| NCT05687188 | Recruiting | Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations | February 22, 2023 | December 2026 | |
| NCT06159478 | Recruiting | Phase 2 | Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume) | March 29, 2023 | September 30, 2027 |
| NCT03065062 | Recruiting | Phase 1 | Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors | February 28, 2017 | January 2026 |
| NCT06403735 | Recruiting | Phase 1 | A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors | April 25, 2024 | April 30, 2027 |
| NCT05802420 | Recruiting | N/A | The Value of Molecular Residual Disease Monitoring Based on ctDNA in Advanced or Metastatic Pancreatic Cancer | February 1, 2023 | February 1, 2025 |
| NCT03498326 | Recruiting | Phase 2 | Gemcitabine and Celecoxib Combination Therapy in Treating Patients With R0 Resection Pancreatic Cancer | April 2, 2018 | March 31, 2030 |
| NCT05462314 | Recruiting | Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies | March 29, 2022 | December 2025 | |
| NCT03190941 | Recruiting | Phase 1/Phase 2 | Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients | September 21, 2017 | June 29, 2028 |
| NCT04426669 | Recruiting | Phase 1/Phase 2 | A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering | May 15, 2020 | January 2024 |
| NCT04951804 | Recruiting | N/A | EUS-CPN With and Without Bupivacaine | October 7, 2021 | September 2027 |
| NCT02012699 | Recruiting | Integrated Cancer Repository for Cancer Research | November 1, 2013 | December 2099 | |
| NCT04984174 | Recruiting | Survival Rate and Treatment Cost in Patients With Pancreatic Cancer With the Advent of New Chemotherapeutic Agents in Korea: An Analysis Using NHIS Database and K-PaC Registry Focusing on the Newest One, Liposomal Irinotecan | August 4, 2021 | December 28, 2024 | |
| NCT05977777 | Recruiting | N/A | Contrast-enhanced Ultrasound and Pancreatic Lesions | November 7, 2022 | June 2025 |
| NCT04194268 | Recruiting | N/A | Pancreatic Cancer and Carbon Ion Radiotherapy | December 3, 2019 | December 3, 2025 |
| NCT06436976 | Recruiting | Phase 2 | The Effect of Probiotics ATG-F4 in Cancer Patients | March 1, 2024 | December 31, 2025 |
| NCT06249321 | Recruiting | Phase 2 | mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to Chemotherapy | April 1, 2024 | March 1, 2028 |
| NCT05721846 | Recruiting | Phase 1 | Nivolumab With Ipilimumab Combined With TGFβ-15 Peptide Vaccine and Radiotherapy for Pancreatic Cancer | May 3, 2023 | December 2025 |
| NCT05298722 | Recruiting | N/A | Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial) | December 12, 2022 | March 2026 |
| NCT04340141 | Recruiting | Phase 3 | Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer | July 1, 2020 | November 2030 |
| NCT02361320 | Recruiting | N/A | Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer | March 9, 2015 | June 27, 2026 |
| NCT05064618 | Recruiting | Phase 1/Phase 2 | Investigator-initiated Clinical Trial of MIKE-1 | August 23, 2021 | April 30, 2025 |
| NCT04588025 | Recruiting | N/A | Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response | October 14, 2020 | October 2025 |
| NCT03745326 | Recruiting | Phase 1/Phase 2 | Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients | May 16, 2019 | December 1, 2028 |
| NCT02632448 | Recruiting | Phase 1/Phase 2 | A Study of LY2880070 in Participants With Advanced or Metastatic Cancer | May 16, 2016 | September 30, 2025 |
| NCT06001658 | Recruiting | Phase 2 | Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers | May 2024 | May 2028 |
| NCT06427447 | Recruiting | Phase 3 | Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC) | May 12, 2024 | June 30, 2029 |
| NCT04605237 | Recruiting | Pancreatic Cancer Recurrence in the Netherlands | January 1, 2014 | July 1, 2023 | |
| NCT05984602 | Recruiting | Phase 1 | A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer | July 14, 2023 | June 1, 2025 |
| NCT05764720 | Recruiting | N/A | Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach | May 14, 2023 | February 15, 2027 |
| NCT05911217 | Recruiting | Phase 1 | A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer | July 11, 2023 | December 31, 2026 |
| NCT04373928 | Recruiting | N/A | Personalized Precision Diagnosis and Treatment of Pancreatic Cancer | November 10, 2017 | December 31, 2024 |
| NCT05494697 | Recruiting | Phase 2 | Ampligen Compared to No Treatment Following FOLFIRINOX in Subjects With Locally Advanced Pancreatic Adenocarcinoma | May 2024 | July 2027 |
| NCT03167814 | Recruiting | N/A | Prevention of Chyle-leak After Major Pancreatic Surgery | August 1, 2017 | December 31, 2025 |
| NCT06145074 | Recruiting | Phase 2 | Examining Safety, Efficacy and Feasibility of Preoperative Propranolol in Patients With PDAC. | March 20, 2024 | December 31, 2035 |
| NCT05355298 | Recruiting | Phase 1/Phase 2 | ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer | May 31, 2022 | May 1, 2025 |
| NCT04927780 | Recruiting | Phase 3 | Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer | September 7, 2021 | July 2029 |
| NCT05057013 | Recruiting | Phase 1/Phase 2 | HMBD-001 in Advanced HER3 Positive Solid Tumours | November 10, 2021 | September 2026 |
| NCT05415917 | Recruiting | Phase 2 | Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy | July 29, 2022 | March 1, 2025 |
| NCT05215574 | Recruiting | Phase 1 | Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors | March 31, 2022 | March 2026 |
| NCT04275557 | Recruiting | Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas | February 18, 2020 | June 2027 | |
| NCT05400681 | Recruiting | Liquid Biopsy for ctDNA in Peritoneal Lavage and Blood in Pancreatic Cancer | August 1, 2020 | December 31, 2024 | |
| NCT05147168 | Recruiting | Quality of Life of Pancreatic Cancer Patients:Psychometric Validation of Chinese Version in Taiwan | November 22, 2021 | November 22, 2024 | |
| NCT02869802 | Recruiting | Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis | October 6, 2016 | December 2027 | |
| NCT03322995 | Recruiting | Phase 2 | Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial | June 21, 2018 | August 1, 2027 |
| NCT05887492 | Recruiting | Phase 1/Phase 2 | Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors | June 12, 2023 | June 2025 |
| NCT04025840 | Recruiting | Phase 4 | Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery | September 11, 2019 | July 2026 |
| NCT05908747 | Recruiting | Phase 2 | Efficacy and Safety of Surufatinib Combined With Gemcitabine and Albumin-bound Paclitaxel in the Peri-operative Treatment of Pancreatic Cancer | May 31, 2023 | May 2026 |
| NCT02674100 | Recruiting | American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry | January 2016 | January 2030 | |
| NCT02393703 | Recruiting | Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer | March 2015 | March 2025 | |
| NCT05617872 | Recruiting | N/A | Vinegar-induced Collection of Duodenal Pancreatic Juice Via Endoscopic Ultrasound | November 1, 2022 | November 2023 |
| NCT06359275 | Recruiting | Phase 2 | PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients | April 1, 2024 | October 1, 2027 |
| NCT04916236 | Recruiting | Phase 1 | Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers | March 31, 2022 | July 2024 |
| NCT04075305 | Recruiting | The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study | February 1, 2019 | May 1, 2025 | |
| NCT06122896 | Recruiting | Early Phase 1 | Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals | November 21, 2023 | October 31, 2041 |
| NCT06391892 | Recruiting | Phase 3 | Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery | January 11, 2024 | December 31, 2026 |
| NCT04805307 | Recruiting | Phase 1 | Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901 | December 24, 2020 | October 2024 |
| NCT05360680 | Recruiting | Phase 1 | A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers | June 14, 2022 | December 2026 |
| NCT05366881 | Recruiting | cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease | May 3, 2022 | December 2026 | |
| NCT04666688 | Recruiting | Phase 1/Phase 2 | LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors | December 15, 2020 | January 2025 |
| NCT06404840 | Recruiting | Phase 2 | Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study | May 6, 2022 | May 31, 2026 |
| NCT04899739 | Recruiting | N/A | Intraoperative Endoscopic Ultrasound for Pancreatic Cancer | December 5, 2021 | December 2025 |
| NCT05141643 | Recruiting | Early Phase 1 | Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer | November 18, 2021 | November 18, 2025 |
| NCT05539430 | Recruiting | Phase 1 | Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma | April 18, 2023 | December 2025 |
| NCT04674267 | Recruiting | N/A | Resilience and Equity in Aging, Cancer, and Health (REACH) | January 18, 2022 | December 31, 2024 |
| NCT04925284 | Recruiting | Phase 1 | Study of XB002 in Subjects With Solid Tumors (JEWEL-101) | June 7, 2021 | October 7, 2024 |
| NCT04048278 | Recruiting | Early Phase 1 | Lidocaine Infusion in Pancreatic Cancer | November 8, 2018 | January 1, 2025 |
| NCT04002479 | Recruiting | N/A | Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer | October 20, 2020 | October 2026 |
| NCT05842187 | Recruiting | N/A | In Vitro Organoid Drug Sensitivity-Guided Treatment for Metastatic Pancreatic and Gastric Cancer | March 3, 2023 | December 31, 2024 |
| NCT05518110 | Recruiting | Phase 2 | PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic Cancer | May 31, 2023 | April 15, 2025 |
| NCT05714111 | Recruiting | Radiology Registry on Pancreatic Malignancies | March 4, 2022 | March 30, 2030 | |
| NCT05277766 | Recruiting | Phase 1 | Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer | November 21, 2022 | January 1, 2027 |
| NCT03679169 | Recruiting | N/A | Evaluation of Complete microscopicE Resection Margin (R0) and Lymph Node Involvement After Standard Pancreatosplenectomy (SPS) Versus Radical Anterograde Modular Pancreatosplenectomy | January 17, 2020 | September 17, 2024 |
| NCT05604560 | Recruiting | Phase 2 | A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer | November 8, 2023 | September 2026 |
| NCT06043921 | Recruiting | Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel | November 1, 2022 | December 2026 | |
| NCT05195281 | Recruiting | N/A | Pancreatic Cancer Evolution Upon Treatment | July 14, 2021 | December 31, 2024 |
| NCT04612530 | Recruiting | Phase 1 | PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer | September 1, 2020 | June 1, 2023 |
| NCT06028724 | Recruiting | A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN) | May 26, 2023 | May 31, 2030 | |
| NCT05922930 | Recruiting | Phase 1/Phase 2 | Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer | October 11, 2023 | July 1, 2028 |
| NCT05396300 | Recruiting | Phase 1 | A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors | May 25, 2022 | May 15, 2025 |
| NCT05351983 | Recruiting | N/A | Patient-derived Organoids Drug Screen in Pancreatic Cancer | September 22, 2022 | June 2023 |
| NCT03323944 | Recruiting | Phase 1 | CAR T Cell Immunotherapy for Pancreatic Cancer | September 15, 2017 | September 2024 |
| NCT04084496 | Recruiting | Phase 2 | mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients | September 1, 2019 | December 31, 2024 |
| NCT04037007 | Recruiting | N/A | Efficacy of Fistulotomy for Biliary Cannulation | July 3, 2019 | December 3, 2022 |
| NCT05776524 | Recruiting | Phase 2 | Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer | June 13, 2023 | July 2029 |
| NCT03551951 | Recruiting | Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow | July 1, 2016 | June 30, 2026 | |
| NCT05633342 | Recruiting | Project CADENCE (CAncer Detected Early caN be CurEd) | July 7, 2022 | May 2025 | |
| NCT02705196 | Recruiting | Phase 1/Phase 2 | LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer | November 2016 | October 2025 |
| NCT05057715 | Recruiting | Phase 1 | huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer | March 2, 2022 | September 2038 |
| NCT05013216 | Recruiting | Phase 1 | Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer | April 11, 2022 | May 1, 2026 |
| NCT05708950 | Recruiting | Phase 1/Phase 2 | A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) | March 3, 2023 | December 31, 2024 |
| NCT04683315 | Recruiting | Phase 2 | PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples | April 1, 2021 | June 2027 |
| NCT04477343 | Recruiting | Phase 1 | A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma | November 23, 2020 | December 31, 2025 |
| NCT06069778 | Recruiting | Phase 1/Phase 2 | Safety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic Adenocarcinoma | March 27, 2024 | June 2031 |
| NCT06244771 | Recruiting | Phase 1/Phase 2 | A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors | February 12, 2024 | April 2028 |
| NCT03460769 | Recruiting | Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT) | November 1, 2017 | June 30, 2025 | |
| NCT05336266 | Recruiting | Early Phase 1 | A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma | July 1, 2022 | December 5, 2025 |
| NCT03937453 | Recruiting | A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus | January 19, 2018 | January 19, 2028 | |
| NCT05583890 | Recruiting | A Case-control Study Comparing Glycaemic Control in Pancreatic Cancer Patients vs Healthy Matched Individuals. | August 25, 2022 | August 30, 2024 | |
| NCT05784311 | Recruiting | Phase 4 | Standard Versus Prolonged Antibiotic Prophylaxis After Pancreatoduodenectomy (SPARROW) | March 6, 2023 | January 2026 |
| NCT05848739 | Recruiting | Phase 1 | A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors | June 5, 2023 | May 31, 2027 |
| NCT04028479 | Recruiting | The Registry of Oncology Outcomes Associated With Testing and Treatment | May 5, 2021 | October 1, 2031 | |
| NCT04553926 | Recruiting | 'OLAP' (OLAparib Regulatory Post-marketing Surveillance) | February 1, 2021 | June 30, 2025 | |
| NCT05428358 | Recruiting | N/A | Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery | August 30, 2022 | September 1, 2027 |
| NCT05247164 | Recruiting | N/A | EUS-guided PORtal Vein Sampling for Circulating Tumor Cells in Pancreatic Cancer Patients | May 17, 2022 | March 2027 |
| NCT05802394 | Recruiting | N/A | The Value of Molecular Residual Disease Monitoring Based on ctDNA in Borderline Resectable or Locally Advanced Pancreatic Cancer | February 1, 2023 | February 1, 2030 |
| NCT00830557 | Recruiting | Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders | October 2000 | September 2024 | |
| NCT03175224 | Recruiting | Phase 2 | APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors | September 27, 2017 | November 30, 2026 |
| NCT05538195 | Recruiting | Phase 1/Phase 2 | Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors | June 7, 2022 | June 7, 2025 |
| NCT06270082 | Recruiting | Phase 1 | Study of IK-595 in RAS- or RAF-altered Advanced Tumors | December 18, 2023 | July 2027 |
| NCT06307080 | Recruiting | N/A | Clinical Study of Multi-mode Thermal Ablation for the Treatment of Pancreatic Cancer With Liver Metastasis | October 8, 2023 | December 31, 2024 |
| NCT06015659 | Recruiting | Phase 2 | ZN-c3 + Gemcitabine in Pancreatic Cancer | November 16, 2023 | June 1, 2027 |
| NCT04033107 | Recruiting | Phase 2 | High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors | July 1, 2020 | December 2024 |
| NCT05740956 | Recruiting | Phase 1 | A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors | June 9, 2023 | October 1, 2026 |
| NCT06119217 | Recruiting | Phase 2 | Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients | March 25, 2024 | June 2027 |
| NCT04157127 | Recruiting | Phase 1 | Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma | August 3, 2020 | November 2027 |
| NCT05837767 | Recruiting | N/A | A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue | July 24, 2023 | July 24, 2026 |
| NCT05945823 | Recruiting | Phase 2 | Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors | July 13, 2023 | May 2025 |
| NCT04678648 | Recruiting | Phase 1 | A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies | February 16, 2021 | March 5, 2024 |
| NCT06238479 | Recruiting | Phase 1 | A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors | March 5, 2024 | March 4, 2027 |
| NCT03809247 | Recruiting | Microbial Diversity of Pancreatic Diseases | February 1, 2019 | December 31, 2025 | |
| NCT04617457 | Recruiting | Phase 2 | Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas | October 10, 2021 | September 30, 2025 |
| NCT05675059 | Recruiting | N/A | Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients | December 21, 2022 | December 2024 |
| NCT05596370 | Recruiting | Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary Cancer | January 6, 2022 | December 31, 2024 | |
| NCT05053555 | Recruiting | N/A | High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies | April 24, 2022 | January 31, 2025 |
| NCT04820179 | Recruiting | Phase 2 | Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer | October 12, 2021 | March 1, 2025 |
| NCT06361316 | Recruiting | N/A | Irinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic Cancer | April 8, 2024 | July 31, 2028 |
| NCT04136132 | Recruiting | N/A | Prospective Monocentric Clinical-biological Database | May 15, 2019 | June 2027 |
| NCT04110769 | Recruiting | N/A | Development of Biomarker for the Evaluation of Response After Neoadjuvant Therapy in Patients With Pancreatic Cancer | July 17, 2019 | December 31, 2023 |
| NCT02838836 | Recruiting | Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers | July 1, 2016 | June 1, 2024 | |
| NCT04931394 | Recruiting | Phase 3 | Organoid-Guided Adjuvant Chemotherapy for Pancreatic Cancer | June 1, 2021 | May 31, 2025 |
| NCT04469504 | Recruiting | N/A | Preoperative Prehabilitation for Sarcopenic Patients Prior to Pancreatic Surgery for Cancer | May 17, 2022 | May 2028 |
| NCT05924789 | Recruiting | Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America | August 11, 2023 | June 17, 2024 | |
| NCT05035147 | Recruiting | Phase 4 | Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic Cancer | March 25, 2021 | December 2026 |
| NCT05642819 | Recruiting | REVOLUTION Surgery (REVOLUTION Surgery) | October 1, 2023 | December 2027 | |
| NCT05783076 | Recruiting | Phase 2 | SBRT Plus vNKT for Pancreatic Cancer | June 25, 2023 | March 1, 2025 |
| NCT05162846 | Recruiting | N/A | Methods for Increasing Genetic Testing Uptake in Michigan | April 21, 2022 | December 31, 2026 |
| NCT03991962 | Recruiting | Phase 2 | Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma | September 19, 2019 | February 2025 |
| NCT03935893 | Recruiting | Phase 2 | Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers | December 3, 2019 | June 30, 2037 |
| NCT05677048 | Recruiting | N/A | Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention | April 14, 2023 | October 31, 2027 |
| NCT06139042 | Recruiting | Early-stage Detection of LIver, Biliary tRAct and pancReatic Cancers | November 1, 2023 | December 31, 2025 | |
| NCT05270564 | Recruiting | N/A | Post-operative Drainage After Pancreaticoduodenectomy | May 1, 2016 | March 31, 2025 |
| NCT05606523 | Recruiting | Microbiota and Pancreatic Cancer Cachexia | August 1, 2022 | April 30, 2025 | |
| NCT04611867 | Recruiting | N/A | Study of PRO in Patients With Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay) | August 17, 2021 | April 1, 2027 |
| NCT05535894 | Recruiting | Endoscopic Radiofrequency Ablation of Celiac Ganglion for Pain Management and Improvement of Quality of Life in Patients With Unresectable Pancreatic Cancer | August 10, 2022 | May 2024 | |
| NCT05141149 | Recruiting | Phase 1/Phase 2 | First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic Cancer | June 5, 2023 | December 2026 |
| NCT05131776 | Recruiting | Phase 2/Phase 3 | EUS-guided Intra-tumour Injection of OncoSil for Locally Advanced Pancreatic Carcinoma. | November 1, 2021 | October 31, 2024 |
| NCT05483075 | Recruiting | N/A | Feasibility of a Health Care Provider Guided Exercise Intervention Prior to Surgical Resection of Pancreatic Cancer | November 15, 2022 | September 1, 2024 |
| NCT05070247 | Recruiting | Phase 1/Phase 2 | A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors | April 14, 2022 | August 11, 2026 |
| NCT05179824 | Recruiting | Tempus Priority Study: A Pan-tumor Observational Study | October 19, 2020 | October 19, 2030 | |
| NCT06008288 | Recruiting | Phase 2 | A Study of JAB-21822 in Patients With KRAS p.G12C Mutated Pancreatic Cancer | October 27, 2023 | November 2025 |
| NCT05703581 | Recruiting | Application of "Heidelberg Triangle" Dissection in Pancreatoduodenectomy and Distal Pancreatectomy | March 1, 2023 | February 1, 2024 | |
| NCT05605197 | Recruiting | Phase 1 | U87 CART in Treatment of Advanced Solid Tumor | October 19, 2022 | October 8, 2025 |
| NCT06438705 | Recruiting | 99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors | February 1, 2024 | January 31, 2026 | |
| NCT06423963 | Recruiting | N/A | Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer | February 8, 2024 | February 2026 |
| NCT06427460 | Recruiting | Phase 2 | Central-boost Ablative Radiation Therapy for Solid Tumors (CBART) | May 12, 2024 | December 31, 2026 |
| NCT04584008 | Recruiting | N/A | Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics | September 23, 2020 | February 2024 |
| NCT03886571 | Recruiting | U01-Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer | September 15, 2018 | September 15, 2024 | |
| NCT05642962 | Recruiting | Phase 1/Phase 2 | Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) | November 30, 2022 | November 30, 2024 |
| NCT05709197 | Recruiting | N/A | The Effectiveness of Adding Braun Anastomosis to Standard Child Reconstruction After Pancreatoduodenectomy | April 17, 2023 | September 2025 |
| NCT06048458 | Recruiting | Cancer Treatment Related Cardiovascular Toxicity: Comprehensive Myocardial and Vascular Phenotyping | May 18, 2022 | February 2024 | |
| NCT05631574 | Recruiting | Phase 1 | Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer | January 12, 2023 | October 2026 |
| NCT05497531 | Recruiting | N/A | Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers | September 7, 2022 | October 2024 |
| NCT06196788 | Recruiting | Phase 2 | Transcatheter Arterial Infusion to Patients With Advanced Pancreatic Cancer | March 1, 2024 | January 1, 2028 |
| NCT03724994 | Recruiting | Chemotherapy, Host Response and Molecular Dynamics in Periampullary Cancer | October 30, 2018 | September 1, 2027 | |
| NCT03454035 | Recruiting | Phase 1 | Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors | January 30, 2018 | April 24, 2026 |
| NCT05934331 | Recruiting | Phase 2 | A LM-302 Combined With Toripalimab Phase II Study | July 27, 2023 | January 1, 2026 |
| NCT05526443 | Recruiting | Austrian Registry for Evaluation of Treatment Patterns and Outcome in Patients With Advanced Pancreatic Ductal Adenocarcinoma (PDAC) | January 13, 2023 | October 2025 | |
| NCT01102556 | Recruiting | PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease | July 2004 | December 2030 | |
| NCT05394259 | Recruiting | Phase 1 | A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer | October 28, 2022 | January 1, 2025 |
| NCT04117087 | Recruiting | Phase 1 | Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic Cancer | May 28, 2020 | August 8, 2025 |
| NCT02830724 | Recruiting | Phase 1/Phase 2 | Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers | April 6, 2017 | January 1, 2028 |
| NCT04338763 | Recruiting | Phase 1 | RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer | April 19, 2021 | December 31, 2025 |
| NCT05524090 | Recruiting | PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer | July 1, 2021 | December 31, 2030 | |
| NCT05736731 | Recruiting | Phase 1/Phase 2 | A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Subjects With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression | April 28, 2023 | December 2028 |
| NCT04834505 | Recruiting | To Differentiate Focal Autoimmune Pancreatitis From Pancreatic Cancer by Endoscopic Ultrasound | May 11, 2021 | March 2025 | |
| NCT06141031 | Recruiting | Phase 1/Phase 2 | Trial of Radiotherapy in Combination With TTI-101 in Patients With Borderline Resectable Pancreatic Cancer | January 16, 2024 | September 2028 |
| NCT02598349 | Recruiting | Phase 2 | Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas | April 2016 | October 2040 |
| NCT05393986 | Recruiting | Phase 1 | Claudin18.2-redirected Chimeric Antigen Receptor T Cells With Co-expression of Cytokines in Solid Tumors | August 4, 2022 | December 30, 2024 |
| NCT06151262 | Recruiting | Phase 2 | A Study of Trilaciclib Combined With mFOLFIRINOX in the Treatment of Patients With Advanced Pancreatic Cancer | January 20, 2024 | October 28, 2026 |
| NCT03983057 | Recruiting | Phase 3 | Combination of Anti-PD-1 Antibody and Chemotherapy in Pancreatic Cancer | April 1, 2019 | December 1, 2024 |
| NCT04644068 | Recruiting | Phase 1/Phase 2 | Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies | November 12, 2020 | December 15, 2026 |
| NCT06342323 | Recruiting | The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy | October 8, 2023 | October 7, 2025 | |
| NCT05679583 | Recruiting | Phase 2 | Preoperative Stereotactic Body Radiation Therapy in Patients With Resectable Pancreatic Cancer | September 26, 2022 | September 25, 2026 |
| NCT05959395 | Recruiting | N/A | Hyperthermia Treatment Added to Chemotherapy Standard of Care for Pancreatic Tumors | August 15, 2023 | April 30, 2024 |
| NCT05163028 | Recruiting | Phase 1 | A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations | December 13, 2021 | December 2024 |
| NCT03958019 | Recruiting | N/A | Rehabilitation Strategies Following Oesophagogastric and Hepatopancreaticobiliary Cancer | January 25, 2022 | December 1, 2024 |
| NCT05218889 | Recruiting | Phase 1/Phase 2 | Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer | August 4, 2021 | February 2025 |
| NCT06405685 | Recruiting | Phase 2 | Nimotuzumab Plus AG in Pancreatic Cancer With Liver Metastasis | April 27, 2023 | October 30, 2025 |
| NCT04969835 | Recruiting | Phase 1 | A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours | July 16, 2021 | June 30, 2023 |
| NCT05872867 | Recruiting | Phase 1 | Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90) | March 14, 2024 | February 22, 2026 |
| NCT04894643 | Recruiting | N/A | Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer | September 14, 2020 | December 31, 2026 |
| NCT06411470 | Recruiting | Gastrointestinal Microflora and Serum Metabolomics in Patients With Pancreatic Cancer and Chronic Pancreatitis | April 20, 2024 | December 31, 2025 | |
| NCT05525286 | Recruiting | Phase 1/Phase 2 | Clinical Trial of SOT102 Antibody Drug Conjugate in Patients With Advanced Gastric and Pancreatic Adenocarcinoma | March 31, 2022 | June 2028 |
| NCT04291651 | Recruiting | UCSF PANC Cyst Registry | October 8, 2019 | January 1, 2030 | |
| NCT06256055 | Recruiting | Phase 1 | Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors | March 5, 2024 | April 2025 |
| NCT03104439 | Recruiting | Phase 2 | Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer | May 10, 2017 | October 2026 |
| NCT05919537 | Recruiting | Phase 1 | Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation | September 6, 2023 | March 1, 2031 |
| NCT04743479 | Recruiting | Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI) | December 1, 2020 | December 30, 2030 | |
| NCT04164602 | Recruiting | The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly | October 9, 2019 | June 30, 2025 | |
| NCT06245330 | Recruiting | Phase 1/Phase 2 | A Phase I/II Study of AST-001 in Subjects With Advanced Solid Tumors | July 7, 2022 | August 31, 2027 |
| NCT05489250 | Recruiting | The PLATON Network | October 28, 2020 | May 31, 2032 | |
| NCT05132244 | Recruiting | N/A | Monitoring and Managing Glucose Levels in People With Pancreatic Cancer | April 16, 2024 | April 2027 |
| NCT05420259 | Recruiting | N/A | Combined Exercise and Nutritional Intervention in GI Cancer Patients | March 21, 2022 | June 28, 2024 |
| NCT04150042 | Recruiting | Phase 1 | SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells | January 13, 2021 | December 2025 |
| NCT05723107 | Recruiting | Phase 1 | EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC) | March 31, 2023 | March 2026 |
| NCT01102569 | Recruiting | Pancreatic Cancer Genetics | January 2008 | December 2026 | |
| NCT05788484 | Recruiting | Phase 1 | A Study of CDX-585 in Patients With Advanced Malignancies | May 11, 2023 | February 2026 |
| NCT06151223 | Recruiting | A Prospective Registry for Patients at High-Risk for Pancreatic Cancer | July 13, 2021 | July 2031 | |
| NCT05102110 | Recruiting | Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer. | December 1, 2021 | December 1, 2024 | |
| NCT06055010 | Recruiting | Improving Pancreatic Cancer Care by the Use of Computational Science and Technology | January 1, 2014 | December 31, 2029 | |
| NCT05391126 | Recruiting | N/A | GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care | September 28, 2022 | May 2025 |
| NCT06069297 | Recruiting | N/A | Prehabilitation in Pancreatic Surgery | July 14, 2023 | July 13, 2026 |
| NCT06289803 | Recruiting | N/A | The Application of Probe Confocal Laser Endomicroscopy in Pancreatic Tumor Surgery | September 1, 2023 | June 30, 2025 |
| NCT05604573 | Recruiting | DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic Cancer | February 9, 2022 | December 31, 2024 | |
| NCT05660915 | Recruiting | N/A | A Prospective Clinical Study Using an Artery-first Intermediate Approach in Robot-assisted Pancreaticoduodenectomy | June 1, 2023 | April 1, 2026 |
| NCT05697198 | Recruiting | PRospective rEgistry OF Advanced Stage cancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine | April 19, 2021 | September 2024 | |
| NCT02416609 | Recruiting | N/A | Low-dose Radiotherapy Plus Chemotherapy With Gem-based Doublets and Stereotactic Radiotherapy for Advanced Pancreatic Cancer | January 2014 | November 2024 |
| NCT06149546 | Recruiting | N/A | Exploring the Impact of a Multi-modal Nutritional Intervention in Patients Undergoing Chemotherapy for Pancreatic Cancer (FEED Trial) | May 1, 2024 | November 2028 |
| NCT03915678 | Recruiting | Phase 2 | Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors | March 31, 2021 | March 2026 |
| NCT06326736 | Recruiting | Early Phase 1 | Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer | April 2024 | December 2026 |
| NCT06094140 | Recruiting | Phase 2 | NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer | May 20, 2022 | June 2026 |
| NCT03525353 | Recruiting | Comparison Of Radiation Exposure To Patients During Endoscopic Retrograde Cholangiopancreatography (ERCP) Performed By Endoscopists Trained In Judicious Use Of Fluoroscopy With Those Without Formal Training | November 2015 | December 2025 | |
| NCT04966143 | Recruiting | Early Phase 1 | Clinical Study of LY011 in the Treatment of Advanced Pancreatic Cancer | August 1, 2021 | August 1, 2024 |
| NCT04484636 | Recruiting | N/A | PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) | October 28, 2020 | July 30, 2024 |
| NCT05252390 | Recruiting | Phase 1/Phase 2 | NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors | March 29, 2022 | November 2026 |
| NCT05596435 | Recruiting | Early Detection of Pancreatic Cancer | October 10, 2022 | October 12, 2024 | |
| NCT06334432 | Recruiting | Phase 1/Phase 2 | Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors | March 14, 2024 | October 2027 |
| NCT06389760 | Recruiting | Phase 2 | Single-arm Study of Nimotuzumab Combined With mFOLFIRNIOX as Postoperative Adjuvant Therapy in Pancreatic Cancer | October 18, 2023 | September 30, 2026 |
| NCT02478892 | Recruiting | Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk | May 2015 | May 2027 | |
| NCT06378047 | Recruiting | Phase 1 | Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer | April 10, 2024 | April 2027 |
| NCT05616494 | Recruiting | Phase 2 | A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer | December 6, 2022 | June 30, 2025 |
| NCT02672917 | Recruiting | Phase 1 | Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies | January 2016 | October 2026 |
| NCT06344156 | Recruiting | Phase 1 | Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer | April 1, 2024 | April 1, 2027 |
| NCT05183243 | Recruiting | Phase 1 | Dose Finding Study of GH21 in Adult Patients With Advanced Solid Tumors | February 20, 2022 | February 20, 2025 |
| NCT03704662 | Recruiting | N/A | Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma | October 22, 2018 | December 1, 2024 |
| NCT05271344 | Recruiting | N/A | Oral Immunonutrition With Synbiotics, Omega 3 and Vitamin D in Patients Undergoing Duodenopancreatectomy for Tumoral Lesion. | April 8, 2022 | March 2026 |
| NCT06337084 | Recruiting | Phase 1 | Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors | April 10, 2024 | June 2025 |
| NCT04751435 | Recruiting | N/A | Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients | November 16, 2021 | August 31, 2026 |
| NCT05044065 | Recruiting | N/A | Blood Flow Restriction Exercise in Patients With Pancreatic, Biliary Tract, and Liver Cancer (PREV-Ex) | May 1, 2022 | December 31, 2024 |
| NCT02451982 | Recruiting | Phase 2 | Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas | March 28, 2016 | December 31, 2025 |
| NCT04600154 | Recruiting | N/A | MS-20 on Gut Microbiota and Risk/Severity of Cachexia in Pancreatic Cancer Patients | August 10, 2021 | June 30, 2023 |
| NCT04981119 | Recruiting | Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing | October 29, 2021 | December 2026 | |
| NCT02843945 | Recruiting | Phase 1/Phase 2 | Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source | May 31, 2017 | May 28, 2027 |
| NCT05729737 | Recruiting | Radiographic Response to Chemotherapy in Unresected Localized Pancreatic Cancer | January 1, 2022 | January 2026 | |
| NCT04632303 | Recruiting | N/A | Early Palliative Care for Patients With Advanced Pancreatic Cancer. | June 23, 2021 | July 1, 2024 |
| NCT04581473 | Recruiting | Phase 1/Phase 2 | Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection | October 23, 2020 | June 30, 2038 |
| NCT06091930 | Recruiting | Phase 1 | A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6 | January 31, 2024 | February 11, 2027 |
| NCT06111872 | Recruiting | Phase 2 | Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography. | July 18, 2023 | June 30, 2024 |
| NCT05864144 | Recruiting | Phase 1/Phase 2 | A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors | May 31, 2023 | June 2027 |
| NCT05472857 | Recruiting | Phase 1 | Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression | August 8, 2022 | December 2024 |
| NCT00899626 | Recruiting | Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients | June 2002 | October 2030 | |
| NCT03334708 | Recruiting | A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma | October 30, 2017 | October 30, 2024 | |
| NCT05193162 | Recruiting | Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic Diseases | February 1, 2019 | July 31, 2026 | |
| NCT02584244 | Recruiting | Phase 1/Phase 2 | Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers | August 4, 2016 | April 2025 |
| NCT05225428 | Recruiting | N/A | Video Education With Result Dependent dIsclosure | August 4, 2022 | September 1, 2026 |
| NCT03069664 | Recruiting | N/A | Palliative Pancreatic Duct Stenting in Patients With Inoperable Pancreatic Cancer | November 17, 2017 | December 2023 |
| NCT04498767 | Recruiting | N/A | Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) | June 10, 2021 | February 1, 2030 |
| NCT03777462 | Recruiting | Phase 2 | Borderline Resectable Pancreatic Cancer Neoadjuvant Chemoradiotherapy Clinicaltrial-1 | April 1, 2019 | December 31, 2023 |
| NCT06090825 | Recruiting | Cross-sectional Survey on Palliative Therapy for Pancreatic Cancer Patient | September 1, 2023 | September 1, 2025 | |
| NCT05356117 | Recruiting | N/A | Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial | September 1, 2022 | August 15, 2025 |
| NCT06239194 | Recruiting | Phase 1/Phase 2 | Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors | June 12, 2024 | February 2029 |
| NCT00536770 | Suspended | Phase 2 | A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer | September 2007 | |
| NCT04452357 | Suspended | N/A | Pulse-low-dose Rate (PLDR) Radiation in Pancreatic Cancer | January 13, 2020 | December 1, 2024 |
| NCT05519930 | Suspended | Pancreatic Cancer Early Detection Registry | October 18, 2016 | December 31, 2025 | |
| NCT00909558 | Suspended | Phase 1 | Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer | May 2009 | |
| NCT03417921 | Suspended | Phase 1/Phase 2 | A Study of ABTL0812 in Pancreatic Cancer | April 26, 2021 | April 26, 2024 |
| NCT00209677 | Suspended | Phase 1/Phase 2 | Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer | December 2004 | December 2007 |
| NCT01445327 | Terminated | Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers | February 20, 2007 | May 22, 2014 | |
| NCT03848182 | Terminated | Phase 2 | Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer | July 21, 2017 | November 11, 2019 |
| NCT00463840 | Terminated | Phase 1/Phase 2 | Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer | June 2004 | October 2015 |
| NCT00179751 | Terminated | Phase 1/Phase 2 | A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas | April 2005 | August 2006 |
| NCT00819169 | Terminated | Phase 1/Phase 2 | QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors | January 2009 | October 2011 |
| NCT01335945 | Terminated | Phase 1 | Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer | August 2011 | January 2015 |
| NCT01754623 | Terminated | Phase 2 | GTX-RT in Borderline Resectable Pancreatic Cancer | February 2013 | October 2014 |
| NCT00415454 | Terminated | Phase 1 | Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma | November 2006 | |
| NCT00898781 | Terminated | Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer | November 2007 | April 2010 | |
| NCT01313416 | Terminated | Phase 2 | Gemcitabine and CT-011 for Resected Pancreatic Cancer | September 2012 | January 2017 |
| NCT01167816 | Terminated | Phase 1 | Phase I Trial of 5-Azacitidine Plus Gemcitabine in Patients With Advanced Pancreatic Cancer | July 2010 | January 2014 |
| NCT01042028 | Terminated | Phase 1/Phase 2 | A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer | January 2010 | January 2014 |
| NCT00613730 | Terminated | Phase 2 | Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint | January 2007 | April 2009 |
| NCT01212887 | Terminated | Phase 1 | Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer | August 2007 | April 2010 |
| NCT00767234 | Terminated | Permission to Collect Blood Over Time for Research | August 2008 | October 2011 | |
| NCT01938716 | Terminated | N/A | Gemcitabine Pharmacokinetics After Preoperative Chemoradiation Therapy | March 2012 | June 3, 2019 |
| NCT01326364 | Terminated | Prognostic Value of Baseline Computed Tomography (CT) Perfusion Parameters of Pancreatic Cancer for Patients Undergoing Stereotactic Body Radiotherapy or Surgical Resection | March 2010 | June 2012 | |
| NCT01683422 | Terminated | N/A | Chemotherapy Plus Proton-chemotherapy for Locally Advanced Pancreatic Cancer | January 2, 2013 | February 19, 2019 |
| NCT03531125 | Terminated | Gene Expression in Pancreatic Cancer | July 2, 2018 | February 28, 2020 | |
| NCT03122106 | Terminated | Phase 1 | Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy | January 5, 2018 | August 13, 2022 |
| NCT00387348 | Terminated | Phase 3 | Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer | March 2006 | April 2011 |
| NCT02580422 | Terminated | Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia | October 1, 2015 | October 26, 2017 | |
| NCT00066677 | Terminated | Phase 2 | Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer | October 2003 | April 2009 |
| NCT02950025 | Terminated | Phase 2 | Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Abdominal Malignancies | January 19, 2017 | March 19, 2018 |
| NCT01760694 | Terminated | N/A | Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer | January 2013 | July 2014 |
| NCT00831493 | Terminated | Phase 1/Phase 2 | Vorinostat Plus Radiation Therapy in Pancreatic Cancer | May 2009 | October 2010 |
| NCT00553813 | Terminated | Phase 2 | A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic Cancer | October 2007 | April 2010 |
| NCT01583686 | Terminated | Phase 1/Phase 2 | CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer | May 4, 2012 | December 17, 2018 |
| NCT02548169 | Terminated | Phase 1 | Dendritic Cell Vaccine and Chemotherapy for Patients With Pancreatic Cancer | August 2015 | April 24, 2017 |
| NCT01025570 | Terminated | Phase 1 | A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer | May 2010 | June 2013 |
| NCT03576131 | Terminated | Phase 1/Phase 2 | GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors | April 30, 2018 | October 12, 2021 |
| NCT00012246 | Terminated | Phase 2 | Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | July 2002 | July 2006 |
| NCT00003434 | Terminated | Phase 1 | Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer | June 1998 | August 2002 |
| NCT01721174 | Terminated | N/A | Endoscopic Biliary Radiofrequency Ablation of Malignant Distal Common Bile Duct Strictures | November 2012 | December 2017 |
| NCT00899132 | Terminated | Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer | February 2007 | September 2012 | |
| NCT00336700 | Terminated | Phase 2 | A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer | June 2006 | November 2011 |
| NCT01303159 | Terminated | N/A | Endoscopic Bipolar Radiofrequency Probe (ENDOHPB) in the Management of Unresectable Bile Duct and Pancreatic Cancer | March 2010 | January 13, 2014 |
| NCT02651727 | Terminated | Phase 1 | Ph 1 Study of VS-4718, a FAK Inhibitor, in Combination With Nab-paclitaxel and Gemcitabine in Advanced Cancer Subjects | September 2015 | January 2017 |
| NCT00429858 | Terminated | Phase 2 | Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer | January 22, 2007 | January 20, 2010 |
| NCT03225781 | Terminated | N/A | Electrochemoterapy With Bleomycin for the Treatment of Unresectable Pancreatic Cancer | July 1, 2017 | December 21, 2018 |
| NCT00783172 | Terminated | Phase 1 | Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer | January 2009 | October 2011 |
| NCT01929941 | Terminated | Phase 1 | An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies | September 2013 | August 2014 |
| NCT02116322 | Terminated | N/A | Endoscopic Ultrasound (EUS) Guided Fine Needle Aspiration (FNA) EUS-FNA of Solid Pancreatic Mass Lesions Using a Novel Corkscrew Technique: a Pilot Study | April 2014 | May 2016 |
| NCT01632306 | Terminated | Phase 1/Phase 2 | A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer | March 2013 | June 2015 |
| NCT00394602 | Terminated | Chemoradiation-Induced Nausea and Emesis: Quality of Life | April 7, 2004 | May 8, 2019 | |
| NCT03469258 | Terminated | Phase 2 | Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma | April 13, 2018 | October 1, 2019 |
| NCT00003851 | Terminated | N/A | Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer | March 1999 | July 2004 |
| NCT01240304 | Terminated | Phase 2 | A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas | November 2010 | October 2019 |
| NCT02047500 | Terminated | Phase 1 | Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer | January 2014 | May 2016 |
| NCT02952859 | Terminated | Impact of Margin-accentuation IRE in Pancreatic Cancer | January 2017 | February 25, 2020 | |
| NCT00414570 | Terminated | Early Phase 1 | An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside Analogs | November 2007 | February 6, 2019 |
| NCT00031837 | Terminated | Phase 3 | Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer | October 2002 | December 2006 |
| NCT03244683 | Terminated | N/A | A Study of the Efficacy of ONS to Reduce Postoperative Complications Associated With Pancreatic Surgery | August 28, 2017 | August 1, 2018 |
| NCT00878657 | Terminated | Phase 1 | Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic Cancer | April 2009 | October 2013 |
| NCT03042780 | Terminated | Phase 2 | FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas | February 1, 2017 | September 7, 2018 |
| NCT05395052 | Terminated | Phase 1 | FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors | May 31, 2022 | August 11, 2023 |
| NCT00493441 | Terminated | Phase 2 | AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer | June 2007 | December 2009 |
| NCT04536077 | Terminated | Phase 2 | Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients | August 13, 2021 | November 21, 2023 |
| NCT00276744 | Terminated | Phase 2 | Individualized Drug Treatment for Treating Patients With Pancreatic Cancer | October 2005 | April 2010 |
| NCT03407040 | Terminated | Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy | January 30, 2018 | September 30, 2019 | |
| NCT01231347 | Terminated | Phase 3 | QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas | April 2011 | December 2012 |
| NCT04131192 | Terminated | Phase 1 | Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer | November 11, 2019 | September 9, 2021 |
| NCT00003085 | Terminated | Phase 2 | Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic Cancer | September 1996 | July 2000 |
| NCT00121745 | Terminated | Phase 1 | Evaluation of Safety of Rexin-G Gene Transfer for Advanced Pancreatic Cancer | July 2005 | July 2007 |
| NCT03519308 | Terminated | Early Phase 1 | A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer | July 29, 2020 | April 18, 2022 |
| NCT01822756 | Terminated | Phase 1 | An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors | April 2013 | August 2016 |
| NCT00769652 | Terminated | N/A | Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer | October 2006 | August 2009 |
| NCT00262951 | Terminated | Phase 2 | Chemoradiation in Locally Advanced Pancreatic Cancer | January 2005 | August 2011 |
| NCT03599362 | Terminated | Phase 2 | Study of Nivolumab, Cabiralizumab, and Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Unresectable Pancreatic Cancer | July 31, 2018 | June 15, 2020 |
| NCT04637698 | Terminated | Phase 1/Phase 2 | OH2 Oncolytic Viral Therapy in Pancreatic Cancer | February 2, 2021 | May 4, 2023 |
| NCT04155008 | Terminated | Phase 4 | Nutrition and Pharmacological Algorithm for Oncology Patients Study | March 1, 2021 | April 5, 2021 |
| NCT04046887 | Terminated | Phase 1 | Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC) | September 11, 2019 | October 4, 2023 |
| NCT03471468 | Terminated | N/A | Kinetics of Microparticles Under Chemotherapy in Patients With Gastric or Pancreatic Cancer | July 23, 2018 | January 2, 2020 |
| NCT02119663 | Terminated | Phase 3 | A Study of Ruxolitinib in Pancreatic Cancer Patients | June 2014 | October 2016 |
| NCT00049608 | Terminated | Phase 1 | Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors | July 2002 | August 2011 |
| NCT00177853 | Terminated | Phase 1 | Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic Cancer | December 2006 | July 2010 |
| NCT01392352 | Terminated | Phase 2 | HYPAZ: Hypertension Induced by Pazopanib | April 2011 | September 2015 |
| NCT01900327 | Terminated | Phase 3 | Neoadjuvant Treatment in Resectable Pancreatic Cancer | February 2014 | July 2017 |
| NCT00766636 | Terminated | Phase 2 | Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy | September 2008 | |
| NCT03207867 | Terminated | Phase 2 | A Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma | August 28, 2017 | February 14, 2023 |
| NCT00660348 | Terminated | N/A | Standard Pain Control or Intrathecal Therapy in Controlling Pain in Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer | March 2008 | March 2011 |
| NCT00159471 | Terminated | N/A | Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer. | February 2005 | July 2006 |
| NCT00907166 | Terminated | Phase 1/Phase 2 | A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients | May 2009 | December 2017 |
| NCT03300921 | Terminated | Phase 1 | A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer | September 28, 2017 | March 23, 2022 |
| NCT03286062 | Terminated | Phase 1 | VM110 in Detection of Microscopic Tumors: A Phase I Study | October 12, 2017 | April 3, 2020 |
| NCT00281996 | Terminated | Phase 1 | Imatinib Mesylate and Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Pancreatic Cancer | March 2005 | October 2008 |
| NCT04327986 | Terminated | Phase 1/Phase 2 | Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas Cancer | June 15, 2021 | February 3, 2022 |
| NCT06371716 | Terminated | N/A | Ex-vivo Ultrasound Guided Radiofrequency Ablation on Pancreatic Solid Lesions | September 12, 2019 | June 12, 2020 |
| NCT01314027 | Terminated | Phase 3 | Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer | September 2009 | May 2019 |
| NCT02743975 | Terminated | Phase 1/Phase 2 | Near-infrared Image Guided Surgery in Pancreatic Adenocarcinoma | December 1, 2016 | May 1, 2018 |
| NCT01688336 | Terminated | Phase 2 | FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer | January 2012 | November 22, 2016 |
| NCT00176735 | Terminated | N/A | Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer | December 2001 | August 2005 |
| NCT03300843 | Terminated | Phase 2 | Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer | April 11, 2018 | September 16, 2019 |
| NCT01167738 | Terminated | Phase 2 | Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer | July 2010 | April 2015 |
| NCT04311047 | Terminated | N/A | Preoperative Detection of Lymph Node Metastases in Pancreatic and Periampullary Carcinoma Using USPIO MRI | May 15, 2017 | March 1, 2021 |
| NCT01071434 | Terminated | Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors | February 2009 | September 2010 | |
| NCT03069599 | Terminated | Immune Response After Pancreatic Cancer Treatment | February 15, 2017 | February 25, 2020 | |
| NCT00683085 | Terminated | Phase 1/Phase 2 | Human Leukocyte Antigen-A*02:01-restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer | May 2008 | May 2009 |
| NCT00116389 | Terminated | Phase 2 | Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas | ||
| NCT04683939 | Terminated | Phase 1/Phase 2 | Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors | January 18, 2022 | July 24, 2023 |
| NCT00364364 | Terminated | Early Phase 1 | Safety Study to Determine the Appropriate Dose of Antibody Against Tumor Cells to Best Target Patients With Pancreatic Cancer. | May 2007 | August 2008 |
| NCT02628535 | Terminated | Phase 1 | Safety Study of MGD009 in B7-H3-expressing Tumors | September 2015 | November 25, 2019 |
| NCT00426127 | Terminated | Phase 2 | Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer | November 2006 | August 2009 |
| NCT01108458 | Terminated | Phase 2 | A Phase 2 Study of Pertuzumab and Erlotinib for Refractory Pancreatic Adenocarcinoma | July 2010 | March 2011 |
| NCT02117479 | Terminated | Phase 3 | Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1) | March 2014 | December 2016 |
| NCT02352831 | Terminated | Phase 1/Phase 2 | Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma | August 31, 2015 | October 19, 2018 |
| NCT02465983 | Terminated | Phase 1 | Pilot Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer | May 2015 | November 2017 |
| NCT01515046 | Terminated | Phase 2 | Clinical Trial of High-dose Vitamin C for Advanced Pancreatic Cancer | September 2012 | December 2016 |
| NCT01012362 | Terminated | Phase 1 | Study of Pazopanib and Ixabepilone in Patients With Solid Tumors | December 2009 | February 2013 |
| NCT03136406 | Terminated | Phase 1/Phase 2 | QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy | August 11, 2017 | November 1, 2019 |
| NCT00470535 | Terminated | Phase 2 | Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic Cancer | January 2007 | September 2010 |
| NCT02872831 | Terminated | N/A | Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle | July 2016 | November 2017 |
| NCT05116917 | Terminated | Phase 2 | Immunotherapy Combined With Radiation and Influenza Vaccine for Pancreatic Cancer. | November 5, 2021 | October 19, 2023 |
| NCT00967291 | Terminated | Phase 2 | Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer | March 2006 | June 2008 |
| NCT00640978 | Terminated | Phase 2 | Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic Cancer | March 2008 | March 2010 |
| NCT00101907 | Terminated | Phase 1 | Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer | December 2004 | April 2008 |
| NCT03073473 | Terminated | Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers | February 28, 2017 | June 13, 2018 | |
| NCT01362582 | Terminated | Phase 3 | Comparing Parenteral Nutrition vs Best Supportive Nutritional Care in Patients With Pancreatic Cancer | March 2010 | September 2014 |
| NCT01104116 | Terminated | N/A | Use of PET Imaging to Distinguish Malignant From Benign IPMN | September 2009 | March 2016 |
| NCT00113256 | Terminated | Phase 2/Phase 3 | Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer | February 2005 | |
| NCT04258150 | Terminated | Phase 2 | Ipilimumab, Nivolumab, Tocilizumab and Radiation in Pretreated Patients With Advanced Pancreatic Cancer | April 16, 2020 | November 23, 2021 |
| NCT00609765 | Terminated | Phase 2 | Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors | August 2007 | March 2008 |
| NCT00642733 | Terminated | Phase 4 | A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer | August 2007 | April 2009 |
| NCT00587132 | Terminated | Phase 1/Phase 2 | Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma | November 2006 | February 2012 |
| NCT02405585 | Terminated | Phase 2 | Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer | April 2015 | July 30, 2016 |
| NCT02908451 | Terminated | Phase 1 | A Study of AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer | April 24, 2017 | February 28, 2021 |
| NCT02926040 | Terminated | Quality of Life After in Situ IRE in Locally Advanced Pancreatic Cancer | October 2016 | February 25, 2020 | |
| NCT02423954 | Terminated | Phase 1/Phase 2 | Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) | April 2015 | November 1, 2017 |
| NCT00889187 | Terminated | Phase 1/Phase 2 | Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer | December 2009 | December 30, 2011 |
| NCT03600623 | Terminated | Early Phase 1 | Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer | September 25, 2017 | July 31, 2020 |
| NCT00307723 | Terminated | Phase 1/Phase 2 | Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer | May 2006 | July 2009 |
| NCT04808362 | Terminated | Phase 1/Phase 2 | Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours | April 28, 2021 | January 11, 2023 |
| NCT02767752 | Terminated | Phase 2 | Gemcitabine and Capecitabine With or Without T-ChOS as Adjuvant Therapy for Patients With Resected Pancreatic Cancer | November 2016 | July 2018 |
| NCT02682082 | Terminated | N/A | EUS Guided Neurolysis Celiac Block w/wo Bupivacaine in Patient Being Treated Palliatively for Pancreatic Cancer | May 27, 2016 | June 14, 2019 |
| NCT04070313 | Terminated | Phase 2 | A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in Taiwan | July 11, 2019 | October 31, 2021 |
| NCT02707328 | Terminated | Phase 1 | Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002) | January 2015 | November 10, 2017 |
| NCT00662688 | Terminated | Phase 3 | Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer | October 2007 | December 2012 |
| NCT01768988 | Terminated | Phase 4 | Efficacy Of Pregabalin In The Treatment Of Pancreatic Cancer Pain. A Randomized Controlled Double-Blind, Parallel Group Study | August 2012 | December 2017 |
| NCT00614601 | Terminated | Phase 2 | Low Dose Vaccine Study for Surgically Resected Pancreatic Cancer | January 2008 | December 2014 |
| NCT00948688 | Terminated | Phase 1/Phase 2 | Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas | August 2009 | November 2013 |
| NCT02514031 | Terminated | Phase 1 | ARQ-761 Treatment With Gemcitabine/Nab-Paclitaxel Chemotherapy In Pancreatic Cancer | March 24, 2016 | May 2022 |
| NCT00529113 | Terminated | Phase 1 | Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer | September 30, 2007 | November 1, 2009 |
| NCT01056601 | Terminated | Phase 2 | Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy | September 2010 | February 2011 |
| NCT00410774 | Terminated | Phase 1/Phase 2 | Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery | July 2006 | October 2007 |
| NCT02242409 | Terminated | Phase 2 | Study of Gemcitabine and Abraxane for Pancreas Cancer | September 2014 | December 2016 |
| NCT00014651 | Terminated | Phase 3 | Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection | March 2001 | April 2002 |
| NCT01050426 | Terminated | Phase 2 | A Clinical Study of UFT/Leucovorin, Radiotherapy With or Without Cetuximab Following Induction Gemcitabine Plus Capecitabine in Patients With Locally Advanced Pancreatic Cancer (PERU) | March 2009 | December 2014 |
| NCT01103128 | Terminated | Validation of a Mouse Model of Pancreatic Carcinogenesis | March 2009 | May 2013 | |
| NCT02576665 | Terminated | Phase 1 | A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6) | July 2016 | December 20, 2019 |
| NCT02722616 | Terminated | N/A | Ultrasound Monitoring of Abdominal Soft Tissue | May 2016 | October 28, 2022 |
| NCT03451773 | Terminated | Phase 1/Phase 2 | M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas | May 17, 2018 | May 5, 2020 |
| NCT05546411 | Terminated | Phase 2 | A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer | January 6, 2023 | October 13, 2023 |
| NCT00310050 | Terminated | Phase 1 | Pemetrexed, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer | October 2005 | May 2008 |
| NCT03724435 | Terminated | Focused Ultrasound for the Treatment of Pancreatic Cancer - an International Registry | December 6, 2019 | November 30, 2023 | |
| NCT02132403 | Terminated | Phase 1 | (PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic Cancer | August 2014 | April 2015 |
| NCT05380557 | Terminated | ARTEMIS: Study of Patients With Early Stage Pancreatic Cancer Who Have Undergone Genetic Testing | August 23, 2021 | September 6, 2022 | |
| NCT03820544 | Terminated | N/A | SEMS Placement Before Surgery in Unblocking Bile Duct in Patients With Periampullary Pancreatic Cancer With Severe Obstructive Jaundice | September 1, 2017 | April 4, 2019 |
| NCT00739609 | Terminated | Phase 1 | IDO Inhibitor Study for Relapsed or Refractory Solid Tumors | August 2008 | October 2012 |
| NCT03956056 | Terminated | Phase 1 | Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy | February 13, 2020 | July 6, 2023 |
| NCT00841035 | Terminated | Phase 2 | 7 Day's of Erlotinib Neo-adjuvant, Followed by Adjuvant Erlotinib-gemcitabine in Pancreatic Cancer Patients | February 2009 | July 2011 |
| NCT02669914 | Terminated | Phase 2 | MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors | September 12, 2016 | January 11, 2018 |
| NCT00544908 | Terminated | Phase 2 | Dasatinib in Treating Patients With Stage IV Pancreatic Cancer | September 2007 | |
| NCT03387098 | Terminated | Phase 1/Phase 2 | QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy | December 28, 2017 | January 15, 2019 |
| NCT01956812 | Terminated | Phase 3 | Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer | December 2013 | November 2016 |
| NCT03757455 | Terminated | N/A | ERAS Protocol in Pancreaticoduodenectomy and Total Pancreatectomy | September 1, 2020 | October 1, 2021 |
| NCT00903396 | Terminated | Phase 2 | Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer | September 2009 | May 2013 |
| NCT03492164 | Terminated | Early Phase 1 | In Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic Cancer | March 20, 2018 | June 11, 2024 |
| NCT03481920 | Terminated | Early Phase 1 | A Trial of PEGPH20 in Combination With Avelumab in Chemotherapy Resistant Pancreatic Cancer | January 10, 2018 | June 10, 2019 |
| NCT04193904 | Terminated | Phase 1 | A Study of Live Biotherapeutic Product MRx0518 With Hypofractionated Radiation Therapy in Resectable Pancreatic Cancer | December 20, 2019 | May 8, 2023 |
| NCT03585062 | Terminated | Phase 2 | Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer | November 20, 2017 | July 1, 2019 |
| NCT02608229 | Terminated | Phase 1 | BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer | June 6, 2016 | May 21, 2020 |
| NCT03140670 | Terminated | Phase 2 | Maintenance Rucaparib in BRCA1, BRCA2 or PALB2 Mutated Pancreatic Cancer That Has Not Progressed on Platinum-based Therapy | September 5, 2017 | August 7, 2023 |
| NCT00550004 | Terminated | Phase 2 | Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine | September 2007 | October 2009 |
| NCT01693276 | Terminated | Phase 1/Phase 2 | Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer | September 2012 | June 2014 |
| NCT00322712 | Terminated | INST 0603C Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer | September 2006 | January 2007 | |
| NCT01276613 | Terminated | Early Phase 1 | Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas | January 2011 | April 19, 2019 |
| NCT01836432 | Terminated | Phase 3 | Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer | May 2013 | March 24, 2017 |
| NCT01940237 | Terminated | N/A | A Pilot Trial of Interpersonal Psychotherapy for the Treatment of Depression in Patients With Prostate, Colorectal, Lung and Pancreatic Cancer | April 2012 | May 2015 |
| NCT03165188 | Terminated | Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy | September 1, 2017 | December 8, 2020 | |
| NCT01188109 | Terminated | Phase 2 | Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of ERCC1 in Treatment Decision | July 2010 | July 2015 |
| NCT01025882 | Terminated | Phase 1 | Margin-Intense Combo Therapy in Pts w/Potentially Resectable Pancreatic Cancer | October 2009 | February 18, 2011 |
| NCT03099265 | Terminated | Phase 2 | Neoadjuvant Modified FOLFIRINOX and Stereotactic Body Radiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma | June 26, 2017 | September 18, 2019 |
| NCT02921737 | Terminated | Phase 2 | TAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy (UF-STO-PANC-003) | November 9, 2017 | July 26, 2020 |
| NCT00753441 | Terminated | N/A | Endoscopic Stenting Versus Surgical Bypass for Low Bile Duct Obstruction by Cancer of the Pancreatic Head | February 1, 2009 | August 16, 2017 |
| NCT04682431 | Terminated | Phase 1 | A Phase 1a/1b FIH Study of PY159 and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors | November 10, 2020 | August 31, 2023 |
| NCT00625586 | Terminated | Phase 2 | Monoclonal Antibody RAV12 and Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer | April 15, 2008 | March 18, 2009 |
| NCT01080248 | Terminated | Phase 2 | Gemcitabine and Pazopanib in Metastatic Pancreatic Cancer | August 2010 | October 2011 |
| NCT02822716 | Terminated | N/A | Irreversible Electroporation for Inoperable Hepatic and Pancreatic Malignancy | July 22, 2013 | September 23, 2020 |
| NCT00564720 | Terminated | Phase 2 | Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Pancreatic Cancer | December 2006 | March 2011 |
| NCT01531712 | Terminated | Phase 2 | Study of Neoadjuvant Treatment in Patients With Pancreatic Cancer That is Potentially Resectable | February 10, 2011 | December 2012 |
| NCT00867126 | Terminated | Early Phase 1 | Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine | March 2, 2009 | February 2012 |
| NCT03637491 | Terminated | Phase 1/Phase 2 | A Study of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or Metastatic RAS-mutant Solid Tumors | August 15, 2018 | February 2, 2021 |
| NCT00658801 | Terminated | Phase 1 | Study of Respiratory Gated Proton Beam Radiotherapy for Inoperable Pancreas Carcinoma | January 2007 | February 2010 |
| NCT04592861 | Terminated | Phase 3 | Carbon Ion RT for Locally Advanced Pancreatic Cancer | November 1, 2020 | August 24, 2022 |
| NCT00896467 | Terminated | Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy | September 2007 | November 2010 | |
| NCT02985801 | Terminated | Phase 1/Phase 2 | PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer | December 2016 | April 2019 |
| NCT00636883 | Terminated | Phase 2 | Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic Cancer | January 2008 | July 2012 |
| NCT00855634 | Terminated | N/A | Resection in Pancreatic Cancer With Minimal Metastatic Disease or Venous Infiltration Trial at Technische Universität München | August 2009 | March 2012 |
| NCT02331251 | Terminated | Phase 1/Phase 2 | Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus) | December 2014 | January 2018 |
| NCT00541021 | Unknown status | Phase 3 | Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | December 2006 | |
| NCT01333631 | Unknown status | Phase 2 | Valproic Acid With Chemoradiotherapy for Pancreatic Cancer | June 2011 | July 2015 |
| NCT05009966 | Unknown status | Phase 1 | Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor | September 16, 2021 | June 2024 |
| NCT03443921 | Unknown status | N/A | Divestment for Artery-involved Pancreatic Cancer | March 2018 | March 2021 |
| NCT03749005 | Unknown status | Impact of Three-dimensional Visualization on Operation Strategy and Complications for Pancreatic Cancer | April 18, 2017 | August 30, 2020 | |
| NCT02246322 | Unknown status | N/A | A Clinical Trial With a New Needle Device Comparing Two Needles for EUS_FNA of Solid Lesions. | August 2013 | November 2014 |
| NCT03685370 | Unknown status | N/A | PERiX: Comparison of Efficacy Between Placement of Epidural Catheters X-ray Guided and LOS Technique | March 1, 2017 | September 30, 2019 |
| NCT02734680 | Unknown status | N/A | IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer | February 2016 | February 2019 |
| NCT04058236 | Unknown status | Phase 4 | Glycocalyx Levels in Patients Undergoing Pancreatectomy | August 15, 2019 | July 31, 2021 |
| NCT04012021 | Unknown status | N/A | EXplanted LIver and Ex-vivo Pancreatic Specimen Evaluation by 7 TESLA MRI | May 24, 2019 | December 31, 2020 |
| NCT05168527 | Unknown status | Phase 2 | The First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer Patients | September 3, 2021 | May 31, 2024 |
| NCT04683497 | Unknown status | N/A | CE-IOUS for Patients With Pancreatic Cancer Undergoing Surgery: A Prospective, Proof-of-concept Trial | January 1, 2021 | December 31, 2023 |
| NCT03435770 | Unknown status | N/A | Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms | March 1, 2018 | September 1, 2019 |
| NCT05114213 | Unknown status | Phase 2 | MR-Guided Adaptive SBRT of Primary Tumor for Pain Control in Metastatic PDAC | December 15, 2021 | May 2024 |
| NCT01867892 | Unknown status | Phase 2 | A Phase II Study of Locally Advanced Pancreatic Cancer | June 2013 | May 2019 |
| NCT04520386 | Unknown status | Phase 2 | OMT-111 for Terminal Stage Solid Tumors | October 2020 | October 2022 |
| NCT01931449 | Unknown status | Phase 3 | Evaluation of A New Digestive Reconstruction Procedure Following Pancreatoduodenectomy | January 2014 | July 2015 |
| NCT04892329 | Unknown status | N/A | A Multi-center Study on the Efficacy and Safety of AI-assisted Navigation System for Biliopancreatic EUS | May 12, 2021 | November 30, 2022 |
| NCT00795977 | Unknown status | Phase 1/Phase 2 | Preoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic Cancer | November 2003 | November 2012 |
| NCT04235556 | Unknown status | Integrated Care Pathway in Oncology (PASSION) | February 21, 2020 | December 31, 2022 | |
| NCT02550847 | Unknown status | Evaluation of Prognosis With Integrated MRI/PET in Patients With Pancreatic Cancer | August 2014 | August 2016 | |
| NCT03779464 | Unknown status | Phase 2 | Study of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pancreas | August 1, 2019 | September 30, 2021 |
| NCT05430841 | Unknown status | N/A | Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT | June 1, 2022 | December 31, 2023 |
| NCT03716596 | Unknown status | Phase 1 | SBRT and Anti-programmed Cell Death Protein 1(Anti-PD-1) in Late Stage or Recurrent Pancreatic Cancer Patients | October 22, 2018 | October 22, 2023 |
| NCT05138302 | Unknown status | A Clinical Study of BRCA and DNA Damage Repair Genes in Blood Samples of Chinese Pancreatic Cancer Patients | April 19, 2021 | April 19, 2023 | |
| NCT04764084 | Unknown status | Phase 1 | Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors | April 1, 2021 | February 28, 2023 |
| NCT04318756 | Unknown status | The Italian Version of Cancer Worry Scale | April 1, 2020 | August 31, 2020 | |
| NCT02756468 | Unknown status | Procalcitonin Reveals Early Dehiscence in Pancreatic Surgery: the PREDIPS Study | January 2015 | December 2016 | |
| NCT03792932 | Unknown status | N/A | Laparoscopic vs Open Pancreatectomy for Body and Tail Pancreatic Cancer | February 2, 2019 | January 31, 2023 |
| NCT03820921 | Unknown status | Evaluation of MMR Status and PD-L1 Expression Using Specimens Obtained by EUS-FNB in Patients With Pancreatic Cancer | February 1, 2019 | January 1, 2022 | |
| NCT02659852 | Unknown status | N/A | A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction | January 2016 | January 2020 |
| NCT04089150 | Unknown status | Phase 2 | MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease | October 1, 2019 | August 30, 2023 |
| NCT02506803 | Unknown status | Phase 1 | Phase I Study of Neoadjuvant Chemotherapy for Patients With Borderline Resectable Pancreatic Cancer. | July 2015 | June 2017 |
| NCT01655641 | Unknown status | Phase 2/Phase 3 | Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery | July 2012 | July 2014 |
| NCT02278458 | Unknown status | Phase 1 | Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer | October 2014 | October 2016 |
| NCT04922515 | Unknown status | N/A | Pancreatic Ductal Adenocarcinoma - Microbiome as Predictor of Subtypes | April 25, 2020 | December 31, 2023 |
| NCT00005870 | Unknown status | Phase 3 | Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas | March 1999 | |
| NCT00275119 | Unknown status | Phase 2 | Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery | November 2003 | |
| NCT01074996 | Unknown status | Phase 2 | Study of S-1 as Second Line Treatment on Advanced Pancreatic Cancers | February 2010 | July 2014 |
| NCT00005869 | Unknown status | Phase 3 | Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer | November 1998 | |
| NCT05313854 | Unknown status | Diagnosis and Survival Prediction of Pancreatic Cancer by Machine Learning of Image Data | January 1, 2021 | December 31, 2023 | |
| NCT03417843 | Unknown status | N/A | Safety and Efficacy of an Ablation Catheter for the Treatment of Pancreatic Premalignant Cyctic Lesions. | February 2018 | February 2021 |
| NCT01811277 | Unknown status | Phase 2 | SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer | July 2010 | July 2014 |
| NCT03821909 | Unknown status | Acquisition of Portal Venous CTCs and Exosomes From Patients With Pancreatic Cancer by EUS | August 1, 2018 | September 2020 | |
| NCT04183478 | Unknown status | Phase 2/Phase 3 | The Efficacy and Safety of K-001 in the Treatment of Advanced Pancreatic Cancer | September 26, 2017 | March 2021 |
| NCT02580747 | Unknown status | Phase 1 | Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso | October 2015 | November 2018 |
| NCT00075452 | Unknown status | Phase 3 | Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma | November 2003 | |
| NCT04783831 | Unknown status | Biodegradable Pancreatic Stents for the Prevention of Postoperative Pancreatic Fistula After Cephalic Pancreaticoduodenectomy | November 1, 2018 | May 1, 2021 | |
| NCT02706782 | Unknown status | Phase 1 | A Study of Mesothelin Redirected Autologous T Cells for Advanced Pancreatic Carcinoma | March 2016 | September 2018 |
| NCT00088660 | Unknown status | Phase 3 | PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen | June 2004 | |
| NCT04054362 | Unknown status | Phase 2 | Paricalcitol Addition to Chemotherapy in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma | November 29, 2018 | June 30, 2021 |
| NCT01897636 | Unknown status | N/A | Efficacy and Safety of Endoscopic Ultrasound Guided Fine-needle Injection of Dendritic Cells Vaccination Into Unresectable Pancreatic Cancer | December 2013 | March 2017 |
| NCT03668418 | Unknown status | Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos | June 1, 2018 | May 31, 2022 | |
| NCT04310553 | Unknown status | N/A | An Open-label, Multicenter, Prospective Study of Irreversible Electroporation (Nano Knife) Combined With Radiotherapy and Chemotherapy in Patients With Locally Advanced Pancreatic Cancer | December 1, 2017 | December 1, 2020 |
| NCT00346281 | Unknown status | Phase 2 | 32P BioSiliconTM in Addition to Gemcitabine in Pancreatic Cancer | June 2006 | June 2008 |
| NCT04425876 | Unknown status | Phase 1 | A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Resectable Pancreatic Cancer | December 17, 2020 | September 1, 2023 |
| NCT00906802 | Unknown status | N/A | Benefit of Roux-en-Y (R-Y) Reconstruction After Pancreaticoduodenectomy | April 2003 | April 2010 |
| NCT03366038 | Unknown status | Shark Mouth Modified Pancreaticojejunostomy | December 8, 2017 | May 1, 2020 | |
| NCT01717807 | Unknown status | C11-Erlotinib PET/CT as a Tool for Identification and Characterization of Tumor With High Expression of Epidermal Growth Factor Receptor(EGFR). | April 2013 | ||
| NCT03662412 | Unknown status | Phase 1/Phase 2 | Study of Sirolimus in Patients With Advanced Pancreatic Cancer | June 1, 2018 | June 30, 2023 |
| NCT02355119 | Unknown status | Phase 3 | Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic Cancer | January 2015 | December 2018 |
| NCT00683358 | Unknown status | Phase 1/Phase 2 | Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer | May 2008 | April 2009 |
| NCT03374293 | Unknown status | Phase 2 | Combination of Radiation Therapy and Anti-PD-1 Antibody in Treating Patients With Pancreatic Cancer | December 1, 2017 | December 31, 2021 |
| NCT03140592 | Unknown status | Pancreatic Cancer Models Developed From EUS Guided Biopsy Tissue | January 14, 2015 | January 2023 | |
| NCT01266720 | Unknown status | Phase 1 | HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1) | April 2008 | March 2012 |
| NCT03960060 | Unknown status | Phase 1 | A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors | May 16, 2019 | June 30, 2023 |
| NCT00553683 | Unknown status | Phase 1/Phase 2 | Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer | October 2007 | July 2014 |
| NCT03638193 | Unknown status | N/A | Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer | July 11, 2018 | February 1, 2022 |
| NCT02646462 | Unknown status | Systematic Lymph Node Sampling and Analysis in Patients With Pancreatic Cancer | June 2015 | December 2016 | |
| NCT00010062 | Unknown status | Phase 2 | Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer | October 2000 | |
| NCT03098160 | Unknown status | Phase 1 | Immunotherapy Study of Evofosfamide in Combination With Ipilimumab | May 10, 2017 | April 2019 |
| NCT03524677 | Unknown status | Mutation of K-RAS, CDKN2A, SMAD4 and TP53 in Pancreatic Cancer: Role of Liquid Biopsy in Preoperative Diagnosis | January 23, 2019 | January 2020 | |
| NCT02479984 | Unknown status | N/A | Diagnostic Laparoscopy in the Preoperative Staging of Pancreatobiliary Cancer | August 2011 | December 31, 2019 |
| NCT04993846 | Unknown status | Pancreatic Cancer and Oral Microbiome | July 26, 2021 | December 31, 2023 | |
| NCT00658840 | Unknown status | Phase 2 | Concurrent Chemo-radiotherapy With Capecitabine for Unresectable Locally Advanced Pancreatic Carcinoma | June 2006 | June 2013 |
| NCT02305186 | Unknown status | Phase 1/Phase 2 | Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer | March 2015 | December 2022 |
| NCT01342354 | Unknown status | Phase 1/Phase 2 | Study of Stereotactic Body Radiation Therapy in Patients With Intact Pancreatic Cancer | April 14, 2009 | June 1, 2022 |
| NCT03400280 | Unknown status | N/A | POstopeRative Standardization of Care: THe Implementation of Best Practice After Pancreatic Resection | January 8, 2018 | February 9, 2020 |
| NCT00639925 | Unknown status | Phase 1 | Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer | March 2007 | March 2013 |
| NCT00964171 | Unknown status | Phase 2 | Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer | August 2008 | |
| NCT01127815 | Unknown status | Identify the Clinical Significance and Potential Implications of Peritoneal Washing Cytology (PWC) in Patients With Pancreatic Cancer | March 2010 | December 2011 | |
| NCT03940027 | Unknown status | N/A | EUS-guided Celiac Plexus Neurolysis for the Treatment of Abdominal Pain in Pancreatic Cancer | February 10, 2019 | February 2021 |
| NCT04638868 | Unknown status | N/A | Silicon Microsieve Device vs Cell Surface Marker-based Platform for the Isolation of Pancreatic Cancer CTCs | November 17, 2020 | December 31, 2021 |
| NCT01882946 | Unknown status | Phase 1/Phase 2 | Safety and Efficacy Study of DCVax-Direct in Solid Tumors | June 2013 | |
| NCT00024375 | Unknown status | Phase 2 | DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer | June 2001 | |
| NCT01994681 | Unknown status | Testing Spectrosense EVA System for Detection of Pancreatic Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air | October 2013 | ||
| NCT00082862 | Unknown status | Phase 2 | Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer | July 2002 | |
| NCT03882866 | Unknown status | N/A | Iodine-125 Seed Implantation Therapy for Locally Advanced Pancreatic Cancer | March 28, 2019 | September 30, 2021 |
| NCT01333332 | Unknown status | Phase 2 | Radiotherapy With Chemotherapy as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas Cancer | August 2010 | |
| NCT02662348 | Unknown status | Phase 1 | T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System | February 2016 | November 2017 |
| NCT00885248 | Unknown status | Integrated Positron Emission Tomography - Computed Tomography (PET-CT) in Patients With Pancreatic Cancer | January 2009 | December 2009 | |
| NCT04294589 | Unknown status | Evaluation of NETs in Patients With Solid Cancers Associated With a High Risk of Venous Thromboembolic Events | July 1, 2019 | December 2020 | |
| NCT02024633 | Unknown status | Phase 1 | Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer | December 2013 | March 2016 |
| NCT04814485 | Unknown status | Phase 2 | Efficacy and Safety of SHR-1020 Combined With Albumin-bound Paclitaxel in the Second-line Treatment of Pancreatic Cancer | April 22, 2021 | July 2023 |
| NCT03634501 | Unknown status | Phase 1/Phase 2 | Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells | October 26, 2018 | September 30, 2022 |
| NCT00079365 | Unknown status | N/A | Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas | May 2001 | |
| NCT00003780 | Unknown status | Phase 2 | Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas | December 1998 | |
| NCT02854072 | Unknown status | Phase 3 | A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients | November 2015 | May 2018 |
| NCT04316507 | Unknown status | N/A | Oncologist-Initiated Cancer Genetic Testing for Pancreatic Cancer Patients | April 1, 2020 | March 31, 2021 |
| NCT03544255 | Unknown status | Drug Screening of Pancreatic Cancer Organoids Developed From EUS-FNA Guided Biopsy Tissues | May 1, 2018 | June 1, 2021 | |
| NCT02934984 | Unknown status | Circulating Cell-free Tumor DNA(ctDNA) in Pancreatic Cancer | July 2016 | January 2021 | |
| NCT01675258 | Unknown status | Identifying Saliva Markers of Patients With Stomach, Colorectal (Including Pre-cancer Polyp) and Pancreatic Cancers | September 2012 | ||
| NCT04158414 | Unknown status | N/A | Applying PET/MR in Oncology - a Prospective Project | November 28, 2019 | November 28, 2021 |
| NCT02685228 | Unknown status | N/A | Decitabine Combined With Gemcitabine in First-line Treatment of AdvancedPancreatic Cancer | March 2016 | December 2018 |
| NCT02707315 | Unknown status | Early Phase 1 | A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer | January 2013 | |
| NCT04337333 | Unknown status | N/A | Two-in-one Covered and Uncovered Metal Stent | May 1, 2016 | December 31, 2021 |
| NCT04813432 | Unknown status | Multiple Arterial Phase Computed Tomography Examination to Improve Detection of Tumors in the Liver and Pancreas | September 10, 2018 | May 2021 | |
| NCT04584996 | Unknown status | CIRcular and Non-coding RNAs as Clinically USeful Biomarkers in Pancreaticobiliary Cancers | October 4, 2020 | November 5, 2023 | |
| NCT00757614 | Unknown status | Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom | February 2008 | ||
| NCT02042859 | Unknown status | Phase 1 | Radiofrequency Probe for Management of Unresectable Bile Duct and Pancreatic Cancer | February 2013 | February 2015 |
| NCT04415385 | Unknown status | Phase 2 | The Combination of Camrelizumab and Apatinib as Second-line Therapy for Advanced Pancreatic Carcinoma | June 1, 2020 | June 1, 2023 |
| NCT00010088 | Unknown status | Phase 2 | Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct | January 1999 | |
| NCT01439698 | Unknown status | Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry | September 2011 | December 30, 2018 | |
| NCT01601808 | Unknown status | Phase 2 | Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma | October 2011 | October 2013 |
| NCT00436267 | Unknown status | Phase 2 | Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery | November 2006 | |
| NCT04323917 | Unknown status | Detection of High Expression Levels of EMT-Transcription Factor mRNAs in Patients With Pancreatic Cancer and Their Diagnostic Potential | November 2, 2017 | November 2022 | |
| NCT01591733 | Unknown status | Phase 2 | FOLFIRINOX + RT for Pancreatic Cancer | May 2012 | January 2022 |
| NCT02457156 | Unknown status | Phase 3 | Cattell-Warren Versus Blumgart Techniques of Pancreatico-jejunostomy Following Pancreato-duodenectomy | April 2015 | December 2021 |
| NCT02954302 | Unknown status | N/A | Proximal Roux-en-y Gastrojejunal Anastomosis on Delayed Gastric Emptying After Pylorus-resecting Pancreaticoduodenectomy | September 2016 | December 2018 |
| NCT02900677 | Unknown status | N/A | Developing Prehabilitation Program in Patients With Operable Pancreatic Cancer Perioperatively and Following Surgery | August 2015 | July 2018 |
| NCT04571489 | Unknown status | Phase 2 | A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer | December 1, 2020 | December 1, 2023 |
| NCT02349724 | Unknown status | Phase 1 | A Clinical Research of CAR T Cells Targeting CEA Positive Cancer | December 2014 | December 2019 |
| NCT03941457 | Unknown status | Phase 1/Phase 2 | Clinical Research of ROBO1 Specific BiCAR-NK Cells on Patients With Pancreatic Cancer | May 2019 | May 2022 |
| NCT01941342 | Unknown status | Phase 2 | Evaluation of Preoperative Biliary Drainage Before Pancreatoduodenectomy | January 2014 | June 2015 |
| NCT04112836 | Unknown status | Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer | March 15, 2019 | August 2020 | |
| NCT03215459 | Unknown status | Cardiopulmonary Exercise Testing: An Assessment of Patients Fitness for Palliative Chemotherapy for Pancreatic Cancer | February 1, 2021 | September 2023 | |
| NCT01218880 | Unknown status | Phase 1 | Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer | June 2010 | December 2011 |
| NCT02811666 | Unknown status | N/A | Impact of Preoperative Sarcopenia on Morbidity and Mortality in Patients Operated on From Digestive Cancers | November 2016 | November 2019 |
| NCT02433626 | Unknown status | Phase 1 | Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies | December 2015 | June 2020 |
| NCT02510066 | Unknown status | Phase 3 | Efficacy and Mechanisms of Acupuncture for Patients With Advanced Pancreatic Cancer Pain | July 2015 | June 2017 |
| NCT00024063 | Unknown status | Phase 1 | SU006668 in Treating Patients With Advanced Solid Tumors | ||
| NCT02424279 | Unknown status | N/A | Invasive Treatment of Pain Associated With Pancreatic Cancer on Different Levels of WHO Analgesic Ladder | September 2014 | September 2017 |
| NCT02423239 | Unknown status | Phase 1 | A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours | April 2015 | December 2016 |
| NCT02798003 | Unknown status | Food Reward in Cachexia Induced by Acute or Chronic Disease | November 2016 | September 2018 | |
| NCT03267173 | Unknown status | Early Phase 1 | Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer. | June 15, 2017 | June 2019 |
| NCT03063554 | Unknown status | N/A | EUS BD vs ERCP TP for Pancreatic Cancer | October 18, 2016 | October 1, 2018 |
| NCT00440167 | Unknown status | Phase 3 | Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine | June 2006 | December 2012 |
| NCT03606148 | Unknown status | SurePathTM Liquid-based Cytology and Conventional Smear Cytology in Pancreatic Lesions | April 17, 2018 | December 31, 2019 | |
| NCT01494155 | Unknown status | Phase 2 | Short Course Radiation Therapy With Proton or Photon Beam Capecitabine and Hydroxychloroquine for Resectable Pancreatic Cancer | December 2011 | January 2023 |
| NCT03058926 | Unknown status | Coordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer | January 19, 2017 | January 2020 | |
| NCT02329717 | Unknown status | Phase 2 | Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma | April 2015 | December 2016 |
| NCT04581876 | Unknown status | Phase 2 | The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic Cancer | November 1, 2019 | March 1, 2023 |
| NCT00108875 | Unknown status | Phase 1/Phase 2 | Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer | April 2003 | |
| NCT03009253 | Unknown status | N/A | Translational Research on Locally Advanced Pancreatic Adenocarcinoma | July 2015 | December 2019 |
| NCT00197431 | Unknown status | Phase 2 | Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer | January 2004 | |
| NCT04418739 | Unknown status | Phase 2 | Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes | January 27, 2020 | November 26, 2022 |
| NCT00813696 | Unknown status | Phase 3 | Gemcitabine or Gemcitabine and Cisplatin in the Treatment of Advanced Pancreatic Cancer | April 2002 | September 2009 |
| NCT04976660 | Unknown status | Phase 1/Phase 2 | TT-4 as a Single Agent in Subjects With Advanced Selected Solid Tumors | December 15, 2022 | September 30, 2023 |
| NCT04024345 | Unknown status | N/A | The Emotional Impact of Surveillance for Pancreatic Cancer | July 1, 2017 | December 31, 2021 |
| NCT03642093 | Unknown status | Phase 4 | HOPE - A Study to Evaluate the Effect of a Prehabilitation Program on GI Cancer Patients Planning to Undergo Surgery | August 1, 2018 | May 2019 |
| NCT01676259 | Unknown status | Phase 2 | A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer | March 7, 2018 | August 2023 |
| NCT03129607 | Unknown status | A Study in Postoperative Pancreatic Fistula | May 1, 2018 | May 1, 2020 | |
| NCT03933111 | Unknown status | N/A | Application of Newly Developed Endoscopic Ultrasound With Zone Sonography Technology for Diagnosis of Pancreatic Caner | June 1, 2018 | June 1, 2019 |
| NCT01659502 | Unknown status | Phase 2 | Investigator's Initiated Phase II Study for Pancreatic Cancer Patients | December 2013 | |
| NCT04348643 | Unknown status | Phase 1/Phase 2 | Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer | February 20, 2020 | April 30, 2024 |
| NCT00003797 | Unknown status | Phase 2 | Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas | March 1999 | |
| NCT02461836 | Unknown status | Phase 2 | Study of Stereotactic Body Radiation Therapy for Patients After Radical Resection of Pancreatic Cancer With Advanced Stages (T3 or N1) | August 2015 | June 2020 |
| NCT05275062 | Unknown status | Early Phase 1 | Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma | February 15, 2022 | May 1, 2024 |
| NCT04440800 | Unknown status | Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Treatment | July 2020 | September 2021 | |
| NCT00268411 | Unknown status | Phase 3 | Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer | September 2004 | |
| NCT01563133 | Unknown status | N/A | Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cystic Tumors of the Pancreas | June 2012 | March 2019 |
| NCT03825328 | Unknown status | Phase 2 | A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC ) | January 30, 2019 | December 30, 2020 |
| NCT04907864 | Unknown status | Phase 2 | Effect of Multi-modal Intervention Care on Cachexia in Patients With Advanced Cancer Compared to Conventional Management (MIRACLE) | January 31, 2020 | June 30, 2022 |
| NCT04549064 | Unknown status | Biomarkers of Pancreatic Cancer and New Way to Detection | September 1, 2020 | December 30, 2021 | |
| NCT03989310 | Unknown status | Phase 1/Phase 2 | An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer | March 1, 2019 | March 31, 2022 |
| NCT01717196 | Unknown status | N/A | Diagnostic Accuracy of FNA: is Aspiration- Related? | October 2012 | |
| NCT03634332 | Unknown status | Phase 2 | Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC | May 1, 2019 | January 2021 |
| NCT02781012 | Unknown status | Project Survival-Prospective Biomarker Discovery | March 2016 | February 2022 | |
| NCT04352023 | Unknown status | Phase 2 | Analgesic Efficacy After Pancreatobiliary Surgery: Intravenous Versus Patient-controlled Epidural | January 1, 2018 | June 30, 2020 |
| NCT05327582 | Unknown status | Phase 1/Phase 2 | An Open-label, Phase I/II Study of PLENA Regimen in Patients With Unresectable Pancreatic Cancer or BTC | April 12, 2022 | April 30, 2024 |
| NCT01438385 | Unknown status | Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders | July 2011 | December 30, 2017 | |
| NCT00855985 | Unknown status | N/A | Anastomotic Techniques in Pancreaticoduodenectomy | July 2004 | October 2011 |
| NCT01111591 | Unknown status | Phase 4 | Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer | November 2008 | June 2017 |
| NCT01801852 | Unknown status | N/A | Autologous Natural Killer T Cells Infusion for the Treatment of Cancer | January 2013 | June 2017 |
| NCT04189393 | Unknown status | Microbiome Analysis in esoPhageal, PancreatIc and Colorectal CaNcer Patients Undergoing Gastrointestinal Surgery | January 1, 2020 | November 1, 2021 | |
| NCT03638206 | Unknown status | Phase 1/Phase 2 | Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies | March 1, 2018 | March 1, 2023 |
| NCT03178812 | Unknown status | N/A | Role of the Cystic Fluid Interleukins and Tumor Necrosis Factor (TNF) Levels in Characterizing Pancreatic Cysts Detected by Endoscopic Ultrasound (EUS) | June 2017 | June 2019 |
| NCT02818907 | Unknown status | N/A | Evaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially Resectable | May 2016 | May 2023 |
| NCT03636308 | Unknown status | Phase 2 | Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic Cancer | July 17, 2018 | August 1, 2021 |
| NCT02514928 | Unknown status | Phase 3 | Resection of the Nerve Plexus on the Right Half of Celiac and SMA Associated With Extended Pancreatoduodenectomy in the Surgical Treatment for Adenocarcinoma of the Head of Pancreas | June 2015 | June 2019 |
| NCT01641003 | Unknown status | Isolation and Characterization of Cancer Stem Cells Using iFP Technique | July 2012 | June 2015 | |
| NCT01821729 | Unknown status | Phase 2 | Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer | July 2013 | September 2021 |
| NCT03435289 | Unknown status | Phase 1 | A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic Cancer | October 19, 2017 | January 2019 |
| NCT04518800 | Unknown status | N/A | PEG-rhG-CSF in Secondary Prevention of Nab-Paclitaxel Combined With S-1 in Advanced Pancreatic Cancer | August 18, 2020 | February 18, 2022 |
| NCT01324856 | Unknown status | Phase 1 | Pancreaticogastrostomy Versus Pancreaticojejunostomy in Reconstruction After Cephalic Duodenopancreatectomy | April 2011 | September 2013 |
| NCT01219192 | Unknown status | Phase 1 | Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure | August 2010 | December 2011 |
| NCT00006117 | Unknown status | Phase 2 | Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | September 1999 | |
| NCT04148755 | Unknown status | The Accurateness of Endoscopic Ultrasound Elastography in the Guidance of EUS-FNA in Solid Pancreatic Lesions | October 29, 2019 | October 30, 2021 | |
| NCT05399394 | Unknown status | Phase 2 | Induction FOLFIRINOX Followed by Chemoradiation in Locally Advanced Pancreatic Cancer | July 1, 2016 | June 1, 2022 |
| NCT02117895 | Unknown status | Phase 3 | Left Celiac Plexus Resection for Pancreatic Cancer at the Body and Tail | January 2014 | January 2017 |
| NCT00005871 | Unknown status | Phase 3 | Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer | November 1998 | |
| NCT03497819 | Unknown status | Early Phase 1 | Autologous CARTmeso/19 Against Pancreatic Cancer | October 1, 2017 | October 31, 2020 |
| NCT03214991 | Unknown status | Circulating Tumor DNA as a Prognostic Marker in Patients With Pancreatic Cancer | May 12, 2017 | March 31, 2021 | |
| NCT00024362 | Unknown status | Phase 2 | BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery | May 2001 | |
| NCT00486460 | Unknown status | Phase 3 | Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer | June 2005 | |
| NCT05052567 | Unknown status | Phase 1/Phase 2 | CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma | October 21, 2021 | May 31, 2023 |
| NCT05329597 | Unknown status | Study on Umorestat Hydrogen Sulfate Capsule in Patients With Locally Advanced/Metastatic Pancreatic Cancer | June 24, 2020 | July 2022 | |
| NCT04387903 | Unknown status | Reoperation After Pancreaticoduodenectomy | January 1, 2000 | August 1, 2020 | |
| NCT03127150 | Unknown status | Chyle Leak After Pancreatic Operation | May 1, 2018 | May 1, 2021 | |
| NCT03460925 | Unknown status | N/A | Improving REsectability in Pancreatic NEoplasms (IRENE) | May 2, 2018 | January 1, 2021 |
| NCT03774589 | Unknown status | N/A | Bilioenteric Anastomosis by Magnetic Compressive Technique | February 1, 2019 | January 31, 2022 |
| NCT03768687 | Unknown status | A Real-world Study of Albumin-bound Paclitaxel in the Treatment of Pancreatic Cancer | December 20, 2018 | June 1, 2020 | |
| NCT02260128 | Unknown status | N/A | Effect of Chewing Gum on Postoperative Bowel Function Following Upper GI Tract Cancer Surgery | November 2014 | December 2015 |
| NCT00010270 | Unknown status | Phase 1 | LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer | April 2001 | |
| NCT03475966 | Unknown status | N/A | Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program | February 22, 2017 | June 30, 2022 |
| NCT00149578 | Unknown status | Phase 2 | A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer | October 2004 | October 2008 |
| NCT01182831 | Unknown status | Phase 1 | Trial Comparing Two Techniques of Celiac Plexus Neurolysis for Treatment of Pain in Carcinoma Pancreas | January 2010 | January 2011 |
| NCT02209415 | Unknown status | N/A | EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer | April 2011 | August 2016 |
| NCT04509687 | Unknown status | Training Endoscopists to Perform On-site Rapid Cytological Evaluation for EUS-FNA of Solid Pancreatic Lesions | December 1, 2019 | November 1, 2020 | |
| NCT03959150 | Unknown status | Phase 2/Phase 3 | Metronomic Chemotherapy With Capecitabine for Pancreatic Cancer | January 5, 2020 | June 30, 2023 |
| NCT04203459 | Unknown status | The Mechanism of Enhancing the Anti-tumor Effects of CAR-T on PC by Gut Microbiota Regulation | October 20, 2019 | December 31, 2022 | |
| NCT01642875 | Unknown status | Phase 4 | Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy | November 2016 | December 2020 |
| NCT02292914 | Unknown status | N/A | Prospective Analysis of Robot-Assisted Surgery | March 10, 2014 | July 10, 2020 |
| NCT03139487 | Unknown status | Phase 2 | A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism | August 7, 2017 | September 30, 2021 |
| NCT03167112 | Unknown status | Phase 2 | A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer | July 3, 2017 | May 2018 |
| NCT03013712 | Unknown status | Phase 1/Phase 2 | A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer | January 2017 | December 2020 |
| NCT01522573 | Unknown status | T-EUS for Gastrointestinal Disorders: A Multicenter Registry | November 2011 | December 30, 2018 | |
| NCT01898741 | Unknown status | Phase 2 | Cone-beam CT Guided Stereotactic Radiation Therapy for Locally Advanced Pancreatic Cancer | July 2013 | July 2016 |
| NCT04517448 | Unknown status | Quality of Life of Patients Over 75 Yars Undergoing Palliative Chemotherapy | October 16, 2020 | March 15, 2022 | |
| NCT01926717 | Unknown status | A Comparative Clinical Research on Single Roux-en-Y and Traditional Roux-en-Y of Pancreaticojejunostomy-choledochojejunostomy For Treatment of Obstruction of Pancreatic Duct and Bile Duct | December 2010 | December 2018 | |
| NCT03891979 | Withdrawn | Phase 4 | Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic Adenocarcinoma | June 25, 2019 | June 1, 2020 |
| NCT05212025 | Withdrawn | Phase 2 | Adavosertib and Gemcitabine in Advanced Pancreatic | June 2022 | December 31, 2023 |
| NCT00968604 | Withdrawn | Phase 1 | C-VISA BikDD: Liposome in Advanced Pancreatic Cancer | March 2015 | March 2017 |
| NCT01473303 | Withdrawn | Phase 1/Phase 2 | Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer | August 2012 | |
| NCT05431582 | Withdrawn | Phase 1 | Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors | December 14, 2022 | December 14, 2022 |
| NCT00027521 | Withdrawn | Phase 1 | Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer | December 2000 | |
| NCT02713984 | Withdrawn | Phase 1/Phase 2 | A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer | March 2016 | July 2019 |
| NCT01130701 | Withdrawn | Phase 2 | A Pilot Study to Evaluate the Efficacy and Safety of Neoadjuvant Chemoradiotherapy With Capecitabine, . . . | May 2010 | December 2015 |
| NCT03358095 | Withdrawn | N/A | Cancer of the Head of the Pancreas: Early Surgery or Preoperative Biliary Drainage? | November 26, 2017 | December 31, 2025 |
| NCT04464967 | Withdrawn | Phase 1/Phase 2 | Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers | March 2021 | February 2023 |
| NCT00025532 | Withdrawn | Phase 1 | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer | April 2001 | |
| NCT04151719 | Withdrawn | Phase 3 | An Extension Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer | February 3, 2020 | February 3, 2024 |
| NCT04130399 | Withdrawn | Phase 2 | Study of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic Cancer | July 1, 2019 | January 1, 2023 |
| NCT01094535 | Withdrawn | N/A | Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) and Pancreatic Function Following Surgery | September 2007 | September 2012 |
| NCT02868632 | Withdrawn | Phase 1 | Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer | August 7, 2016 | March 4, 2019 |
| NCT03718650 | Withdrawn | Early Phase 1 | Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer | April 1, 2021 | April 1, 2023 |
| NCT01094626 | Withdrawn | N/A | Secretin-enhanced Magnetic Resonance Imaging (S-MRI) for Pancreatic Cancer Detection | April 2010 | March 2013 |
| NCT00005591 | Withdrawn | Phase 2 | Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Pancreas | October 1999 | April 2003 |
| NCT04034745 | Withdrawn | Open Label Study to Analyze the Effect of Telotristat Ethyl on Weight Regulation/Gain | October 2020 | November 2023 | |
| NCT00837135 | Withdrawn | Phase 1 | GI-4000 With Adoptive Transfer in Pancreatic Cancer | January 2008 | October 2009 |
| NCT01094600 | Withdrawn | N/A | Comparison of Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) to Endoscopic Pancreatic Function Test (ePFT) in Diagnosing Pancreatic Exocrine Insufficiency | June 2012 | June 2012 |
| NCT02851381 | Withdrawn | N/A | Compassionate Single Subject Use of FG-3019 (FibroGen) in Locally Advanced, Unresectable Pancreatic Cancer | August 2016 | August 2017 |
| NCT01895790 | Withdrawn | Phase 1/Phase 2 | Endoscopic Pancreatic Duct Stenting for Relief of Obstructive Pain in Patients With Pancreatic Cancer | July 2014 | May 2016 |
| NCT05379907 | Withdrawn | Observational Study of ctDNA in Resectable and Borderline Resectable Pancreatic Cancer | August 23, 2022 | August 23, 2023 | |
| NCT02745197 | Withdrawn | Phase 2 | A Study to See Whether a Nutritional Supplement is Beneficial for Patients With Pancreatic Cancer | May 2017 | October 2018 |
| NCT03536208 | Withdrawn | Early Phase 1 | Biological Effect of Warfarin on Pancreatic Cancer | May 15, 2019 | June 2022 |
| NCT04105062 | Withdrawn | Phase 1/Phase 2 | LS301 Uptake in Tumors of Patients Undergoing Liver, Pancreas, or Gastric Surgery | December 31, 2021 | December 31, 2023 |
| NCT01707758 | Withdrawn | Detection of Cancer-Specific Active Proteases in Blood Via Fluorescence | October 2012 | February 2013 | |
| NCT01386502 | Withdrawn | Phase 1 | CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors | June 15, 2011 | October 31, 2011 |
| NCT01510561 | Withdrawn | Phase 1 | A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies. | March 2012 | September 2015 |
| NCT01569282 | Withdrawn | N/A | Double Bypass Versus Stent-treatment in Irresectable Pancreatic Cancer | October 2011 | October 31, 2015 |
| NCT00671463 | Withdrawn | N/A | Pancreatic Stent to Prevent Leak After Distal Pancreatectomy | April 2008 | |
| NCT00524069 | Withdrawn | N/A | Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery | January 2007 | |
| NCT04420130 | Withdrawn | N/A | A Trial of Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metastasis（SHR-1210-HLJ-009） | August 1, 2020 | August 1, 2023 |
| NCT01913275 | Withdrawn | N/A | Comparison Between Endoscopic Stenting and Cholecystojejunostomy for PreoperativeDrainage Before Pancreaticoduodenectomy | March 2006 | February 2014 |
| NCT03001505 | Withdrawn | Registry for Pancreatic Cancer | May 4, 2017 | April 2037 | |
| NCT03649035 | Withdrawn | Phase 3 | Eus-guided Cryothermal Ablation in Stage III Pancreatic Adenocarcinoma | July 12, 2018 | December 31, 2020 |
| NCT05043987 | Withdrawn | Phase 1 | Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Cancers | November 16, 2022 | November 16, 2022 |
| NCT02106871 | Withdrawn | Phase 1 | Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer | April 2014 | June 2017 |
| NCT02449967 | Withdrawn | Phase 1/Phase 2 | HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Cancer | May 2015 | June 2020 |
| NCT05251038 | Withdrawn | Phase 1/Phase 2 | Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer | September 13, 2022 | January 31, 2023 |
| NCT01598584 | Withdrawn | Phase 2/Phase 3 | Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer | June 2012 | December 2015 |
| NCT02159248 | Withdrawn | Phase 1 | Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring Radiation | March 2014 | December 2019 |
| NCT01031056 | Withdrawn | Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers | January 2010 | January 2099 | |
| NCT02919553 | Withdrawn | N/A | Modified Wet Suction Versus Capillary Techniques for EUS Guided Fine Needle Aspiration and Biopsy of Solid Lesions | January 2018 | December 2021 |
| NCT03350763 | Withdrawn | N/A | Biliary Drainage Preceding Possible Pancreaticoduodenectomy. Are Self-expandable Metallic Stents (SEMS) Superior to Plastic Stents? | November 18, 2017 | December 2025 |
| NCT01017822 | Withdrawn | Phase 1/Phase 2 | Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer | ||
| NCT02442739 | Withdrawn | Early Phase 1 | Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers | August 15, 2016 | November 3, 2017 |
| NCT04276909 | Withdrawn | N/A | Feasibility Study of LUM Imaging System for Pancreatic Cancer | January 2026 | January 2026 |
| NCT02446379 | Withdrawn | Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery | |||
| NCT02581501 | Withdrawn | Phase 1 | Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer | February 2016 | December 2016 |
| NCT00386399 | Withdrawn | Phase 2 | Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene | October 2006 | February 2008 |
| NCT04083651 | Withdrawn | Phase 2/Phase 3 | A Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer | January 6, 2020 | October 15, 2023 |
| NCT02366858 | Withdrawn | N/A | Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures | October 2013 | June 2015 |
| NCT03908333 | Withdrawn | Phase 1/Phase 2 | High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | May 1, 2019 | May 1, 2023 |
| NCT00882765 | Withdrawn | Phase 2 | Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery | May 2009 | |
| NCT00580021 | Withdrawn | Clinical Outcomes in Hereditary Cancer | January 2006 | January 2016 | |
| NCT03697239 | Withdrawn | Phase 1/Phase 2 | High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer | June 2019 | December 2022 |
| NCT04123574 | Withdrawn | Early Phase 1 | A Pilot Study of BXCL701 in Patients With Pancreatic Cancer | October 15, 2019 | December 6, 2021 |
| NCT03038477 | Withdrawn | Phase 2 | A Study of Durvalumab in Patients With BR PDA Following Neoadjuvant Therapy and Successful Surgical Resection | June 12, 2017 | April 1, 2019 |
- Exact Synonym (Disease Ontology)
- Ca body of pancreas
- Exact Synonym (Disease Ontology)
- Ca head of pancreas
- Exact Synonym (Disease Ontology)
- Ca tail of pancreas
- Exact Synonym (Disease Ontology)
- malignant neoplasm of body of pancreas
- Exact Synonym (Disease Ontology)
- malignant neoplasm of head of pancreas
- Exact Synonym (Disease Ontology)
- malignant neoplasm of tail of pancreas
- Exact Synonym (Disease Ontology)
- pancreas neoplasm
- Exact Synonym (Disease Ontology)
- pancreatic neoplasm
- Exact Synonym (Disease Ontology)
- pancreatic tumor
- Disase is a (Disease Ontology)
- DOID:170
- Cross Reference ID (Disease Ontology)
- GARD:9364
- Cross Reference ID (Disease Ontology)
- ICD10CM:C25.0
- Cross Reference ID (Disease Ontology)
- ICD10CM:C25.1
- Cross Reference ID (Disease Ontology)
- ICD10CM:C25.2
- Cross Reference ID (Disease Ontology)
- ICD9CM:157.0
- Cross Reference ID (Disease Ontology)
- ICD9CM:157.1
- Cross Reference ID (Disease Ontology)
- ICD9CM:157.2
- Cross Reference ID (Disease Ontology)
- ICD9CM:157.8
- Cross Reference ID (Disease Ontology)
- KEGG:05212
- Cross Reference ID (Disease Ontology)
- MESH:D010190
- Cross Reference ID (Disease Ontology)
- NCI:C3305
- Cross Reference ID (Disease Ontology)
- ORDO:1333
- Cross Reference ID (Disease Ontology)
- ORDO:217074
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:126859007
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:187796007
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:93715005
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:93823001
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:94082003
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0030297
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0153458
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0153459
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0153460
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0153463